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Abstract
Aldosterone and corticosterone are the main mineralocorticoid and 
glucocorticoid products of the rat adrenal cortex. They share a common biosynthetic 
pathway until the final stage where the substrate deoxycorticosterone (DOC) is 
converted to either aldosterone or corticosterone by the actions of the enzymes 
aldosterone synthase (CYP11B2) or llp-hydroxylase (CYP11B1) respectively. 
These enzymes are the products of highly homologous genes whose expression, 
along with that of other components of the corticosteroidogenic pathway, was long 
thought to be confined to the adrenal cortex. In recent years, however, due to the 
advent of more sensitive molecular biological techniques, evidence has accumulated 
to suggest that this is not the case and that certain extra-adrenal tissues may be 
capable of autonomous aldosterone and corticosterone production.
In chapter 3, RT-PCR was used to detect transcripts from the CYP11B1 and 
CYP11B2 genes in a number of different tissue types. The transcription of genes 
encoding other components of corticosteroidogenesis, such as the side-chain 
cleavage enzyme and adrenodoxin, was also examined. O f the tissues examined, only 
brain tissue was found to contain transcripts from all these genes.
Chapter 4 describes attempts using an SDS-polyacrylamide gel electrophoresis 
and immunoblotting technique to show that these transcripts are translated within 
brain tissue to result in the enzymes themselves. This utilised two monoclonal 
antibodies raised against non-homologous regions of the rat aldosterone synthase and 
11 P-hydroxylase enzymes. However, no evidence o f translation in extra-adrenal 
tissue was obtained using this technique, despite the identification of a positive band 
corresponding to 11 p-hydroxylase in adrenal tissue fractions.
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In chapter 5, the same antibodies were used to detect aldosterone synthase and 
11 P-hydroxylase within extra-adrenal tissues by immunostaining methods. Using 
adrenal tissue sections, the two antibodies were found to be highly specific for their 
respective antigens and apparently free of the cross-reactivity which might be 
expected between such highly homologous enzymes. Positive staining was also 
produced in brain tissue, where the enzymes were found to colocalise within the 
hippocampus and the cerebellum. Although previously published work had 
established that steroidogenesis occurs in the glial cells of the central nervous 
system, strong positive staining within the Purkinje cells o f the cerebellum in this 
study presented strong evidence for neuronal expression. Rigorous control 
experiments confirmed the specificity of these results. Attempts to produce specific 
staining within heart tissue were unsuccessful.
Primary cultures of rat fetal hippocampal neurons permitted the study of 
CYP11B1 and CYP11B2 expression within a homogenous neuronal cell type. This 
work is described in chapter 6. CYP11B1 and CYP11B2 transcription and translation 
within these neuronal cells was demonstrated by the techniques used previously. In 
addition, the substrate DOC was incubated with the cells for 24-hour periods. Upon 
extraction and partial purification, the aldosterone and corticosterone content of the 
cell medium was measured by radioimmunoassay and shown to be significantly 
higher than that of control medium incubated in the absence of DOC.
In summary, this thesis provides compelling evidence of the production of 
aldosterone and corticosterone within the rat central nervous system. It also includes 
detailed information concerning the distribution of the aldosterone synthase and 11 p- 
hydroxylase enzymes that produce these steroids. Finally, it demonstrates that
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neuronal cells cultured from the fetal rat hippocampus are capable o f converting 
DOC into their respective products.
These findings could have profound implications for the diverse physiological 
processes that are regulated by corticosterone and aldosterone.
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Chapter 1
Corticosteroid Production In Adrenal And Extra-Adrenal Tissues: A Review
1.1 Introduction
The steroid hormones are among the most important primary regulators of 
metabolism. They act principally to switch the expression of genes on or off, thus 
regulating the synthesis of proteins, although other mechanisms of control have now 
been discovered. The estrogens, androgens and the corticosteroids were long 
assumed to be the exclusive products of specific endocrine glands from which they 
were secreted into the circulation to act at a distance on target organs. Exciting recent 
evidence now strongly suggests that they may also be produced and act locally in 
target organs. This raises the possibility that their synthesis may be controlled 
differently at these sites and that their effects may be qualitatively different. The 
implications for explaining disease processes and for treating them are clearly 
immense.
The corticosteroids are products of the adrenal cortex. The following review 
considers the evidence that they are synthesised and act locally in other organs, 
particularly the brain. In order to do this, a brief preliminary survey of their structure, 
synthesis and control in the adrenal cortex and their action in target organs is 
presented.
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1.2 Corticosteroid Biosynthesis
1.2.1 The corticosteroids
The common and systematic names of various steroids are listed in table 1.2.
The structures o f the more important steroids are shown in figure 1.2a. The
corticosteroid hormones are separated into mineralocorticoids (aldosterone, DOC) 
and glucocorticoids (cortisol, corticosterone). The mineralocorticoids cause the distal 
renal tubules and other ion-transporting epithelia, such as the large bowel and
salivary gland, to retain sodium in exchange for the loss of K+ and H+. The
glucocorticoids assist in the control of carbohydrate metabolism but they also have a 
significant effect on blood pressure regulation (see section 1.5.4). The production of 
the main mineralocorticoid, aldosterone, is confined to the adrenal zona glomerulosa. 
The zona fasciculata-reticularis is the source of the main glucocorticoid which in 
man is cortisol and in the rat is corticosterone.
1.2.2 Cholesterol translocation
Before steroidogenesis can proceed, cholesterol must first be delivered to the 
mitochondrion. Cholesterol may be synthesised from acetate de novo within the 
adrenal cortex, although the majority comes from cholesterol esters stored within 
intracellular pools. These pools are created by the endocytosis of circulatory 
lipoproteins, in particular low density lipoprotein (LDL) which, once internalised, 
release cholesterol esters into the cell. High density lipoprotein (HDL) is a primary 
source of cholesterol for steroidogenesis in rodents (Simpson et al. 1989). It is from 
such sources that the lipid droplets visible within the cells of the zona fasciculata- 
reticularis are created, and these must be mobilised for steroidogenesis. This is done
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by the enzyme cholesterol ester desmolase, which hydrolyses cholesterol esters in 
response to hormonal stimulation, mobilising free cholesterol for steroid synthesis.
Common Name Systematic Name
Cholesterol Cholest-5-en-3P-ol
Pregnenolone 3 p-Hydroxy-pregn-5-en-20-one
17-Hydroxypregnenolone 3 p, 17a-Dihydroxy-pregn-5-en-20-one
Dehydroepiandrosterone (DHEA) 3 p-Hydroxyandrost-5 -en-17-one
Progesterone Pregn-4-ene-3,20-dione
17-Hydroxyprogesterone 17a-Hydroxypregn-4-ene-3,20-dione
11-Deoxycorticosterone (DOC) 21 -Hydroxypregn-4-ene-3,20-dione
11-Deoxycortisol (S) 17a,21 -Dihydroxypregn-4-ene-3,20-dione
Cortisol (F) 11P, 17a ,21 -Trihydroxypregn-4-ene-3,20-dione
Cortisone (E) 17a,21 -Dihydroxypregn-4-ene-3,11,20-trione
Corticosterone (B) 11 p,21-Dihydroxypregn-4-ene-3,20-dione
11-Dehydrocorticosterone 21 -Hydroxypregn-4-ene-3,11,20-trione
18-Hydroxycorticosterone 
(18-OHB)
11 p,l 8,2 l-Trihydroxy-4-ene-3,20-dione
18-Hydroxydeoxycorticosterone 
(18-OHDOC)
18,21 -Dihydroxy-4-ene-3,20-dione
Aldosterone (Aldo)
11 P,21-Dihydroxy-3,20-doxopregn-4-en-18-al 
(as ll-»18-hemiacetal)
Table 1.2 Common and systematic names of adrenal steroids.
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HO
Cholesterol
HO
Pregnenolone Progesterone
11 -Deoxycorticosterone 
(DOC)
:h .o h
c h
Aldosterone
:h:Oh
r ' O H
Cortisol (F)
:h j o h
Corticosterone (B)
Figure 1.2a Steroid structures and common names.
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The rate-limiting step of steroidogenesis is the delivery of mobilised 
cholesterol to the side-chain cleavage enzyme (see section 1.2.4) on the inner 
mitochondrial membrane. A number of translocation systems have been identified, 
including sterol carrier protein 2 and the peripheral benzodiazepine receptor (PBR), 
but the most important involves the steroidogenic acute regulatory protein (StAR).
StAR is essential for efficient adrenal and gonadal steroidogenesis. Congenital 
lipoid adrenal hyperplasia (lipoid CAH), a condition especially common in Japanese 
and Korean populations, is caused by mutation of the StAR gene and results in the 
impairment or lethal absence of steroidogenesis (Miller, 1997). Targeted disruption 
of the StAR gene in rats results in a similar phenotype. Although the mechanism of 
StAR-mediated translocation is not fully understood, it appears to act on the outside 
of the mitochondrion. Despite having a mitochondrial targeting sequence, cleavage 
of this sequence from the protein does not affect steroidogenesis (Arakane et al. 
1998). StAR expression can be controlled in order to regulate steroidogenesis (see 
section 1.4).
1.2.3 Cytochrome P450 enzvmes
Corticosteroid hormones are synthesised from cholesterol by a series of 
enzyme-catalysed reactions, progressively shortening the side chain and adding 
substituents in a locus- and stereo-orientation-specific manner. These reactions occur 
in the mitochondria and the microsomes of the steroidogenic tissues, necessitating 
translocation between these two compartments (Miller, 1988).
Two types o f enzyme are involved: a hydroxysteroid dehydrogenase enzyme, 
bound to the endoplasmic reticulum, and the mixed function oxidases, or cytochrome 
P450 enzymes with which this work is principally concerned. They possess haem
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prosthetic groups and their apoprotein moieties all have molecular weights of around 
50,000. This protein consists of well-defined helical and p-pleated sheet regions 
arranged in such a way as to leave a cavity through which the substrate may bind to 
the catalytic site at the centre o f the molecule (von Wachenfeldt and Johnson, 1995). 
The widest sequence diversity is found within the substrate-binding regions of the 
cytochrome P450s, accounting for the great substrate specificity often demonstrated 
by these enzymes.
The overall reaction performed by the cytochrome P450s involves the 
enzyme’s insertion of one atom from molecular oxygen into the substrate; the other 
atom combines with hydrogen to form water:
NADPH + H+ + 0 2 + RH -> R—OH + H20  + NADP+
The complex pathway by which this is accomplished by the cytochrome is 
described by Dawson (1988). The reducing power for the reaction is derived from 
the nicotinamide adenine dinucleotide phosphate (NADPH) + H+ and is supplied to 
the cytochrome P450 enzymes through one of two electron transport systems, 
depending upon whether the cytochrome P450 in question is mitochondrial or 
microsomal. Mitochondrial systems (e.g. 11 p-hydroxylase) require the non-haem 
iron protein, adrenodoxin, while microsomal systems (e.g. 21-hydroxylase) use 
NADPH cytochrome P450 reductase to transfer electrons from NADPH to the 
enzyme (Kominami et al. 1984). This is summarised in figure 1.2b.
1.2.4 Biosynthetic pathways
The sequence of reactions which converts cholesterol to corticosteroids in the 
human adrenal cortex is summarised in figure 1.2c. The sequence in the rat adrenal 
cortex, which lacks 17a-hydroxylase, is shown in figure 1.2d.
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Side-chain cleavage enzyme (P450scc) This enzyme catalyses 20a-hydroxylation, 
22-hydroxylation and the cleavage of the cholesterol side-chain between carbons 20 
and 22 to yield isocaproic acid and pregnenolone. P450scc is the product of the 
CYP11A1 gene. It is a multisubunit protein bound to the inner mitochondrial 
membrane, possessing a single active site in contact with the membrane. Its low Vmax 
leads to an accumulation of reaction intermediates in the mitochondrion (Morisaki et 
al. 1980).
NADPH
NADP NADPH
Ar° NADP
FMN FAD 
Reductase
P-450 P-450
M itochondrial Microsomal
Figure 1.2b Electron transfer systems present in mitochondria and microsomes. 
In mitochondria, the FAD-containing adrenodoxin reductase binds adrenodoxin 
(Ar) and transfers to it electrons derived from NADPH. The reduced Ar forms a 
new complex with cytochrome P450 to which the steroid substrate (S) is bound. 
After reduction of P450, the oxidised Ar returns to the reductase. In 
microsomes, the FMN- and FAD-containing NADPH cytochrome P450 
reductase tranfers electrons from NADPH to cytochrome P450 (Kominami et al. 
1984).
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Figure 1.2c Corticosteroidogenic reactions in the human adrenal cortex.
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3 p-Hydroxy steroid dehydrogenase/isomerase (3P-HSD) Pregnenolone must pass 
into the smooth endoplasmic reticulum to be converted to progesterone by 3P-HSD. 
It is not a cytochrome P450 enzyme and has several isoforms whose expression is 
tissue-specific (Zhao et al. 1991). The enzyme is also able to convert 17a- 
hydroxypregnenolone to 17a-hydroxyprogesterone. The enzyme does not need 
adrenodoxin or NADPH cytochrome P450 reductase in order to function although 
the presence of certain phospholipids is required.
17a-Hydroxylase (P450cl7) Pregnenolone and progesterone may both undergo 
17a-hydroxylation to form 17a-hydroxypregnenolone and 17a-
hydroxyprogesterone, respectively. These reactions are performed by P450cl7, a 
microsomal cytochrome P450 enzyme. 17a-Hydroxypregnenolone can then be 
converted to 17a-hydroxyprogesterone by 3p -HSD (see above). 17a- 
Hydroxypregnenolone and 17a-hydroxyprogesterone are precursors for 
glucocorticoids. Alternatively, they may be converted to adrenal androgens by 
P450cl7’s 17,20-lyase activity. The zona glomerulosa contains no 17a-hydroxylase 
activity.
21-Hydroxylase (P450c21) This microsomal enzyme mediates the conversion of 
progesterone to 11-deoxycorticosterone (DOC) and 17a-hydroxyprogesterone to 11- 
deoxycortisol (S). DOC must be transported back to the mitochondrion for the 
subsequent reactions.
11 p-Hydroxylase (P45011p)The actions of P45011P and aldosterone synthase 
(P450aldo) were originally attributed to a single enzyme encoded by a single gene 
locus (Miller, 1987). This remains true o f the bovine, porcine and frog P45011P 
(Ogishima et al. 1989; Nonaka et al. 1991). However, in man, the rat and the mouse, 
the final stages of glucocorticoid and mineralocorticoid synthesis are performed by
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two different enzymes (Okamoto et al. 1995). P45011P catalyses the conversion of 
11-deoxycortisol to cortisol and 11-deoxycorticosterone to corticosterone. It is a 
mitochondrial cytochrome P450 found only in the zona fasciculata-reticularis 
(Cumow et al. 1991; Ogishima et al. 1992). It is this that limits glucocorticoid 
production to the inner regions of the adrenal cortex. P45011P can also catalyse the 
18- and 19-hydroxylations o f DOC, resulting in 18-OHDOC (18-hydroxy-ll- 
deoxycorticosterone) and 19-OHDOC (19-hydroxy-11-deoxycorticosterone), 
respectively as well as the conversion of corticosterone, to 18-OHB (18- 
hydroxycorticosterone) (Okamoto andNonaka, 1992).
Aldosterone synthase (P450aldo) In human subjects and the rat and mouse, DOC 
produced in the zona glomerulosa undergoes three reactions, all catalysed by 
P450aldo, to become aldosterone. The reactions occur in the sequence:
1) 11 p-hydroxylation to form corticosterone (as with P45011P in the rat zona 
fasciculata-reticularis).
2) 18-hydroxylation, producing 18-hydroxycorticosterone.
3) 18-oxidation, resulting in aldosterone.
It is probable that these reactions occur without intermediate release from the 
binding site. Structurally, aldosterone synthase is extremely similar to l lp -  
hydroxylase (see section 1.3) and its expression is restricted to the zona glomerulosa 
(Yabu et al. 1991; Vinson et al. 1995).
The next section will concentrate on the genes which encode aldosterone 
synthase and 11 P-hydroxylase.
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1.3 The CYP11B Genes
1.3.1 The hum an CYP11B genes
The human genome contains the genes CYP11B1 and CYP11B2 which encode 
the enzymes 11 (5-hydroxylase and aldosterone synthase, respectively (Chua et al. 
1987; Momet et al. 1989; Zhang and Miller, 1996). They are located in tandem on 
chromosome 8, approximately 40kb apart, with each gene spanning approximately 
7kb of genomic DNA. Their exon nucleotide sequences are 95% identical, with 
homology falling to 90% in the introns. The resulting enzymes are composed o f 503 
amino acids which share 93% identity (Kawamoto et al. 1992).
1.3.2 The ra t CYP11B genes
The rat possesses four CYP11B genes, all on chromosome 7 (Nomura et al. 
1993; Mukai et al. 1993). With the exception o f CYP11B4, where exon 3 and part of 
exon 4 have been deleted, all the genes comprise nine exons and eight introns (see 
figure 1.3a). CYP11B4 is thought to be a pseudogene.
<---------------------------------------- 6,000bp ------------------------------------- ►
Exon: 1 2  3 4  5 6 7 8 9
Figure 1.3a Exon-intron arrangem ents of the ra t CYP11B1 and CYP11B2 genes 
(not to scale)(Mukai et al. 1993).
CYP11B3 is transcribed in the zona fasciculata-reticularis o f the rat adrenal 
cortex for only a short period after birth. It can be detected in 18-day-old rats but not
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in adult or 2-day-old rats (Mellon et al. 1995). During this period, levels o f CYP11B3 
transcripts in the adrenal gland are higher than those of either CYP11B1 or 
CYP11B2. CYP11B3 transcription is regulated by adrenocorticotrophic hormone 
(ACTH) (see section 1.4.1) during this time. Mellon et a l  (1995) demonstrated that 
the enzyme resulting from CYP11B3, P450cllB3, possesses 18- and 11-hydroxylase 
activities. CYP11B3 transcript levels are known to be significantly higher in the 21- 
day-old spontaneously hypertensive rat (SHR) than in WKY animals o f the same age 
(Malee and Wu, 1999).
CYP11B1 and -B2 code for 11 p-hydroxylase and aldosterone synthase (see 
appendix 1), although the rat forms of these enzymes are smaller than those in man, 
each containing 499 amino acids. Whereas CYP11B1, -B3 and -B4 all share at least 
95% sequence identity, CYP11B2 has only 90% identity to the others throughout its 
coding region (Mukai et al. 1993). However, extensive regions o f difference occur 
only in exons 3, 4 and 5. At exon 5, CYP11B1 has only 65% nucleotide homology to 
CYP11B2, resulting in just 52% identity at the amino acid level. This presumably 
accounts for the differences in the resulting enzymes’ catalytic functions.
Studies of chimeric forms of the rat CYP11B1 and CYP11B2 genes have shown 
that exon 5 is essential for aldosterone synthase activity. If the hybrid form of these 
genes contains the first five exons o f CYP11B1 and the last four of CYP11B2, the 
expressed protein has 11 P-hydroxylase, but not 18-hydroxylase or 18-oxidase, 
activity (Zhou et al. 1994). Similar studies of the human forms of the genes showed 
that exons 5 and 6 o f CYP11B2 are essential for 18-hydroxylase and 18-oxidase 
activities. The alteration o f just two residues within these exons, from the CYP11B1 
to the CYP11B2 forms, is sufficient to restore the 18-hydroxylase and 18-oxidase 
activities (Cumow et al. 1997).
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1.3.3 The CYP11B gene promoters and transcription factors
The promoter or 5’-untranslated regions (5’-UTRs) of the rat CYP11BI and 
CYP11B2 genes share the least homology of all, which is unsurprising given the 
great differences in the transcriptional regulation of the two genes. For the first 500 
bases of the 5’-flanking regions, the CYP11B1 and CYP11B2 sequences are 50% 
homologous.
The promoter regions of all the CYP1 IB  genes investigated so far share six cis- 
elements which appear to be well conserved between species. These regions, first 
identified in the bovine CYP11B gene, were originally named Adi to Ad6 
(Morohashi et al. 1993). See figure 1.3b.
-400 -300 -200 -100
_____________1 w TATA |— ►
k )
Ad4 Ad3 Ad6 Ad5 Ad2 Adi 
(CRE)
Figure 1.3b Schematic diagram of the bovine CYP11B prom oter (M orohashi et 
al. 1993).
Despite the marked differences in the regulation of the bovine gene by 
comparison with the CYP11B1 and CYP11B2 genes of various other mammals, 
conserved sequences can be aligned with relative ease. Only Ad6 appears to have 
been poorly conserved, while the position of Ad5 has shifted upstream by about 
lOObp in the human, mouse and rat genes (Nomura et al. 1993). See figure 1.3c.
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Figure 1.3c Comparison of the 5’ upstream  regions of the CYP11B genes. 
Nucleotides are numbered relative to the first translated codon and conserved 
bases are shaded. Panel A shows the best alignment for A dl-4 . Panel B shows 
the best alignment for Ad5 (Nomura et al. 1993).
Some of the factors that bind these and other promoter sites are as follows:
The cAMP-responsive element-binding protein (CREB) Adi is now known to be 
a cAMP-responsive element (CRE), which has the consensus sequence 
TGACGTCA. CREs are to be found in many other genes whose transcription is also 
dependent on cyclic-AMP levels. The cAMP cascade activation is summarised 
below, and in figure 1.3d.
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1) An extracellular hormone binds to a transmembrane receptor, which is coupled 
to a guanine nucleotide-binding regulatory protein (G protein). G proteins exist in 
two forms: the stimulatory form (Gs) and the inhibitory form ( G j ) .  Here, hormone 
binding to the Gs protein causes it to bind GTP instead of GDP. This change 
stimulates adenylate cyclase activity, increasing intracellular cAMP production and 
thus activating cAMP-dependent protein kinase (PKA).
2) The PKA catalytic subunit enters the nucleus and phosphorylates transcription 
factors of the CREB/ATF1 (CRE-binding protein/Activating transcription factor-1) 
family.
3) Phosphorylation permits CREB also to bind the CREB binding protein (CBP) 
(Groussin and Bertherat, 1998). CBP may be a component of certain RNA 
polymerase II holoenzyme complexes so, when phosphorylated, CREB’s binding to 
the CRE DNA site, causes the transcriptional machinery to assemble at the start site 
(Montminy, 1997).
9 +CREB phosphorylation can also be regulated by CaM kinases via the Ca 
pathway (see section 1.4.2).
Steroidogenic factor 1 (SF-1) The Ad4 element confers tissue-specific cAMP 
responsiveness upon the bovine CYP11B promoter in the presence of the Adi (CRE) 
region. A nuclear hormone receptor subsequently purified from steroidogenic tissue, 
the Ad4 binding protein (Ad4BP), has since adopted the additional name 
steroidogenic factor 1 (SF-1). It binds the Ad4 and, less strongly, Ad5 sequences in a 
number of steroidogenic promoters from a variety of species, including rat, human 
and mouse, recognising the sequences CCAAGGTC and AGGTCA (Morohashi et 
al. 1992). SF-1 has been regarded as an orphan nuclear receptor as its ligand was
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unknown, although 25-, 26- and 27-hydroxycholesterols may fulfil this role (Lala et 
al. 1997; Bertherat, 1998).
It is clear that SF-1 is an important transcription factor, regulating the 
expression of genes for cytochrome P450s and StAR (Sandhoff et al. 1998). Little is 
known about its regulation.
Figure 1.3d The cAMP signalling pathway (Groussin and Bertherat, 1998).
Chicken ovalbumin upstream  prom oter-transcription factor-I (COUP-TF)
COUP-TF is an orphan receptor belonging to the steroid receptor superfamily. It was 
observed to be overexpressed in a nonfunctioning adrenocortical tumour, a DOC- 
producing adenoma and a tumour from a patient with Cushing’s syndrome but its 
levels were low in aldosterone-producing and corticosterone-producing adenomas 
(Shibata et al. 1998). COUP-TF may therefore be of importance in the regulation of
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steroidogenesis. The same study showed that CYP17 mRNA was low in those 
tumours that overexpressed COUP-TF, and vice versa. The CYP17 promoter has a 
COUP-TF binding site which overlaps an SF-1 site. Thus, the two transcription 
factors may compete for the same site, one acting as a repressor, the other as a 
promoter of gene transcription. The Ad5 region of the human CYP11B2 promoter has 
recently been shown to contain sites for SF-1, COUP-TF and one other unidentified 
protein (Clyne et al. 1999).
Activator protein-1 (AP-1) The Jun family of proteins (Jun, JunB, JunD) and Fos 
family of proteins (c-Fos, FosB, Fra-1, Fra-2) can homo- or heterodimerise in a 
variety of combinations to form the transcription factor called AP-1 which is 
associated with the regulation of CYP11B1 expression and appears to be responsible 
for 11 P-hydroxylase’s zonal distribution within the adrenal cortex (Mukai et al.
1995). The Jun/Fos composition of AP-1 may be important for the activation of 
CYP11B1 transcription in response to ACTH (see section 1.4.1) (Mukai et al. 1998). 
An SF-1 site is immediately adjacent to this AP-1 element but its presence is not 
required for CYP11B1 transcription. In the rat CYP11B2 promoter, the SF-1 site is 
conserved but the AP-1 site is not. The mechanism by which AP-1 achieves tissue- 
specific expression of CYP11B1 and the role of SF-1 at this site are still unclear.
Clearly, the factors which control gene expression must interact with these or 
as yet undiscovered sites in the promoter. While the control of extra-adrenal 
corticosteroidogenesis is not understood, control in the adrenal cortex has received 
intense scrutiny. This is the subject o f the next section.
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1.4 Regulation of corticosteroid secretion
The different physiological effects of the mineralocorticoids and the 
glucocorticoids requires that their secretion from the adrenal cortex is regulated 
separately. Detailed evidence from studies o f the rat adrenal (Oertle and Muller, 
1993) confirms that this is the case. Intra-adrenal storage of the corticosteroids is 
minimal. Control therefore operates at the level of corticosteroid synthesis and 
stimulation of zonal growth. The mechanisms include second messenger-activated 
protein activation which result in immediate -  i.e. acute -  stimulation of synthesis 
and secretion together with induction of the synthesis of new proteins such as growth 
factors. These latter proteins contribute to adrenocortical growth due to both 
hypertrophic and hyperplastic changes, a chronic response which increases overall 
adrenocortical capacity. A number o f factors are concerned with this control. Since 
several recent reviews are available, these factors are briefly summarised with 
particular attention to their modes of interaction with the genome.
1.4.1 Adrenocorticotrophic hormone (ACTH)
Glucocorticoid secretion by the zona fasciculata-reticularis is regulated almost 
exclusively by the hypothalamic-pituitary-adrenal axis. See figure 1.4a.
Hypophysectomy reduces glucocorticoid levels to 5 percent of basal values 
within two hours. This fall can be prevented by the administration o f ACTH (also 
known as corticotrophin), a peptide hormone secreted by the anterior pituitary 
(Vinson et al. 1992). ACTH’s precursor molecule, pro-opiomelanocortin (POMC), is 
synthesized within the corticotroph cells of the anterior pituitary and gives rise to a 
number of biologically active peptides, including ACTH, melanocyte-stimulating 
hormone and p-endorphin. ACTH is a single peptide chain of 39 residues, released
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from POMC by enzymatic cleavage. ACTH’s activity resides within the highly- 
conserved first 24 amino acids (Vinson et al. 1992).
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CRH
ANTERIOR PITUITARY 
ACTH
Figure 1.4a The hypothalamic-pituitary-adrenal (HPA) axis.
The secretion of ACTH from the anterior pituitary is pulsatile and obeys a 
circadian rhythm. In the rat, which is nocturnal, ACTH levels peak in the late 
afternoon. In human subjects, it peaks between 6-9a.m., with the lowest point being 
in the evening. ACTH secretion is also subject to stimulation by a variety of 
‘stresses’ such as physical and emotional stress, hypoglycaemia, hypotension, 
electric shock and surgical procedures which induce hypothalamic neurons to secrete 
corticotrophin releasing hormone (CRH) from the hypothalamus (see figure 1.4a). 
Arginine vasopressin (AVP) and certain neurotransmitters, such as epinephrine, also
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induce ACTH release. The increased corticosteroid production induced by ACTH 
acts on the hypothalamus and anterior pituitary to inhibit further CRH and ACTH 
secretion, respectively.
ACTH action on the zona fasciculata-reticularis ACTH’s primary action is to 
increase glucocorticoid secretion from the zona fasciculata-reticularis. It upregulates 
the expression of adrenodoxin, adrenodoxin reductase, P450scc, P450c21, P450cl7 
and P4501 lp , although the extent to which expression is increased is highly variable 
(e.g. a 14-fold increase in P450cl7 mRNA but a less than threefold increase in 
P450scc mRNA) (Waterman and Simpson, 1985; Raikhinstein and Hanukoglu, 1994; 
Engeland et al. 1997).
Each zona fasciculata cell possesses approximately 7200 high-affinity 
receptors, as well as some 630,000 low-affinity ACTH-binding sites (Gallo-Payet 
and Escher, 1985), but only a small receptor occupancy is required to obtain the 
maximal steroidogenic response. ACTH’s most important second messenger, cAMP, 
exerts its effects via protein kinase A (PKA) phosphorylation of CREB (see section
1.3.3 and figure 1.3d). It also phosphorylates cholesterol desmolase, increasing the 
levels of free cholesterol within the cell (Boyd et al. 1983). Human StAR protein 
possesses a PKA consensus phosphorylation site which, when phosphorylated, 
increases its host cell’s steroidogenic activity (Arakane et al. 1997). cAMP also 
increases transcription of the StAR gene (Kiriakidou et al. 1996; Ariyoshi et al. 
1998). This StAR response occurs in both the zona glomerulosa and zona fasciculata. 
The increase is apparently in two phases: an early stimulatory phase, presumably 
induced by modifications such as phosphorylation, and a more chronic effect which 
probably relies on induction of new StAR synthesis (LeHoux et al. 1998).
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Evidence suggests that the ACTH-mediated stimulation o f CYP11B1 
expression also involves AP-1 factors. An interesting mechanism has been suggested 
whereby ACTH stimulates changes in the Jun/Fos composition o f AP-1 by inducing 
the expression of certain members o f the Jun and Fos families (see section 1.3.3). 
Although these changes in composition do not affect A P -l’s DNA-binding affinity, 
they may alter its transcriptional activation capabilities (Mukai et al. 1998).
The intracellular Ca2+ concentration is also important to ACTH-stimulated 
glucocorticoid production. If  free calcium within the cell is chelated or the uptake of
calcium into the cells is prevented, then ACTH stimulation o f glucocorticoid
<21 •
production is impaired. An influx of extracellular Ca is required by ACTH to 
activate adenylate cyclase (Davies et al. 1985).
ACTH action on the zona glomerulosa It is surprising that zona glomerulosa cells 
possess far more ACTH-binding sites than zona fasciculata cells (65,000 high- 
affinity and approximately 1,000,000 low-affinity sites per glomerulosa cell) (Gallo- 
Payet and Escher, 1985). Initially, some of the confusion over ACTH’s actions in the 
outer region of the cortex was due to an inability to purify zona glomerulosa cells. 
Because of this, the rise in aldosterone observed upon acute ACTH infusion was 
attributed to contaminating zona fasciculata cells. However, in human subjects an 
acute increase in aldosterone secretion can be achieved by infusion o f ACTH, with a 
maximum response achieved after 15 minutes, as is the case with angiotensin II and 
potassium (see below), although aldosterone output falls below that of controls 
within 24 hours (Quinn and Williams, 1988). This aldosterone escape response is 
observed in many species. In the sheep, cells o f the zona glomerulosa adopt an 
intermediate glomerulosa/fasciculata phenotype after five days of ACTH 
administration. In the rat, CYP11B2 transcripts rise and then fall over a 24 hour
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period of ACTH infusion (Holland and Carr, 1993). It is therefore apparent that 
CYP11B2 transcription is not regulated by cAMP-dependent mechanisms alone. 
Vascular effects of ACTH ACTH causes a marked increase in blood flow through 
the adrenal gland, which has implications for the release of corticosteroids into the 
bloodstream. If this flow increase is prevented, the rise in corticosteroid secretion is 
significantly reduced. The response is observed even when steroidogenesis is 
inhibited, so it is unlikely that corticosteroids are responsible. Instead, it appears 
probable that it is caused by serotonin and histamine from mast cells within the 
adrenal capsule (Hinson et al. 1989; Vinson et al. 1992).
Chronic effects of ACTH The adrenal gland’s weight and blood content increase as 
a result o f chronic ACTH administration. These effects can be seen within 1-2 days. 
The response of individual steroidogenic genes to prolonged ACTH treatment is 
variable. Adrenodoxin, adrenodoxin reductase, P450scc, P450aldo and P450cl7 gene 
transcripts fall back to their basal levels after 48 hours (Holland and Carr, 1993; 
Raikhinstein and Hanukoglu, 1994). Transcripts for 11 P-hydroxylase, however, have 
been shown to remain elevated for at least four days, and may even be increasing 
throughout this period. This would be consistent with its unique regulatory 
mechanism utilising AP-1 (see section 1.3.3). In situ hybridisation work has shown 
that the inner fasciculata cells, which normally do not express CYP11B1, are 
recruited for 11 p-hydroxylase expression after long periods of stress or ACTH 
activation (Engeland et al. 1997). There is evidence to suggest that the fasciculata 
may also expand outward under such conditions, altering cells from a glomerulosa to 
a fasciculata phenotype, with all the morphological and biosynthetic alterations this 
implies (Vazir et al. 1981).
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1.4.2 Angiotensin II (A nglll
The most important stimulus to aldosterone secretion is an alteration in 
electrolyte and fluid levels. Restriction of dietary sodium causes hypertrophy o f the 
zona glomerulosa, increasing the adrenal cortex’s capacity for aldosterone secretion, 
while glucocorticoid levels remain unaffected. Reduced plasma sodium does not 
work directly on the cells of the zona glomerulosa. Instead, a number of factors are 
involved in modulating aldosterone secretion, including the renin-angiotensin system 
which is illustrated in figure 1.4b. Ang II is the major active product o f this system 
but the heptapeptide, Ang III, and the hexapeptide, Ang IV, have also received some 
attention (Semple and Morton, 1976; Peach et al. 1976).
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Figure 1.4b The renin-angiotensin system (RAS).
44
Angiotensin II action on adrenal cortex Angll receptors are found in two forms on 
the surface of adrenocortical cells: a high-affinity receptor, ATI, and a less 
numerous, lower affinity receptor, AT2, which is believed to be of less physiological 
importance (Matsusaka and Ichikawa, 1997). Two forms of ATI, ATI A and AT1B, 
are present in the rat. ATI is found in especially high levels on renin-producing cells, 
including juxtaglomerular cells, and may play a role in a negative feedback 
mechanism. ATI receptors are found in the inner adrenocortical regions, but they are 
most numerous in the zona glomerulosa where they mediate the Angll regulation of 
aldosterone secretion. Sodium depletion causes an increase in the concentration and 
affinity of Angll receptors, increasing the sensitivity of the adrenal cortex to Angll 
stimulation, and Angll has been reported to upregulate its own receptors. Chronic 
ACTH administration and dietary sodium loading have the opposite effect (Vinson et 
a l  1992).
Angll stimulates the transcription of CYP11B2 (Imai et al. 1992). It exerts its 
intracellular effects via membrane receptors. These are linked to a G protein system 
that generates the second messengers 1,2-diacylglycerol (DAG) and inositol 1,4,5- 
triphosphate (IP3) which activate protein kinases and release Ca2+ from intracellular
stores, respectively. See figure 1.4c.
2 _|_
Ca is released into the cytosol from the extracellular medium or from 
intracellular stores. Adrenal glomerulosa cells possess T-type and L-type voltage- 
operated Ca2+ channels at their surface which are activated by raised extracellular 
potassium levels (see section 1.4.3). Ca2+ entering into the cell via L-type channels 
passes freely into the cytosol, raising the cytosolic calcium ion concentration 
([Ca2+]jC). However, Ca2+ arriving through the T-type channels may be delivered
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directly to the mitochondrial matrix via a ‘pipeline’ (possibly part of the endoplasmic
• • • • 7+- •reticulum) without any apparent rise in [Ca ]c (Rossier, 1997).
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Figure 1.4c A model of intracellular calcium signalling (Rossier, 1997).
• t  i  • • 2 + 1  •Intracellular stores are rapidly depleted but the initial rise in [Ca ] jC is 
sufficient to activate calcium release-activated calcium (CRAC) channels in the 
membrane. The CRAC channels carry more Ca2+ to the mitochondrion while 
simultaneously replenishing intracellular Ca stores via the pipeline. CRAC 
channels also stimulate a specific adenylate cyclase to increase cAMP formation. 
DAG activates protein kinase C (PKC) which phosphorylates various proteins 
including the Ca2+/calmodulin-dependent protein kinases (CaM kinases) 
(Rasmussen, 1989).
2 +
The actions of Angll -  increased cAMP formation, Ca influx and the 
phosphorylation of CaM kinases -  are all of importance in aldosterone biosynthesis
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and are able to interact in complex ways to regulate transcription. For example, 
Angll and ACTH (acting through the cAMP pathway) can exert antagonistic effects 
over the transcription of fo s  and jun  genes which could account for the differential 
regulation of various steroidogenic genes by adrenocortical cells in response to these 
hormones (Viard et al. 1992). The cAMP and Ca2+ pathways can also converge to 
regulate CREB phosphorylation, cAMP acting through PKA (see section 1.3.3) and 
Ca2+ via the CaM kinases.
CaM kinases I, II and IV are able to interact with each other. CaM kinases I 
and IV are small enough to shuttle freely between the cytosol and nucleus. Their 
transcriptional activation is significantly upregulated by Ca2+/calmodulin-dependent 
protein kinase (CaMK kinase). The CaMK kinases probably link Ca2+ signals and 
CYP11B2 transcription (Clyne et al. 1997). CaM kinase II may also be involved in 
the regulatory phosphorylation of StAR (Arakane et al. 1997).
CaM kinases I and IV (but not CaM kinase II) can activate CREB and another 
protein of the same family, activating transcription factor-1 (ATF-1) (Sun et al.
1996). ATF-1 can heterodimerise with CREB and may, therefore, be able to mediate 
transcriptional activity through CRE sequences. ATF-1 is not responsive to PKA but 
is stimulated by raised [Ca2+]lc, suggesting that it may discriminate Ca2+ pathways 
from cAMP pathways (Heist and Schulman, 1998).
Studies of the human CYP11B2 promoter show that two elements are required 
for effective Ca -regulated transcription, one containing a CRE site and the other 
consisting of an SF-1 and COUP-TF site. These sites are also required for regulation 
of the same gene by cAMP, suggesting both mechanisms exploit the same site, 
although this does not explain the long-term differences in CYP11B2 expression by 
these two pathways (Clyne et al. 1997).
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Ca2+ is involved in so many intracellular pathways that one might wonder how 
the signal for a particular pathway is not engulfed by the signal for another. For this 
reason, the concept o f compartmentalisation of the cell Ca2+ was postulated. For 
example, the mitochondrial pipeline concentration might rise without affecting the
I
cytosolic concentration. There is evidence to support this idea. Nuclear [Ca ] is 
significantly higher than that o f the cytosol. High nuclear calcium is known to be 
necessary for CREB activation. Furthermore, the opening of CRAC channels, 
stimulated by the delivery of large amounts of Ca2+ to the mitochondrion, appears to 
be solely responsible for AngH’s modulation of the ACTH-induced rise in cAMP.
1.4.3 Potassium
Extracellular potassium is maintained within narrow limits. Slight rises in 
extracellular K+ concentration ([K+]0) stimulate aldosterone secretion and also raise 
the sensitivity o f the cortex to Angll, possibly through up-regulation o f ATI 
receptors (Matsusaka and Ichikawa, 1997). Also, higher [K+]0 triggers action 
potentials in glomerulosa T-type and L-type Ca2+ channels (Pardo et al. 1992; 
Rossier, 1997) allowing calcium influx. It is striking that manipulation of 
adrenocortical cell membrane potential is a key process in response to agonists. This 
is, of course, a principal mechanism in brain neurotransmission, a function which is 
modulated by corticosteroids (see section 1.7.4). Therefore, it is also a possible 
factor in the control o f neural corticosteroid synthesis (see section 1.8).
1.4.4 Neuroactive substances as agonists of adrenal function
ACTH, Angll and potassium are the most important regulators of 
corticosteroid secretion but other factors have effects.
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Low concentrations of serotonin (5-hydroxytryptamine or 5-HT) stimulate 
aldosterone secretion in vitro, via serotonin type 2 receptors on zona glomerulosa 
cells. Serotonin also increases corticosterone secretion rates (Hinson et al. 1989). 
The physiological significance o f this finding has been questioned, as serotonin in 
the blood would quickly be taken up by platelets. However, local release o f serotonin 
may occur from the mast cells of the adrenal capsule (see earlier).
The adrenal cortex has cholinergic innervation. Cholinergic stimulation 
increases aldosterone secretion in bovine adrenal cortex, possibly through the 
calcium second messenger system (Kojima et a l  1986). However, ovine adrenal 
glands transplanted to the neck work normally, their function unimpaired by the 
severing of the adrenal nerve connections.
Nerve terminals supplying the adrenal capsule and zona glomerulosa contain 
vasoactive intestinal peptide (VIP). VIP infusions into rats can stimulate 
aldosterone secretion, although only when ACTH is also present (Nussdorfer and 
Mazzocchi, 1987).
Vasopressin is found within the adrenal cortex and has stimulatory effects on 
aldosterone secretion in vivo. It is thought to act through the phosphatidylinositol 
second messenger system (Woodcock et al. 1986).
Somatostatin is a 14 residue peptide released by the hypothalamus which can 
inhibit the Angll-stimulated release o f aldosterone, probably by blocking Angll 
receptors. Somatostatin has no effect on basal or ACTH-stimulated steroidogenesis. 
Specific somatostatin receptors have been found in the zona glomerulosa of several 
species, including the rat, albeit only at very low concentrations (Srikant and Patel, 
1985).
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Catecholamines stimulate the glomerulosa, increasing cAMP production in 
vitro through p-adrenergic receptor binding (De Lean et al. 1984). Small amounts of 
catecholamines (adrenaline and noradrenaline) have been isolated from the adrenal 
cortex. These may derive from the adrenal medulla (Pratt et al. 1987).
Dopamine agonists inhibit aldosterone secretion, suggesting dopamine exerts 
some control over steroidogenesis in the zona glomerulosa (Carey et al. 1979). 
Dopamine antagonists such as metoclopramide increase aldosterone secretion. 
Dopamine receptors of the DA-1 and DA-2 subtypes have been identified in the zona 
glomerulosa, with DA-2 apparently inhibiting adenylate cyclase activity, thereby 
reducing aldosterone secretion (Missale et al. 1986). However, dopamine infusion 
studies performed on dogs suggest that the levels of dopamine required to affect 
aldosterone secretion by the zona glomerulosa would greatly exceed those 
encountered under physiological conditions (Ball et al. 1981).
In vitro studies suggest that type E prostaglandins stimulate aldosterone 
secretion while type F prostaglandins inhibit it or have no effect. Interpretation of 
studies in vivo is complicated because prostaglandins also influence renin secretion 
(Vinson et al. 1992).
In summary, the neuroactive substances which exert an effect on adrenal 
corticosteroid secretion are many and varied but their effects are small, often 
requiring high concentrations in vitro to elicit a response. These factors -  and even 
elevated [K+] -  are unable to sustain adrenocortical function in the absence o f either 
ACTH or Angll. However, given the neuroactive nature o f these substances, it is 
tempting to speculate that the true target o f their steroidogenic actions is not the 
adrenal gland but the brain.
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1.5 Corticosteroid Action And Effects
1.5.1 Classical corticosteroid action
The classical mechanism of corticosteroid action is summarised in figure 1.5a.
STEROID
RECEPTOR S T E R O ID -IN D U C E D
P R O T E INBinding
TranslationActivation \  
and >
Dimerization
m R N A
NUCLEUS
Transcription
Translocation
Figure 1.5a Classical steroid action
Corticosteroid receptors are intracellular. They are part of an oligomeric cluster 
comprising a number of other proteins such as heat shock proteins (see below), from 
which they dissociate on ligand binding. The corticosteroid receptors are ligand- 
dependent transcription factors. In the presence of ligand, they undergo structural 
changes which facilitate the transfer of the hormone-receptor complex to the nucleus 
where, as a homodimer, they bind chromatin at specific steroid response elements, 
modulating gene transcription. This modulation results in increased or decreased 
levels of certain mRNAs and, ultimately, proteins which account for the 
physiological effects of corticosteroids.
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1.5.2 The mineralocorticoid and glucocorticoid receptors
The amino acid sequences of the major steroid receptor superfamily members 
have been deduced in recent years, including those of the glucocorticoid receptor and 
the mineralocorticoid receptor. Remarkable sequence homology is evident 
throughout the superfamily, most especially in the 70 amino acid DNA-binding 
domain. This domain forms two ‘zinc fingers’, each composed of four cysteines 
coordinating one zinc atom. It is this region which specifically recognises the steroid 
response elements adjacent to target genes. It has been suggested that the first finger 
is responsible for sequence specificity while the second stabilises the binding o f the 
receptor to its response element. The C-terminal region of the receptors is also highly 
conserved and is required for high-affinity ligand binding. Conversely, the amino- 
terminal region is extremely variable and is thought to contribute to the diverse range 
of receptor specificities evident throughout the superfamily.
The glucocorticoid receptor (GR, also known as the type I receptor) is a 
monomer with a molecular weight of -94,000. In target organs it has a concentration 
of around 25,000 molecules per cell. The human form of the mineralocorticoid 
receptor (MR or type II receptor) has a molecular weight of 107,000. The two share 
57% amino acid identity in their ligand-binding domains and 94% identity in their 
DNA-binding domains (DBD) (Arriza et al. 1987). They share a similarly high DBD 
homology with the androgen receptors (AR) and progesterone receptors (PR). This is 
reflected in the fact that these receptors share a nuclear hormone response element 
(HRE) sequence, the consensus of which is AGAACAnnnTGTTCT. The fact that 
this sequence is an inverted palindrome means that members of the MR/GR/PR/AR 
subfamily can bind the HRE as homodimers or heterodimers (Funder, 1997).
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The MR and GR ligand-binding domains possess slight but significant 
differences in their binding specificities (Vinson et al. 1992). The two may be 
characterised on the basis o f the hierarchy of binding affinities they show for 
different steroids, as shown below:
MR: Aldosterone > DOC > Corticosterone > Cortisol > Dexamethasone 
GR: Dexamethasone > Corticosterone > Cortisol = Aldosterone
The cascade of events that follow ligand binding of GR is more complicated 
than the above summary would suggest. The ligand-free form of GR has a molecular 
mass of 310kDa and consists of a single hormone-binding GR, two molecules o f the 
90kDa heat shock protein (Hsp90) and several other proteins and polyunsaturated 
fatty acids. The Hsp90 is thought to stabilise the complex in the cytosol. Once bound 
by ligand, the multiprotein complex dissociates to leave a 90kDa complex (see 
figure 1.5b) and the DBD is exposed. The receptor is also now able to 
homodimerise. The complex may then be translocated into the nucleus by specific 
transport through the nuclear pore. Inside, ligand-bound GR can bind glucocorticoid 
responsive elements (GREs) on the chromatin with its Zn-fingers. Once bound to this 
element, the homodimer can interact with other dimers or transcription factors. The 
nature of this interaction at a particular regulatory unit will ultimately determine how 
the GR modulates gene transcription. Although the activation o f MR has not been 
investigated to the same extent as GR, it is likely to follow a similar activation 
mechanism.
In vitro systems have shown that GR and MR appear to have equivalent 
transcriptional activity when bound by an appropriate ligand. However, there are 
clear-cut differences in the actions o f GR and MR. HREs do not modulate gene 
transcription in isolation. Steroid receptors must interact with other factors bound
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nearby, and it is these interactions, unique to GR or MR, which are responsible for 
their specific effects (Robins et al. 1994).
Ligand binds receptor
/IJQ D G   ^ Dissociation o f  
r l o r y y  complex
->► a
Passage into nucleus
HRE
Gene transcription/ 
repression
Figure 1.5b Activation of the glucocorticoid receptor
The GR is vital for life. Mice whose GR gene is knocked out die from 
respiratory failure shortly after birth as their lungs fail to mature in the absence of 
certain surfactant proteins. Surprisingly, GRs which cannot dimerise are not lethal. 
GRdimdim mjce sui3j ected to a ‘knock-in’ mutation which prevents dimerisation 
survive. The GR monomer is unable to influence transcription either positively or 
negatively via its HRE sites but it is still capable of repressing the activity of AP-1 
regulated promoters, either through some direct effect on AP-1 itself, or through an 
interaction with some other component of the transcription initiation complex. This 
interaction of the GR monomer, which does not bind DNA, is sufficient to permit the 
survival of GRdirn/dim mice (Reichardt et al. 1998).
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1.5.3 Classical mineralocorticoid effects
The net effect of mineralocorticoid action is to increase extracellular volume 
and blood pressure. Steroids with mineralocorticoid activity, of which aldosterone is 
the most important example, increase the reabsorption of sodium in the distal tubules 
and cortical collecting ducts of the kidney and in secretory epithelia. Unsurprisingly, 
there is a dense population of MR at these locations. Although reabsorption o f less 
than 0.5% of the filtered sodium is aldosterone-dependent, this is essential for life; 
adrenalectomised animals must be given 0.9% NaCl as drinking fluid to compensate 
for these losses. The reabsorption of sodium by aldosterone-responsive epithelia is 
made possible by the asymmetric organisation of sodium pumps and amiloride- 
sensitive sodium channels in the cell membrane (see fig 1.5c).
Amiloride-sensitive 
Na+ channels if
Lumen Na*-Krz>+ Cell
Na7K+ ATPase
Interstitium
Figure 1.5c Sodium reabsorption by epithelial cells
Aldosterone drives this process by increasing the number o f open sodium 
channels in the apical membrane. This could be achieved by increasing the 
proportion o f time each channel is open, possibly by methylation, or by increasing 
the number o f channels in the membrane (White, 1994). Chronic exposure o f these 
cells to aldosterone increases the number of Na+/K+ ATPase molecules due to
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increased Na+ entering the cell (Petty et al. 1981). The amiloride-sensitive epithelial 
sodium channels (EnaC) is a hetero-oligomer. Increased Na+ transport is due to EnaC 
activation. Aldosterone may activate existing channels and induce the synthesis of 
new channels. Increased synthesis of the mRNAs coding for these Na+ pumps’ a  and 
P subunits has been detected (Verrey et al. 1987). However, activity is apparently 
unaffected in mice lacking MR. The specific role of aldosterone remains uncertain 
(Zennaro, 1998). Aldosterone also affects salt appetite in rats (see section 1.7.9).
Aldosterone is also of importance in the regulation o f potassium metabolism, 
determining the level of potassium excretion following an acute load, possibly 
through increased K+ channel activity at the apical membrane (Adam et al. 1987). 
The secretion of K+ and H* are closely linked. Mineralocorticoid excess results in 
hypokalemic alkalosis.
Excess aldosterone, as in primary hyperaldosteronism or Conn’s syndrome, 
results in hypokalaemia, high body sodium, increased plasma and extracellular fluid 
volumes and hypertension. Blood pressure is directly proportional to the exchangable 
sodium level (Fraser et al. 1989). In salt-sensitised rats, aldosterone increases blood 
pressure without necessarily increasing blood volume or cardiac output (Vinson et al. 
1992) suggesting that mineralocorticoids might act in combination with Na+ to 
increase vascular resistance by direct actions on the central nervous system (CNS) or 
on vascular smooth muscle.
1.5.4 Classical glucocorticoid effects
Glucocorticoids are involved in a much wider range o f physiological processes 
than the mineralocorticoids (Vinson et al. 1992). They affect the metabolism, 
protecting against glucose deprivation by increasing protein catabolism,
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glycogenesis, hepatic gluconeogenesis and lipolysis. They also affect the growth of 
skeletal muscle, kidney and liver tissue. Glucocorticoid action on bone can result in 
osteoporosis. They are anti-inflammatory and immunosuppressive, reducing 
lymphocyte numbers, inhibiting interleukin production and, at higher concentrations, 
suppressing antibody production. In the brain, glucocorticoids affect many aspects of 
behaviour, including mood and learning (see sections 1.7.6 and 1.7.8).
Finally, glucocorticoids affect blood pressure. 70-80% of individuals with 
glucocorticoid excess (i.e. Cushing’s syndrome) are hypertensive. Unlike 
mineralocorticoid hypertension, this is not sodium dependent and can be blocked 
only by specific GR antagonists. Although various mechanisms, such as increases in 
vascular tone and responsiveness to Angll, are involved in the development of 
glucocorticoid-induced hypertension, their relative contributions are not known 
(Mantero andBoscaro, 1992).
1.5.5 The llB-hvdroxvsteroid dehydrogenases
Although, as mentioned earlier, MR has ligand-binding properties which are 
different to those of GR, its affinities for cortisol, corticosterone and aldosterone in 
vitro are quite similar. Moreover, glucocorticoid concentrations are often 
approximately a thousand times those of mineralocorticoid. Therefore, the question 
arises of how some MR are able to selectively bind aldosterone in vivo? In some 
tissues, MR shows no preference for aldosterone over glucocorticoid -  i.e. it is 
‘nonselective’ -  but in the distal nephron and other aldosterone target tissues there is 
very definite selectivity. This is achieved not by receptor specificity but by complete 
destruction of cortisol in the tissue.
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These selective tissues possess abundant lip-hydroxysteroid dehydrogenase 
(llp-HSD). It is able to confer aldosterone selectivity by rapidly converting cortisol 
to cortisone and corticosterone to 11-dehydrocorticosterone which cannot bind MR. 
Aldosterone’s 11-18 hemiacetal bridge protects it from llp -H S D ’s action. See 
figure 1.5d.
:h 2o h :HjOh
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Cortisone
Figure 1.5d Actions of llp-hydroxysteroid dehydrogenase
There are two distinct forms of lip-HSD: type 1 (or lip-HSD-1) and type 2 
(lip-HSD-2) (Seckl, 1997). The two isozymes have been identified in a number of 
species including human, rat, sheep and rabbit. lip-HSD-1 is widespread and can 
catalyse both oxidation and reduction of the 11-oxygen function. It probably 
functions predominantly as a reductase in vivo. It is NADP(H)-dependent, with a 
high Km for glucocorticoids that renders it a poor protector of MR. Its activity is 
inhibited by several substances, including licorice and bile acids. It probably acts to
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maintain high cortisol concentration in tissues such as the liver. 11 p-HSD-2 has a 
much higher affinity for glucocorticoids and, unlike 11 P-HSD-1, is exclusively a 
dehydrogenase, requiring NAD as a cofactor. It is this form of 11 p-HSD that confers 
aldosterone specificity upon the MR of certain tissues. See figure 1.5e.
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Figure 1.5e lip-H SD  isozymes (Seckl, 1997).
1.5.6 Nongenomic corticosteroid effects
Genomic steroid hormone action requires a time lag or latent period of 1-2 
hours between steroid-receptor binding and the eventual alteration of protein levels 
within the target cell (Wehling, 1995). However, some responses occur between a 
few seconds and 2 minutes after steroid administration and cannot be blocked by 
inhibitors of DNA transcription or protein synthesis. These are therefore described as 
nongenomic. Some may occur through nonspecific interactions with proteins and/or
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membrane lipids at high steroid concentrations. However, others appear to be 
specific and require relatively low levels o f steroid (Wehling, 1997). For example, 
the generation of IP3 and DAG in rat vascular smooth cells (VSMC) is significantly 
stimulated by aldosterone within 30 seconds of its administration. Rapid increases in 
the activities of Na+/H+ countertransporters and Na+/K+ ATPases are also observed in 
these cells and in mononuclear leucocytes with very low aldosterone doses (Wehling, 
1995).
Plasma membrane aldosterone binding sites of very high affinity have been 
identified in rat VSMC and human mononuclear leukocytes (HML). They have a IQ 
of ~0.04nM, significantly higher than the IQ of 1.4nM for MR. IP3 generation 
responds rapidly to 0.1 nM aldosterone which is close to physiological levels of free 
aldosterone (Wehling, 1995). Unlabelled aldosterone (but not cortisol) inhibits the 
binding of 3H-aldosterone, so they appear to be free of the nonspecificity 
encountered in MR and GR (Wehling, 1997).
These discoveries have led to the proposal of a two-step model for steroid 
action, whereby steroids exert a number of initial rapid effects which then give way 
to the more familiar genomic mechanisms. Importantly, these two actions could, 
after the latency period, occur simultaneously within the cell, comodulating a range 
o f cellular steroid effects. Second messengers are known to be capable o f modulating 
steroid-induced transcription (Moyer et al. 1993). Thus, steroids could control their 
own genomic effects through their nongenomic actions (Wehling, 1997).
Rapid steroid effects are not restricted to aldosterone, nor are they confined to 
VSMC or HML cells. In fact, their most important role may be in the modulation of 
neurons.
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1.6 Extra-Adrenal Corticosteroid Synthesis.
Until relatively recently, the production of corticosteroids was assumed to be 
solely a function of the adrenal cortex. This view was challenged by the discovery of 
corticosteroidogenic enzymes in several other tissues. Considered together with the 
discovery that corticosteroids are also now known to affect the metabolism of 
‘nonclassical’ target tissues -  the effect of aldosterone on leucocytes (Wehling,
1995) is an example -  this raised the possibility of a novel paracrine or autocrine role 
for these hormones. To sustain the hypothesis that corticosteroids have such a role, it 
is essential to establish that they have special local effects, that the biosynthetic 
apparatus (see section 1.2) is present and active and that the tissue also possesses the 
specific receptors necessary to exert their effects. Moreover, since systemic 
corticosteroids are lipophilic and therefore have unimpeded access to all cells, local 
synthesis must either produce significantly higher local concentrations or be 
controlled locally and possibly differently from that o f the adrenal cortex. The next 
section summarises the evidence for ectopic production in the heart. This is followed 
by a more detailed review of the action, synthesis and roles of corticosteroids in the 
brain.
1.6.1 Production of adrenal corticosteroids in the cardiovascular system
Aldosterone rapidly alters the membrane permeability o f vascular smooth
94-muscle cells to Ca through changes in channel and transporter expression (see 
section 1.5.6). This permeability increases smooth muscle tone and responsiveness to 
various vasoconstrictive agents (Morano, 1992; Hatakeyama et al. 1994). Over 50 
years ago, Selye found that DOC and aldosterone promoted collagen deposition, thus 
enhancing vascular repair. He termed this effect remodelling and saw it as an
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adaptation to arterial hypertension (Slight et al. 1999). Since then, chronic 
aldosterone administration has been shown to stimulate collagen deposition by 
cardiac fibroblasts in the rat myocardium, thus increasing myocardial stiffness (Brilla 
and Weber, 1992; Funder, 1995). For fibrosis to develop, both increased sodium 
intake and chronic aldosterone administration are necessary. This aldosterone-salt 
induced fibrosis can be prevented by low doses of the mineralocorticoid receptor 
antagonist spironolactone, suggesting that collagen deposition results from a direct 
action on MRs, which are known to be present in myocardium and blood vessels 
(Komel, 1993). However, higher doses o f spironolactone are required to prevent the 
associated hypertension and LVH (Funder et al. 1988; Brilla et al. 1993). The action 
on MRs by aldosterone would require the presence of 11 P-HSD-2 within the heart; 
both 11 p-HSD-1 and 11 P-HSD-2 have been detected (Slight et al. 1996).
The induction of cardiac fibrosis may involve Angll acting through ATI 
receptors. The density of Angll receptors in the tissue is increased by aldosterone, an 
effect which is blocked by spironolactone (Robert et al. 1999). Angll has growth- 
promoting properties and could be responsible for the proliferation of myofibroblasts 
observed in fibrosis.
Evidence of local synthesis has been obtained by demonstrating gene 
transcription -  i.e. increased mRNA levels -  and by specific identification of the 
compounds themselves. Furthermore, this synthesis may be controlled locally but by 
conventional means. Several corticosteroidogenic enzyme genes are expressed within 
the cardiovascular system. CYP11B2 mRNA has been detected in endothelial and 
smooth muscle cells isolated from human pulmonary artery (Hatakeyama et al. 
1994). Using RT-PCR, expression in the same cells of the genes encoding MR, type I 
and II 3P-HSD, P450c21, P450cl8, but not P450scc or P4501 ip  was also established
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(Takeda et a l  1995; Hatakeyama et al. 1996). Human vascular endothelial cells 
(HVECs) derived from umbilical veins produce both CYP11B1 and CYP11B2 
mRNAs. In the same cell type, Angll and K+ increase CYP11B2 but not CYP11B1 
mRNA, while ACTH raises CYP11B1 mRNA but leaves CYP11B2 levels unaffected 
(Takeda et al. 1996). It is relevant here that biochemical and molecular biological 
techniques show that all components of the renin-angiotensin system are expressed in 
blood vessels and in the heart, undergoing regulation at an autocrine-paracrine level 
(Samani, 1994)
Perfusion of Wistar-Kyoto (WKY) rat mesenteric arteries yields detectable 
amounts of corticosterone and aldosterone, albeit at much lower levels than in the 
adrenal cortex or plasma (Takeda et al. 1995; Takeda et al. 1995). Aldosterone 
production in the rat mesenteric vessels is significantly reduced by quinapril (an 
ACE inhibitor), and significantly increased by elevated Angll or K+ levels. 
Corticosterone secretion is unaffected by quinapril.
3P-HSD activity was identified in the heart by Zhao et a l (1991). Using 
quantitative RT-PCR, Silvestre et a l  (1998) were able to detect CYP11B1 and 
CYP11B2 mRNA in the four cardiac chambers of the adult rat heart. CYP11B2 
mRNA was also present in 21-day-old but not adult rat hearts. Aldosterone and 
corticosterone were detectable in homogenised and in perfused rat hearts and their 
levels were increased by treating rats with Angll, ACTH, or a low sodium diet for a 
week. Similarly, ventricular CYP11B1 mRNA was increased by Angll or ACTH, 
while CYP11B2 mRNA was raised by Angll or low sodium diets (Silvestre et al.
1998). These increases were not directly related to changes in plasma levels and 
therefore suggest independent regulatory mechanisms. However, studies of the
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chronic regulation of the cardiac steroidogenic system conclude that it is controlled 
by pathways similar to those described in section 1.4 (Delcayre and Silvestre, 1999).
The physiological and clinical significance o f local synthesis is unknown. The 
importance of aldosterone levels in hypertension and cardiac disease is unambiguous 
(Pitt et al. 1999; Davies et al. 1999). However, there is as yet no direct evidence that 
local gene expression has a significant effect on the development of cardiac fibrosis. 
Nevertheless, rat myocardial aldosterone was found to have a concentration of 16nM, 
a level 17 times that found in the plasma. This difference may be due to slower 
aldosterone degradation in the heart than in the plasma, intracellular segregation or to 
local delivery of aldosterone to extracellular spaces rather than into the bloodstream 
(Delcayre and Silvestre, 1999). Regardless of the mechanism involved, this relatively 
high local aldosterone concentration in the heart suggests that it has some 
independent paracrine or autocrine action. A more general role in the etiology of 
hypertension is also possible. Stroke-prone spontaneously hypertensive rats (SHRSP) 
are a genetic model for human hypertension, although the precise cause of their 
hypertension is unknown. Aldosterone production and CYP11B2 levels were found 
to be significantly higher in the mesenteric arteries of young (2 week old) SHRSP 
rats compared to WKYs of the same age but these differences did not persist into 
later life (Takeda et al. 1997). However, the mRNA coding for the a i subunit of 
Na+/K+ ATPase, an aldosterone-responsive activity, was significantly higher in the 
mesenteric arteries of the SHRSP strain at all ages that were examined.
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1.7 Corticosteroid Action In The C entral Nervous System
The brain is a complex endocrine gland, producing unique hormones and 
controlling the production of others. It is also a target tissue for many hormones. 
Adrenocortical activity is modulated by the brain. The lipophilic properties of 
steroids ensure that their entry into the brain is not impeded by the blood-brain 
barrier and the brain is amply supplied with MR and GR. Abnormal brain function 
alters the rate and pattern o f adrenocortical activity; abnormal corticosteroid 
secretion profoundly affects mental processes. What effects do corticosteroids have 
on brain metabolism and how and where do they act? Are they synthesised locally? 
These questions are addressed in the following sections.
1.7.1 Structure and general functions of the brain.
The principal components of the rat brain are illustrated in figure 1.7a. The 
central nervous system (CNS) is composed of the brain and the spinal cord. The 
neurons consist of a cell body composing the grey matter and axons and dendrites, 
the former of which are enclosed in myelin sheaths and constitute the white matter. 
The neurons are interspersed with glial cells which, among other things, assist in 
feeding the neurons. The ventricles contain cerebrospinal fluid, a lymph-like filtrate 
of blood.
Regions of the brain can often be related to particular functions; the more 
complex functions require the integration of the functions of several regions. For 
example, the cerebellum coordinates movement and balance. Two region of 
particular relevance to corticosteroid action are the hypothalamus and the 
hippocampus. The hypothalamus, whose role in adrenal function has already been 
described (see section 1.4.1), is involved in the regulation of homeostatic processes,
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Figure 1.7a Diagrams of rat brain sections, a; sagittal brain section at -0.1mm 
from the midline; b: sagittal brain section at 3.4mm from the midline; c: detail 
of the CA1-3 cells of Ammon’s horn and the dentate gyrus within the 
hippocampus of a sagittal section at 3.4mm from the midline (Paxinos and 
W atson, 1998).
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modulating body temperature, hunger and thirst and is involved in behavioural 
responses such as the ‘fight or flight’ reaction. The limbic system comprises the 
amygdala and hippocampus and, in collaboration with the cerebral cortex, is 
associated with emotion and memory.
Other regions are important in the regulation o f blood pressure. The 
subcommissural organ (SCO), dorsal to the third ventricle, responds to aldosterone 
introduced to the cerebrospinal fluid, by increasing sodium excretion; this is the 
converse o f its renal action (Dundore et al. 1984). The AV3V area, comprising the 
anterior hypothalamic periventricular nuclei (PVN), the periventricular and median 
preoptic nuclei and the anterior wall of the third ventricle, integrates information on 
blood volume, thirst, sodium appetite and AVP secretion. Mineralocorticoid 
hypertension and the hypertensive response to salt in the Dahl salt-sensitive rat can 
be attenuated or prevented by destruction of this area (Gomez-Sanchez, 1997).
1.7.2 Central mineralocorticoid and glucocorticoid receptors
In the 1960s, it was observed that tritiated corticosterone administered to 
adrenalectomised (ADX) rats was retained in the hippocampus and other regions of 
the limbic forebrain (McEwen et al. 1968). The same was true o f other species, such 
as dogs and primates which secrete cortisol instead of corticosterone. The 
distribution of corticosteroid receptors within the brain has now been investigated in 
greater detail using radioligand binding, immunohistochemistry and in situ 
hybridisation (Reul and De Kloet, 1986; Agarwal et al. 1993; Roland et al. 1995). 
Such studies showed that GR is widely distributed but that it is especially abundant 
in the hippocampus, lateral septum, cerebral cortex, amygdala and the nucleus tractus 
solitarii. All cells within the CNS probably possess GR. However, in most regions
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there are fewer MR than GR, with high concentration limited to the hippocampus, 
the septum and the granular cells o f the cerebellum (Reul and De Kloet, 1986; 
Agarwal et al. 1993). Although GR and MR colocalise in the hippocampus, MR is 
distributed evenly throughout the region, while GR is most concentrated in the 
granule cells of the dentate gyrus (DG) and pyramidal cells o f CA1/2, decreasing in 
CA3/4. See figure 1.7a.
The rates o f GR and MR gene expression within the hippocampus are 
dependent on corticosteroid levels (O'Donnell and Meaney, 1994). However, such 
effects are short-lived. In the rat, hippocampal GR gene expression follows a diurnal 
rhythm, with its mRNA falling during the dark, active phase, when corticosterone is 
at its peak. Tests for a diurnal rhythm of hippocampal MR expression have tended to 
be inconclusive or contradictory. However, stress increases MR and GR 
concentrations in the hippocampus, although such changes are dependent on the type 
and duration of stress imposed. Whether this relates to steroid levels or to other 
stress-induced neuroactive substances is not known; the latter would appear more 
likely since, as noted above, GR mRNA is at its lowest when corticosterone levels 
peak. Monoamines such as methamphetamine reduce MR and GR mRNA levels. 
Antidepressant drugs, which potentiate monoaminergic transmission, increase MR 
and GR concentrations in the hippocampus (Seckl, 1996). Splice variants of MR 
(MRa, -P and -y) occur in the brain; all can be found within the rat hippocampus. 
M Ra is most concentrated in the CA1 and dentate gyrus while MRp and -y are found 
in the pyramidal layer. M Ra, but not MRp, is upregulated after adrenalectomy and 
this effect can be reversed by steroid administration. As both splice variants result in 
identical proteins, the significance o f this finding is unclear, although differences in
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their 5’-untranslated regions may result in different translation efficiencies or 
transcript stabilities (Kwak et al. 1993).
Confocal microscopy revealed that GR and MR are concentrated in 
approximately 1000 discrete domains within the nuclei of rat hippocampal CA1 
neurons. Some domains consist exclusively of GR or MR but a significant amount 
contain both (van Steensel et al. 1996). These heterogenous clusters present a 
possible way for MR and GR to interact and regulate gene expression in a 
coordinated manner. However, in other cell types, these receptor clusters may not 
colocalise with RNA polymerase II and are therefore unlikely to be involved in 
transcriptional activation (van Steensel et al. 1995). Nevertheless, these clusters have 
added significance to the discovery that GR and MR are capable o f forming 
heterodimers in vitro (Trapp et al. 1994) which has implications for the regulation of 
gene transcription in muscle and kidney cells and in certain regions of the brain, 
including the hippocampus, where MR and GR colocalise (Trapp and Holsboer,
1996).
1.7.3 llB-Hvdroxvsteroid dehydrogenases in the brain
The structure and mechanism of action of the GR and MR have been explained 
(see section 1.5.2) as has the the importance of MR colocalisation with 11 P-HSD-2 
in maintaining specificity. In the absence of this crucial enzyme, the MR will be 
occupied by glucocorticoid. Indeed, the MR has a higher affinity for glucocorticoid 
than the GR. This is important in some regions of the brain. 11 P-HSD-1 (see section 
1.5.5) may reduce or oxidise the 11-oxygen function although in tissues such as liver, 
it acts principally as a reductase.
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MR in the brain has been reported on several occasions to bind corticosterone 
and aldosterone in vivo with equal affinity, suggesting an absence of 11 P-HSD-2. 
However, individual regions differ. The hippocampus has low enzyme activity so 
one would expect its MR to be nonselective. The anterior hypothalamus and parts of 
the brain stem are selective and have been found to possess 11 P-HSD-2 transcripts 
(Zhou et al. 1995). 11 p-HSD activity has been demonstrated in homogenates o f rat 
cerebellum and hippocampus at levels o f 10-30% of those found in the kidney and 
liver (Moisan et al. 1990; Seckl, 1997). The lower levels o f 11 P-HSD-2 in certain 
regions of the thalamus may modulate the access o f glucocorticoids to receptors, 
perhaps affecting sensory processing, but such low levels o f 11 P-HSD-2 activity are 
difficult to detect against the more intense background o f 11 p-HSD-1 activity 
(Robson et al. 1998).
11 P-HSD-2 is present in some regions of the neonatal rat brain, particularly the 
thalamus and cerebellum. In the early weeks o f life, these levels fall sharply as the 
enzyme becomes localised to fewer cells which also tend to produce less enzyme. In 
the adult rat brain, high 11 p-HSD-2 expression is found only in the SCO, the 
ventromedial nucleus of the hypothalalmus (VMN), scattered cells within the 
amygdala and the nucleus of the solitary tract (NTS) (Robson et al. 1998). The high 
levels of 11 p-HSD-2 in the neonatal cerebellum and thalamus are thought to 
attenuate the neurotoxic effects of excess glucocorticoid rather than to confer MR 
selectivity on these regions, which possess little or no MR anyway.
The reversible form of the enzyme, 11 p-HSD-1 is also widespread in brain 
cells, more so in neurons than glia. Immunostaining has detected it in axons and 
dendrites, as well as within the cell body (Sakai et al. 1992). There has been much 
debate over whether brain 11 p-HSD-1 acts predominantly as a dehydrogenase or a
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reductase in vivo. High glucocorticoid levels predispose to neuronal death and, 
indeed, may be part of the mechanism of degeneration following hippocampal 
damage. Recent experiments used kainic acid, a nonspecific neurotoxin, which was 
administered to the rat hippocampus (Ajilore and Sapolsky, 1999). If reductase 
activity was predominant, the higher local corticosterone concentrations would be 
expected to exacerbate the neurotoxicity of kainic acid whereas dehydrogenase 
activity would tend to be protective. The authors concluded that reductase activity 
was predominant in the hippocampus. Its effect could be blocked by carbenoxolone.
1.7.4 Corticosteroids and brain function
In vivo studies o f corticosteroid action in the brain have followed one of two 
approaches. In intact animals, it can be assumed that the high-affinity MR is already 
substantially saturated by endogenous corticosteroids and that exogenous 
corticosteroids activate the GR. In adrenalectomised (ADX) animals, receptors will 
be unoccupied and MR- or GR-selective ligands can be used to distinguish GR- and 
MR-mediated physiological actions (Joels, 1997). Other in vitro studies have tested 
the neuronal activity in brain slices from animals pretreated with steroids by 
measuring ion fluxes and electrical activity.
Neuronal excitability
Like most cells, the neuron has a high intracellular K+ concentration and a low 
Na+ concentration, generated and sustained by the Na+-K+ ATPase pump. The axonal 
membrane is therefore polarised with the intracellular surface being negatively 
charged compared with the extracellular surface. Thus, in the quiescent axon, there 
exists a potential difference -  the resting potential -  of -60mV. A nerve impulse or 
action potential is generated by a progressive reversal of polarity -  i.e. depolarisation
71
-  along the axon (see figure 1.7b). This is followed rapidly by a Na+-K+ATPase- 
facilitated repolarisation. Factors which lower the resting potential will sensitise the 
neuron to produce an action potential; those which increase it (i.e. hyperpolarise the 
neuron) will desensitise it.
+35 — Action potential (spike)
a.
Threshold
- 5 0 - -
Resting potential
Resting
potential
0 3 4
Time (milliseconds)
Figure 1.7b Depolarisation of an axon membrane resulting in an action
potential.
Transmembrane ion fluxes are controlled by voltage-dependent sodium and 
potassium channels (VDSC and VDKC respectively). On arrival at the terminal 
synapse, the action potential operates voltage-dependent (VDCC) calcium channels 
which couple excitation to neurotransmitter release. Studies of the adult rat CA1 
hippocampal neurons show that changes in protein synthesis caused by MR- or GR- 
mediated transcription alter the membrane properties of neurons, affecting ion 
channel function and receptor-mediated neurotransmitter responses.
Studies of corticosteroid effects on neuronal excitability have been performed 
in the spinal cord, hypothalamus and hippocampus. Only the hippocampus shows
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any effects with the distinctive time-lag that can be attributed to classical GR or MR 
action (Joels, 1997). Corticosteroids do not alter rat CA1 hippocampal resting 
membrane potentials and membrane resistances under basal conditions but only 
when the cells are hyperpolarised or depolarised. This suggests that corticosteroids 
have a homeostatic role in the brain (De Kloet et al. 1998).
Corticosteroids affect the inwardly-rectifying potassium current, 7q, in adult rat 
CA1 neurons, which is a device activated by very negative membrane potentials to 
prevent strong hyperpolarisation. The current is small when recorded 1-3 hours after 
predominant MR activation but increases when GRs are also occupied. Activation of 
GRs alone does not induce the large response, showing that cooperativity between 
MR and GR is necessary. This effect is known to require protein synthesis (Karst et 
al. 1993).
Depolarisation of hippocampal neurons induces a short burst of action 
potentials, during which there is considerable calcium influx. After prolonged 
stimulation, the cell ceases firing due to the activation of calcium-dependent K+ 
channels and consequent K+ efflux. This is called accommodation, and prevents the 
transmission of further excitatory signals. When the depolarising stimulus ceases, 
this K conductance ( / a h p )  is slowly deactivated leading to a brief lowering of 
membrane potential termed the afterhyperpolarisation (AHP) (see figure 1.7c).
The predominant occupation of MRs (i.e. at low glucocorticoid levels) reduces 
accommodation and the amplitude of AHP, indicating that calcium-dependent K+ 
conductance is suppressed. When GR is also occupied (i.e. at higher agonist 
concentrations), accommodation is enhanced as well as the amplitude and duration of 
AHP; calcium current amplitudes (7ca) are increased considerably (Joels and De 
Kloet, 1989; Joels and De Kloet, 1990). ADX animals have elevated 7ca and AHP
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responses intermediate to those found in MR and MR+GR occupation (see figure 
1.7d) (Karst et al. 1994). These effects take at least an hour to develop and can be 
prevented by the inhibition of protein synthesis (Karst and Joels, 1991). The 
mechanism of action, which has yet to be resolved, may involve a direct effect on 
calcium-dependent K+ channels, or an alteration in the calcium availability within the 
cell through factors such as Ca-influx, local intracellular buffering and calcium 
efflux from the cell.
To summarise, hippocampal output is maintained at a relatively high tone when 
MRs are predominantly activated, and is reduced when GRs are also activated.
accommodation afterhyperpolarization
 I I___________
activation of Iahp deactivation of Iahp
Figure 1.7c Accommodation and afterhyperpolarisation in a rat CA1 
hippocampal neuron (Joels, 1997).
Neurotransmitters
Neurotransmitters are released, usually from granules in the neuron terminus, 
into the synaptic spaces where they interact with specific postsynaptic receptors to 
propagate the nerve impulse or to institute processes such as secretion or muscle 
contraction. Corticosteroids affect the components of these systems also. The
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principal neurotransmitter systems are discussed individually below and their effects 
in combination with corticosteroids are summarised in table 1.7.
Occupied
Receptors
Transmitter Action Consequence
mACh Less depolarisation Less modulatory
5HT1A Less binding/hyperpolarisation input
MR
EPSP/FP Stable with repeated stimulation Stable amino acid
IPSP Stable with repeated stimulation transmission
AHP Less accommodation/AHP
Neuroprotection
Ca Less influx
mACh More depolarisation
5HT1A More synthesis and turnover; 
hyperpolarisation restored
NA Less cAMP; more accommodation Initial reduction in
MR + GR EPSP/FP
Attenuated with repeated 
stimulation; more free glutamate
excitability
sIPSP Decreased
AHP More accommodation/AHP
Ca More influx, less extrusion Delayed increase 
in vulnerability to 
neurodegenerationGlucose Less uptake/breakdown
Table 1.7 Effects of predominant MR or MR+GR occupation in combination
with neurotransmitters in hippocampal subfields. MR activation stabilises 
excitability in the CA1 area and protects neuronal integrity in the dentate gyrus. 
In the short-term, GR-mediated actions reduce local excitability but become 
damaging over a longer timescale (Joels and De Kloet, 1994).
Glutamate Glutamate has three types o f receptor, each named after their preferred 
agonists: A-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazole- 
proprionic acid (AMPA) and kainate (KA). They are ionotropic i.e. they contain a 
cation channel. Glutamate causes the channel to open, thus depolarising the cell
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towards its action potential-firing threshold. Therefore, glutamate is an excitatory 
peptide.
Treatment of ADX rats with high corticosterone doses increases brain basal 
and stimulated extracellular glutamate levels (Stein-Behrens et al. 1992). This could 
be due to increased release o f glutamate or to decreased uptake by neurons and glia. 
In contrast to skeletal muscle (Max et al. 1988), glutamate synthetase synthesis is not 
regulated by corticosteroids in the brain (Tombaugh and Sapolsky, 1990).
Extracellular recording o f excitatory postsynaptic potentials (EPSPs) can be 
performed on a group o f cells, where the number of cells generating an action 
potential determines the amplitude o f the so-called population spike. Predominant 
MR activation (and GR antagonism) is associated with larger population spikes. 
Occupation of GRs as well as MRs sharply reduces the population spike upon 
repeated stimulation. This effect is enhanced by elevated extracellular calcium 
concentrations, indicating that it is at least partly due to increased Ca-influx. In ADX 
animals, this population spike response is also attenuated, indicating that the dose- 
response relationship for corticosterone-mediated effects on glutamate transmission 
follows an inverted U-shape (Joels and De Kloet, 1994). Response to GR agonists 
usually occurs within 20 minutes which is rapid for a gene-mediated event. However, 
rapid responses to steroid which require mRNA and protein synthesis that occur 
within 30 minutes have been described (Wehling, 1995). The effects persist for less 
than an hour, suggesting rapid turnover.
y-Aminobutyric acid (GABA) This transmitter system is inhibitory. Synaptic 
stimulation of the CA1 hippocampal area induces an EPSP followed by a sequence 
of fast inhibitory postsynaptic potentials (flPSPs) and slow inhibitory postsynaptic 
potentials (sIPSPs). GABA mediates fast inhibition through its ionotropic GABAa
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and G A B A c  receptors which admit negative ions -  mainly Cl" -  but not positive 
ones, thus holding the membrane potential at a resting or even hyperpolarised value 
and making depolarisation of the cell more difficult. GABAa receptors are to be 
found on neurons and glial cells. They also bind drugs such as benzodiazepines, 
barbiturates and certain steroids which compete with G A B A  and reduce the 
proportion of time that its ion channel is open. GABAa receptors mediate fast 
inhibitory postsynaptic potentials (flPSPs), which are not greatly affected by changes 
in MR/GR occupation, although very high corticosterone concentrations depress 
inhibitory responses to G A B A  (De Kloet et al. 1998). Slow inhibitory postsynaptic 
potentials (sIPSPs) are mediated through GABAb receptors which are affected by 
steroids. Unlike GABAa and G A B A c ,  GABAb is linked, through a G-protein, to 
potassium and calcium channels. Repeated stimulation of rat hippocampal CA1 
pyramidal neurons results in a slow decline in the GABAb receptor-mediated IPSP. 
In ADX rats and at low agonist doses where predominantly MR are occupied, the 
amplitude of the sIPSP remained more stable. At higher doses where MR and GR are 
both occupied, there is a gradual decline in sIPSP. This mirrors the U-shaped dose- 
response observed with glutamate-mediated EPSPs. The difference between steroid 
modulation of flPSP and sIPSP would appear to rule out a steroid-mediated 
reduction in G A B A  release, except possibly at very high steroid concentrations.
To summarise, where MRs are predominantly activated, both excitatory and 
inhibitory outputs are stable. When GRs also become occupied, excitatory 
transmission, and therefore CA1 hippocampal output, is reduced. At higher steroid 
concentrations, inhibitory mechanisms are also impaired. Therefore, ionic 
conductances and the responsiveness o f transmitters may vary throughout the day
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and after stress due to the changing levels of circulating corticosteroid (Joels et al. 
1994).
Noradrenaline (NA) NA can cause increased excitability within the CA1 
hippocampal area. This effect is achieved via p-adrenergic receptors and cAMP, 
resulting in the blockage of the slow calcium-dependent potassium conductance and 
thus suppressing AHP and accommodation. The occupation of GRs (high 
corticosterone levels) reduces this effect, after an hour’s delay (Joels and De Kloet, 
1989). The effect of NA is inversely related to the initial plasma corticosterone 
concentration (Joels et al. 1991). The accommodation-suppressing effect of NA is 
even more pronounced in ADX animals (Joels and De Kloet, 1994). In addition, mild 
glucocorticoid excess has been reported to increase pressor sensitivity to 
noradrenaline in the rat (Russo et al. 1990) and in man (Whitworth et al. 1986). 
Dopamine (DA) Corticosteroids increase DA turnover observed in mouse and rat 
brain but these effects are transient. Adrenalectomy causes decreases in the number 
of DA receptors in certain regions of the brain and this effect can be reversed by the 
administration o f dexamethasone (Biron et al. 1992).
Acetylcholine (ACh) Two classes of membrane receptor are triggered by 
acetylcholine, the nicotinic (nACh) and the muscarinic ACh receptors (mACh). High 
chronic corticosterone treatment has been reported to decrease nACh binding 
strength in mouse brain, while chronic stress increases mACh binding strength in cell 
preparations from rat hippocampus. In CA1 neurons, small postsynaptic 
depolarisations induced by the cholinergic analogue carbachol (CCh) acting through 
mAch are observed during predominant MR activation; additional GR activation 
significantly increases this CCh-induced depolarisation. However, these steroid 
effects are probably of little consequence when compared with other CCh actions in
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the CA1, such as the evocation of EPSPs and IPSPs, which are unaffected by steroids 
(Joels and De Kloet, 1994; Hesen and Joels, 1996).
Serotonin (5HT) The effects of corticosteroids upon the serotonergic system are 
more pronounced. Tryptophan is actively transported into the brain and converted by 
tryptophan hydroxylase (TPH) into 5-hydroxytryptophan, the rate-limiting step in 
serotonin formation. It is then converted to 5-hydroxytryptamine (5HT or serotonin) 
by amino acid decarboxylase and stored in vesicles at nerve terminals. Serotonin 
transporters located on serotonergic nerve terminals remove free 5HT from the 
synapse, catabolising and excreting it. Most 5HT-containing cell bodies are found in 
the two raphe nuclei of the brainstem. The effects on the raphe-hippocampal 5HT 
system, which sends ascending projections from the median raphe into the 
hippocampus, septum, hypothalamus and amygdala will be described here. Fourteen 
mammalian 5HT receptor subtypes have been identified thus far, comprising ligand- 
gated ion channels, neurotransmitter transporters and G protein-coupled receptors. 
Each subtype has its own distinctive distribution and corticosteroids regulate their 
expression. The 5HT ia receptor is the best characterised and is distributed 
throughout the brain, with particularly high levels in the hippocampus, 
hypothalamus, septum, amygdala and dorsal raphe. This distribution correlates well 
with that of GR (Reul and De Kloet, 1986; McKittrick and McEwen, 1996). The 
5HTib receptor is far less abundant and is found mainly in the hippocampus, 
striatum, cerebellum and raphe. The 5HTi receptors are coupled to G proteins, 
sharing an ability to inhibit adenylate cyclase and a very high affinity for 5HT. 
5HTia and 5HTib are both upregulated within the dentate gyrus following 
adrenalectomy; 5HTiA also increases in CA2-4 regions o f the hippocampus.
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Physiological doses of corticosterone reverse this effect (Mendelson and McEwen, 
1992).
Steroids also affect 5HT synthesis through TPH. They do not affect enzyme 
quantity but have a permissive effect on TPH activity, with ADX reducing and 
corticosterone enhancing it (Azmitia and McEwen, 1969). Dexamethasone 
administered to ADX rats, on the other hand, reduces 5HT turnover. This difference 
between corticosterone and dexamethasone treatments suggests that MR and GR 
may have different effects, with MR stimulating and GR inhibiting 5HT synthesis. 
This would result in an inverted U-shaped dose-response to corticosterone like that 
observed in glutamate transmission (Joels and De Kloet, 1994).
The 5HTja receptor-mediated hyperpolarisation of the membrane is the 
principal effect of 5HT in CA1 hippocampal neurons. Predominant MR occupation 
suppresses this hyperpolarisation by comparison with ADX or adrenally intact 
animals. Additional GR occupation increases the amplitude of the hyperpolarisation, 
causing marked suppression of excitatory transmission in the CA1 region after a 
delay of approximately 2 hours (Joels and De Kloet, 1992). The timescale, together 
with the fact that corticosteroids do not have this effect in the presence of protein 
synthesis inhibitors, supports a genomic mechanism of steroid action (Karst and 
Joels, 1991).
Thus, in general, predominant MR activation tends to evoke small effects on 
neurotransmitter function while simultaneous MR+GR activation usually results in 
large effects. Only the effect on noradrenaline action, which is suppressed by high 
occupation of GR, defies this general trend. The range o f corticosteroid receptor 
occupancies, from predominant MR to MR+GR, represents the range encountered 
due to circadian rhythmicity and stress induction of corticosteroids. In more extreme
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cases, as represented by adrenalectomised animals or, at the other end of the scale, 
application of very high amounts of corticosteroids to normal animals (or therapeutic 
doses in man), responses are explicable by MR+GR occupation, thus resulting in the 
distinctive inverted U-shape referred to previously. This is illustrated in figure 1.7d.
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Figure 1.7d Plot of various CA1 neuron responses in vitro under varying 
conditions of MR and GR occupation, resulting in a U-shaped dose-response 
relationship (Joels and De Kloet, 1994).
1.7.5 Central effects of corticosteroid deficiency and excess
Predominant MR activation, which would occur during the circadian trough of 
corticosteroid levels, tends to promote excitability within the CA1, thus resulting in 
excitatory hippocampal output from steady inputs. The GR-mediated actions reduce 
excitablility within the CA1 region. This may be of importance in returning the brain
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to normal after a stressful experience. Sustained high levels of corticosteroids can be 
harmful.
Corticosteroid excess and deficiency both result in structural changes to 
hippocampal neurons. Within three days of adrenalectomy, the degeneration of 
mature granule cells in the adult rat dentate gyrus -  but not the other hippocampal 
fields -  can be seen (Gould et al. 1990). This degranulation can be prevented by 
exogenous corticosterone or aldosterone indicating that MR occupation alone is 
sufficient to protect the granule cells but that basal secretion of corticosterone 
normally performs this function. The granule cells are, along with the olfactory bulb, 
the only region of the adult brain to continually replace neurons in a behaviorally- 
regulated manner. Adrenalectomy not only increases the rate of degeneration within 
the dentate gyrus, but also the density o f new neurons and glia (Gould et al. 1992).
It now appears that NMDA glutamate receptors (see section 1.7.4) and 
corticosteroids interact to regulate neuronal death and neurogenesis in the adult 
dentate gyrus. By enhancing excitatory input through the hippocampus, MR 
activation may maintain the balance between cell birth and death in the region. 
Occupation of MRs may not, therefore, directly affect neurons, but stimulate the 
excitatory transmission required by the cells for their survival. This theory is 
supported by the fact that new neurons which appear in the dentate gyrus after 
adrenalectomy do not possess MR or GR (De Kloet et al. 1998).
Chronically high corticosteroid levels also lead to hippocampal 
neurodegeneration or suppression of neurogenesis, most particularly in the CA3 
region, where the apical dendrites of CA3 pyramidal neurons atrophy. The CA1 and 
dentate fields are also vulnerable (Arbel et al. 1994). These effects can be mimicked 
by subjecting rats to restraint stress. Similar effects have been observed in some
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studies o f primates and man (Reagan and McEwen, 1997) but not in others 
(Leverenz et al. 1999).
These neurodegenerative effects may be mediated by the NMDA receptors. 
Blockage of the NMDA receptor prevents dendritic atrophy (Magarinos and 
McEwen, 1995). Also, the gene for glutamine synthetase contains a HRE and is 
upregulated by chronically high corticosterone levels, thus depleting the cell of the 
glutamate required for synaptic transmission.
Short-term GR activation decreases responsiveness to glutamate and reduces 
excitability by the activation of Ca-dependent K conductances (see section 1.7.4), 
which may produce a beneficial damping effect in stressful situations. Chronic 
activation may, however, substantially raise intracellular Ca levels, thus increasing 
responsiveness. CA3 neurons are thought to lack the calcium-buffering capabilities 
of other hippocampal neurons due to the absence of calcium-binding proteins such as 
calbindin-D28k and parvalbumin (Sloviter et al. 1993).
The turnover o f hippocampal neurons in adult life is due to the involvement of 
hippocampal function in spatial learning and memory. The more an animal requires a 
knowledge and memory of large spaces, the greater is its hippocampal volume. In 
mice, an enriched environment enlarges the dentate gyrus volume by stimulating 
neuronal survival but leaving neurogenesis unaffected. In subsequent tests, those 
mice with greater dentate gyrus volume performed better at certain spatial learning 
tasks (Kempermann et al. 1997). Similarly, chronically-stressed tree shrews have 
impaired spatial learning and memory, although whether this is due to dendritic 
atrophy of CA3 or to reduced dentate gyrus neurogenesis is unclear (McEwen,
1999). Regardless of this, the balance between neuronal apoptosis and neurogenesis, 
in which corticosteroids play a part, is clearly of importance.
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1.7.6 Long-term potentiation and memory
Stressful experiences and steroid hormones produce short-term deficits in 
episodic and spatial memory, both in animal models and in man. Corticosteroids 
have been implicated in these effects which are consistent with the modulation of 
long-term potentiation (LTP), where the same information is repeatedly passed down 
a particular neuronal pathway. It has often been linked to memory formation. NMDA 
receptors and calcium influx are required for its induction. Corticosterone 
potentiation within the CA1 region is also found to follow an inverted-U dose- 
response relationship, with potentiation strongest in animals with intermediate levels 
of corticosterone, corresponding to predominant MR occupation. A similar effect 
occurs in the dentate gyrus. LTP is attenuated in the CA1 region o f animals subjected 
to novel environments or psychological stress, which would increase corticosterone 
levels (Joels, 1997). However, no link could be seen between LTP and diurnal 
corticosterone rhythm in intact rats.
The neuronal cell adhesion molecules, PSA-NCAM, are associated with the 
maturation of newborn granule cells and with LTP. PSA-NCAM expression is 
increased within the hippocampus of ADX rats and can be suppressed by 
corticosterone. Thus, PSA-NCAM could contribute to the stress- and age-related 
effects of corticosteroids on the hippocampus (Rodriguez et al. 1998).
1.7.7 Central corticosteroids and the hvpothalamic-pituitarv-adrenal axis
The actions of corticosteroids on the hypothalamic-pituitary-adrenal (HPA) 
axis are summarised in figure 1.7e.
Corticosteroids exert a negative feedback effect on the HPA axis (see section 
1.4.1) via GR in the neurons of the hypothalamic paraventricular nucleus (PVN) and
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the anterior pituitary gland. In addition, stress and corticosteroids can convey 
excitatory inputs to the PVN via GR in the brain stem. The PVN also receives 
excitatory and inhibitory information from the suprachiasmatic nucleus (SCN), an 
effect which is modulated by GR in the SCN according to a circadian rhythm. 
Finally, GABA-ergic neurons exert an influence over the PVN through both MR and 
GR in the hippocampus and the amygdala (De Kloet et al. 1998).
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Figure 1.7e Corticosteroid modulation of the HPA axis (De Kloet et al. 1998).
The amygdala, which is involved in anxiety and fear responses, secretes CRH. 
In contrast to the PVN, this is stimulated by corticosteroids. The overall effect of the 
amygdala appears to be stimulatory.
The hippocampus exerts an inhibitory influence on the activity of the HPA 
axis, with dorsal hippocampectomy increasing basal activity, particularly at the
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circadian trough (Herman et al. 1989). Administration o f small doses of 
corticosterone to the dorsal hippocampus suppresses ADX-induced rises in ACTH 
via MRs which allow corticosterone to maintain the basal HPA activity (Kovacs and 
Makara, 1988) and maintain hippocampal excitability. However, at higher doses of 
corticosterone, GRs are activated and suppress this output. This GR effect disinhibits 
the GABA-ergic influence o f the hippocampus over PVN neurons, stimulating the 
release of CRH and ACTH. Therefore, HPA regulation is critically regulated by the 
balance of MR- and GR-mediated effects (De Kloet et al. 1998).
1.7.8 Stress, psychological disorders and ageing 
Stress
The HPA axis of animals subjected to chronic stress can become adapted to 
these conditions, altering adrenal sensitivity to ACTH. This is important, as it 
demonstrates that emotion can affect the physiological stress response systems. 
When animals are behaviourally adapted to stress, then the negative feedback actions 
override the excitatory influences on the HPA axis from the various 
extrahypothalamic sources. An inability to react to stress results in an imbalance of 
signals to the PVN. Altered CRH and ACTH responses will then occur.
The set points o f HPA regulation and of MR and GR balance are genetically 
determined but can be reset by interactions between mother and infant, with the 
effects persisting into adulthood. A pup separated periodically from its mother to be 
handled will have blunted emotional responses and adrenocortical reactivity in 
adulthood. The severity o f these effects is dependent on the duration, frequency and 
age of the pup at the time of separation. Moreover, changes in brain GRs can be 
detected. Sex differences are also apparent; handling decreases hippocampal GR
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concentration in males but increases it in females. Wistar rats that have been handled 
during development have more effective glucocorticoid feedback mechanisms and, 
in their old age, have lost fewer neurons, possibly suffering less from chronically 
raised corticosteroid levels, (see section 1.7.5) (Meaney et al. 1988). While 
impairing mother-pup interactions has profound effects on the HPA axis, other mild 
psychological and physiological stressors do not. The important factor in the 
separation o f mother and pup appears to be the loss of physical contact; stress effects 
can be avoided simply by stroking the animal for 45 seconds. This also increases -  
but does not completely restore -  ACTH secretion (van Oers et al. 1998; van Oers et 
a l  1999).
Psychological disorders
Maternal deprivation is a possible predisposing factor to psychological 
disorders in later life, given its effects upon the HPA axis. In man, about 50% of 
patients suffering from depression have a hyperactive HPA system and raised 
cortisol levels. Correction of hypercortisolism by administration of dexamethasone 
decreases the psychopathology significantly (Dorn et al. 1997). Healthy subjects at a 
genetic risk o f depression have HPA feedback resistance and mild hypercortisolism 
(Holsboer et al. 1995). Beneficial behavioral effects are obtained in chronically 
stressed rats by the application of antiglucocorticoids to the dentate gyrus (De Kloet 
et al. 1988). The suppression of 5HT turnover in the hippocampus by high 
glucocorticoid levels (see section 1.7.4) is similar to that seen during depression.
The balance between MR and GR expression in the brain may also be 
important to the development of depression. The tricyclic antidepressants restore 
5HT and noradrenergic transmission and increase GR and MR levels within the 
brain, normalising the HPA tone (Seckl, 1996). Administration of
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antimineralocorticoids impairs the efficacy of these antidepressants, further 
implicating MRs in vulnerability to depression (De Kloet et al. 1998).
In contrast, enhanced feedback to the HPA axis and reduced cortisol 
production is characteristic of post-traumatic stress disorder and chronic fatigue 
syndrome. Post-traumatic stress disorder may involve hippocampal MRs. Chronic 
fatigue syndrome, on the other hand, appears to be caused by impaired CRH 
secretion, resulting in reduced adrenocortical output (Demitrack et al. 1991).
Ageing
In old animals, the response o f the HPA to stress is both more sensitive and 
more prolonged, leading to relative increases in ACTH and corticosterone levels. 
Older animals also possess fewer MR and GR in the hippocampus and PVN than 
younger ones. This would predispose the animal to dendritic atrophy and an 
increased rate o f cell death (see section 1.7.5). Aged animals lose the ability to 
produce hippocampal granule neurons. Adrenalectomy restores this ability (Cameron 
and McKay, 1999). Higher corticosteroid levels and decreased neurogenesis may, 
therefore, provide an explanation for age-related memory deficits.
Individuals with Alzheimer’s disease have increased cortisol levels which 
correlate with mental deterioration and decreased hippocampal volume. The 
neurodegeneration encountered in Alzheimer’s disease may, however, result from a 
resistance to corticosteroids that causes an inability to suppress the immunological 
defence reaction against deposits of p-amyloid from glial cells, a reaction which 
would also result in neurodegeneration (De Kloet et al. 1998).
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1.7.9 Central effects of corticosteroids on blood pressure
As noted previously, the SCO is one of the few brain areas to maintain high 
11P-HSD2 expression into adult life. The SCO is located dorsal to the third cerebral 
ventricle. Infusion o f 5ng/h aldosterone into the roof of the third ventricle, close to 
the SCO, results in increased urinary sodium excretion and adrenal (but not plasma) 
corticosterone concentrations (Dundore et al. 1987). In the Dahl Salt-Sensitive (SS) 
rat, mineralocorticoid hypertension and salt-induced hypertension can be attenuated 
or prevented by the destruction o f tissue anteroventral to the third cerebral ventricle, 
the AV3V area, which comprises the anterior hypothalamic periventricular nuclei 
(PVN), the periventricular and median preoptic nuclei and the anterior wall of the 
third ventricle. This area integrates information concerning blood volume, thirst, 
sodium appetite and AVP secretion. However, it is probable that the hypertension of 
the SS rat involves several genes. For example, it possesses polymorphic alleles of 
CYP11B2 which affect mineralocorticoid synthesis.
In order to define the role of mineralocorticoids in the brain, the group of Elise 
Gomez-Sanchez compared the blood pressures of rats subjected to varying 
subcutaneous sc and icv doses of GR and MR agonists and antagonists. Continuous 
icv infusion o f doses o f aldosterone as low as 5ng/hour into rats resulted in a 
significant increase in blood pressure. Similar doses had no effect on blood pressure 
when administered sc. The effects were blocked by simultaneous infusion o f the MR 
antagonist, prorenone (G6mez-Sanchez, 1986). Furthermore, if  aldosterone was 
administered sc at doses which do increase blood pressure, then the administration of 
the MR antagonist RU28318 blocked this if  administered icv but not sc (Gomez- 
Sanchez et al. 1990). However, prevention o f hypertension through the icv infusion 
of RU28318 does not prevent the development o f cardiac hypertrophy and fibrosis
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caused by systemic mineralocorticoid excess (see section 1.6.1). Also, increases in 
cardiac mass can only be caused by systemic excess and not by icv administration.
Thus the pressor effects of aldosterone are distinct from those on fluid and 
electrolyte balance, salt appetite and the trophic effects on the vasculature and the 
heart. Moreover, the icv dose of RU28318 required to block the mineralocorticoid 
hypertension is less than that required to inhibit the increased salt appetite that is also 
associated with mineralocorticoid excess. A dose o f lOng/h of aldosterone 
administered icv induced the same pressor response to lpg/h sc. The icv dose of 
lOng/hour was insufficient to increase circulating aldosterone concentration. It is 
now known that the increases in Na+ retention, K+ excretion, salt appetite and 
drinking produced by systemic mineralocorticoid excess do not occur after lOng/h, 
or even 15ng/h, o f aldosterone administered icv although blood pressure does rise 
(Gomez-Sanchez, 1997). However, the icv infusion of the higher dose o f 45ng/h of 
aldosterone does stimulate salt appetite. The effects of MR antagonists and antisense 
oligonucleotides support the conclusion that the MR of the amygdala mediate the salt 
appetite response to mineralocorticoids (Sakai et al. 1996). Angll also stimulates salt 
appetite, although neither Angll nor aldosterone is essential to changes in appetite 
(Johnson and Thunhorst, 1997).
The mechanism of the steroid action is unclear. The timescale of the effect is 
consistent with a genomic route. Two possibilties are that they modulate the activity 
o f the local renin-angiotensin system and that they alter neuronal electrolyte 
metabolism.
Components of the renin-angiotensin system are distributed throughout the 
brain. ATI and AT2 Angll receptor subtypes are found in several regions of the 
brain and both glucocorticoids and mineralocorticoids can alter their binding
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properties. GR and MR agonists increase ATI binding in the hypothalamic PVN and 
the subfomicular organ (SFO) which projects along the AV3V region (see figure 
1.7a). Animals treated with both agonists had a greater salt appetite than those 
treated with either separately. There is also evidence that GR agonists increase 
angiotensinogen expression in the preoptic region of the adult rat brain. No MR- 
mediated effect was apparent (Riftina et al. 1995).
Mineralocorticoids enhance Na+ transport in the brain. They increase the 
number o f open amiloride-sensitive Na+-channels in the luminal face o f target 
epithelial cells (see section 1.5.3). The amiloride analogue benzamil, when 
administered icv at systemically-insignificant doses, prevents the hypertensive 
response to aldosterone administered icv or sc in rats. Again, salt appetite is not 
affected (Gomez-Sanchez and Gomez-Sanchez, 1994). It seems likely that, by 
altering their membrane potential and excitability, mineralocorticoid-induced 
increases in neuronal [Na+]1C modulate the activity o f the cardiovascular system, 
(Gomez-Sanchez, 1997).
The central hypertensive effect o f aldosterone is mediated by MR (see above) 
which are protected from glucocorticoids. The 11 (3-HSD inhibitor carbenoxolone is 
able to induce hypertension when infused icv at systemically insignificant doses. 
This would suggest that glucocorticoids are being inactivated by 11P-HSD in regions 
of the brain involved in blood pressure control. However, this is certainly an 
oversimplification. Icv infusion of corticosterone at the same time as aldosterone 
attenuates the blood pressure increase in a dose-dependent manner (Gomez-Sanchez 
et al. 1990). This suggests that glucocorticoids and mineralocorticoids interact at the 
MR to mediate pressor/depressor responses. This was confirmed by the injection of 
GR and MR agonist or antagonist pellets into the lateral ventricles of normotensive
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rats at high levels. The opposing actions of GR and MR have different latency 
periods and durations; glucocorticoid agonists and antagonists affected blood 
pressure 24 hours after administration whereas mineralocorticoids acted earlier (Van 
den Berg et al. 1990).
Corticosteroids injected into the rostral ventrolateral medulla (RVLM) rapidly 
increase heart rate and blood pressure. This region is important in the control of 
cardiovascular function. Corticosterone has an excitatory effect on the cardiovascular 
neurons o f the RVLM, such as the bulbospinal pre-sympathetic neurons, which 
coincides with a rise in blood pressure. Whether corticosterone exerts this effect 
through putative membrane receptors (see section 1.5.6) or through interactions with 
other neurotransmitters is as yet unknown (Rong et al. 1999).
This section shows the important effects of corticosteroids on neural function 
via their modulation o f neurotransmitter efficacy. The main theme o f this thesis, 
however, is the synthesis of corticosteroids within the brain by specific neurons. 
Clearly, the relationship here must be reversed. Neurotransmitters would be expected 
to modulate corticosteroid synthesis. What little is known of this relationship is 
detailed in the following section.
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1.8 Corticosteroid Production in the Central Nervous System
From the previous section, it is beyond question that corticosteroids exert 
profound effects on brain metabolism and consequently on behaviour and many 
aspects of systemic metabolism. The importance of the brain as a source o f these 
hormones is now examined.
The term neurosteroids was devised to describe steroids synthesised within the 
central nervous system from cholesterol or similar early precursors; pregnenolone 
and dehydroepiandrosterone (DHEA) synthesised from cholesterol within the rat 
brain were early examples (Baulieu and Robel, 1990). Local synthesis obviously 
requires local enzyme activity. The evidence supporting the CNS expression o f the 
genes of each enzyme in the steroid pathway from cholesterol to aldosterone and 
corticosterone (see section 1.2.4) will be described.
StAR: The presence of StAR transcripts in the CNS of the adult rat has been 
detected by RNase protection assay, RT-PCR and in situ hybridisation (Furukawa et 
al. 1998). They are abundant in the cerebral cortex, the pyramidal cell layers o f the 
hippocampus and dentate gyrus, and the olfactory bulb. The cerebellum has the 
highest levels o f all. StAR mRNA levels in the brain are approximately two to three 
orders of magnitude lower than those in the adrenal gland. No sex differences are 
apparent.
P450scc: The initial discovery of P450scc within the white matter of the rat 
brain is widely regarded as one of the most significant findings in neurosteroid 
research (Mensah-Nyagan et al. 1999). Using an antibody raised against bovine P- 
450scc, the rat form of the enzyme could be detected in tracts of myelinated fibres 
within the olfactory bulb and throughout the white matter. Cell bodies were also 
immunolabelled, with the staining restricted to the cytoplasm; it was unclear whether
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these cells were neuronal or glial (Le Goascogne et al. 1987). Later studies showed 
immunohistochemical P450scc staining to be confined to glial cells (Iwahashi et al. 
1990).
CYP11A1 transcripts have been detected in the rat brain by RT-PCR, always at 
lower levels than those found in adrenal tissue (Mellon and Deschepper, 1993; Sanne 
and Krueger, 1995; Stromstedt and Waterman, 1995; Furukawa et al. 1998). Indeed, 
brain transcripts cannot be detected by the ribonuclease (RNase) protection assay 
(Mellon et al. 1991; Mellon and Deschepper, 1993; Furukawa et al. 1998). There 
appear to be no significant sex differences in the distribution o f brain CYP11A1 
transcripts. Expression is highest in the cerebral cortex but it is also detectable in the 
amygdala, hippocampus, midbrain and the granule layer of the cerebellum (Mellon 
and Deschepper, 1993; Sanne and Krueger, 1995). Using primary cell cultures, 
CYP11A1 transcription was shown to occur in glial cells (Mellon and Deschepper, 
1993; Sanne and Krueger, 1995). Such cells can convert cholesterol to pregnenolone 
in vitro (Jung-Testas et al. 1989), and the presence o f P450scc within them has also 
been confirmed by immunoblotting, using two different types of P450scc-specific 
antibodies (Mellon and Deschepper, 1993). However, P450scc is not confined to 
glial cells and has recently been found within the Purkinje cells o f the cerebellum 
(Ukena et al. 1998).
CYP11A1 transcripts have also now been identified in the human brains of 
children and adults. Positive results were obtained using hippocampal and frontal 
lobe specimens, with levels in adults tending to be higher than those in children. 
Women tended to have higher CYP11A1 mRNA levels in the frontal lobe than men, 
although Watzka et al. attribute this finding to shortcomings in their RT-PCR
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technique rather than to real differences in transcript concentrations (Watzka et al. 
1999).
Adrenodoxin: The mRNA of adrenodoxin has been found in virtually all the 
rat tissues that have been examined (Mellon et al. 1991; Stromstedt and Waterman, 
1995). It is present at a higher level than CYP11A1 transcripts as it is detectable by 
RNase protection assay, Northern blotting and RT-PCR. The latter method does not 
require the sensitivity o f Southern blotting to visualise the transcripts; they can be 
seen directly on ethidium-bromide stained gels.
NADPH-cytochrome P450 reductase: Like adrenodoxin, NADPH-
cytochrome P450 reductase has been detected in all tissues that have been tested and 
at sufficient levels to render Southern blotting unnecessary (Stromstedt and 
Waterman, 1995).
3p-Hydroxysteroid dehydrogenase: The rat isoenzymes of 3P-HSD, types I-  
IV, are expressed in a tissue-specific manner. In the brain, transcripts for types I, II 
and IV can be detected by restriction of RT-PCR products (Sanne and Krueger, 
1995). Interestingly, the absent type III has a completely different activity to the 
other isoenzymes, possessing a 3-ketosteroid reductase activity (Mensah-Nyagan et 
al. 1999). In situ hybridisation localised these transcripts to the cerebral cortex, 
hippocampus, cerebellum, thalamus, hypothalamus and olfactory bulb. The highest 
levels o f 3P-HSD expression within the hippocampus are found within the CA1-2 
fields and the dentate gyrus while, in the cerebellum, expression is strongest in the 
Purkinje cells, granule cells and stellate/basket cells (Guennon et al. 1995; Furukawa 
et al. 1998; Ukena et al. 1999). In the rat CNS, 3P-HSD mRNAs have only been 
detected in neurons. However, cultured astrocytes and oligodendrocytes have been
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found to express 3p-HSD, suggesting that glial cells may acquire this ability in vitro 
(Jung-Testas et al. 1989; Mensah-Nyagan et al. 1999).
17a-Hydroxylase: The evidence for 17a-hydroxylase expression in the adult 
rat brain is conflicting. CYP17 transcripts have been detected by RT-PCR and 
Southern blotting in four different brain homogenates -  brain stem, cerebellum, 
cerebral cortex and the remainder of the brain -  by Stromstedt & Waterman (1995) 
but other groups failed to detect transcripts in whole brain homogenates or primary 
glial cultures by the same method (Mellon and Deschepper, 1993). The fact that 
expression was not detected in whole brain homogenates may have been due to the 
confinement of CYP17 transcripts to a few brain cells. When homogenised with the 
rest o f the brain, these transcripts may become so diluted as to be undetectable.
21-Hydroxylase: Failure to detect CYP21 transcripts in the rat brain by RNase 
protection assay led to claims that extraadrenal 21-hydroxylation was mediated by 
another enzyme (Mellon and Miller, 1989). However, this method assumed that 
human and rat forms of CYP21 are relatively similar. RNase protection assays had 
already failed to pick up brain CYP11A1 (see above). Unfortunately, the rat CYP21 
sequence is unknown and RT-PCR analysis is therefore not possible. Brain CYP21 
transcription has been demonstrated by RT-PCR in the mouse, where the sequence is 
known, but the rat gene is sufficiently different to disqualify the use o f these same 
amplifying primers in the rat (Stromstedt and Waterman, 1995).
11 P-Hydroxylase: A paper describing the immunohistochemical detection of 
11 p-hydroxylase in rat brain tissue was published in 1991 (Ozaki et al. 1991). As the 
existence o f the highly homologous aldosterone synthase enzyme was not known at 
the time, the authors understandably made no attempt to ensure that their polyclonal 
antibodies, raised against bovine 11 P-hydroxylase, did not cross-react with the rat
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aldosterone synthase enzyme. The fact that immunohistochemistry performed with 
these antibodies on rat adrenal gland sections produced positive staining in all three 
adrenocortical regions suggests that their findings are flawed. Nevertheless, the 11P- 
hydroxylase/aldosterone synthase antibodies still provide interesting data. 
Immunoblots o f rat adrenal and brain homogenates yield a single band with a 
molecular weight o f approximately 45,000. From sequence information, l lp -  
hydroxylase and aldosterone synthase would be expected to have very similar 
molecular weights. Immunohistochemical localisation within rat brain tissue require 
amplification by the avidin-biotin complex (ABC) method. In this way, staining can 
be identified within the white matter o f the brain. Upon closer investigation, it is 
restricted to the tracts o f myelinated fibres in such regions as the cerebellum and the 
olfactory bulb. There are no age or sex differences and antibody binding can be 
inhibited by preincubating the antibodies with bovine 11 p-hydroxylase.
Since the cloning of CYP11B1 and CYP11B2, most work on 11 P-hydroxylase 
and aldosterone synthase expression has been performed at the transcript level. 
Several groups have detected CYP11B1 mRNA in rat brain tissue homogenates using 
RT-PCR (Mellon and Deschepper, 1993; Stromstedt and Waterman, 1995; Gomez- 
Sanchez et al. 1996), RNase protection assay (Mellon and Deschepper, 1993) and 
Northern blotting (Erdmann et al. 1996). Transcripts can be detected in whole brain 
samples, as well as cerebellum, cerebral cortex, amygdala, hippocampus and 
hypothalamus homogenates. According to RT-PCR studies, female rats have 
consistently higher CYP11B1 transcript levels in the hippocampus than males 
(Mellon and Deschepper, 1993). The strongest in situ hybridisation signal is in the 
cerebral cortex. A weak signal is also seen in the hippocampus but this is probably a 
non-specific interaction as it also appears in control sections exposed only to a sense
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probe (Erdmann et al. 1996). The positive signal cannot be seen in the white matter, 
and is apparently confined to nerve cells. CYP11B1 mRNA cannot be detected in 
primary cultures o f glial cells (Mellon and Deschepper, 1993). Brain minces are able 
to convert DOC to corticosterone, proving that 11 P-hydroxylase activity is present in 
the rat brain (Gomez-Sanchez et al. 1996).
Aldosterone synthase: Apart from immunohistochemical detection of 
aldosterone synthase due to the cross-reacting bovine 11 p-hydroxylase polyclonal 
antibodies (see above), the occurrence of aldosterone synthase in the brain has been 
investigated at the transcript level. One group failed to find CYP11B2 transcripts in 
brain tissue by RNase protection assay or RT-PCR, nor could they be detected in 
primary cultures of glial cells (Mellon and Deschepper, 1993). However, others have 
since used RT-PCR to detect CYP11B2 mRNA in whole brain and in cortex, 
cerebellum, brain stem, hippocampus, hypothalamus and amygdala homogenates 
(Stromstedt and Waterman, 1995; Gomez-Sanchez et al. 1997). Brain minces 
converted DOC to aldosterone, corticosterone, 18-OH-DOC and, in the greatest 
amounts, to 11 -dehydrocorticosterone.
Evidence of specific functions for locally-synthesised corticosteroids is sparse. 
19-Ethynyldeoxycorticosterone irreversibly inactivates aldosterone synthase 
(Johnston et al. 1995). When administered sc to the Dahl SS/jr rat, it decreases salt- 
induced blood pressure. The icv infusion of 19-ethynyldeoxycorticosterone in the 
Dahl SS/jr rat is able to achieve this effect at far lower doses (Gomez-Sanchez et al. 
1997). Thus, aldosterone produced within the brain may be capable o f exerting real 
physiological effects.
There is preliminary evidence, therefore, that CYP11B1 and -B2 are expressed 
in the brain but, because of the similarity of their transcripts and protein products,
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ambiguity remains. This is exacerbated by the very low levels o f expression. The 
following experimental work, using a variety o f biochemical and cell and molecular 
biological methods, is designed to demonstrate specific transcription, translation and 
synthetic activity and to identify more precisely those regions o f the brain where this 
occurs.
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Chapter 2 
Materials And Methods
Unless otherwise stated, all standard chemicals and reagents were purchased 
from Sigma (Sigma-Aldrich Chemical Co. Ltd., Poole, Dorset, U.K.). For further 
details of buffers, reagents, etc. see appendix 3.
2.1 Reverse Transcription-Polvmerase Chain Reaction (RT-PCR) And Southern 
Blotting Of Steroidogenic Gene Transcripts
Due to the instability o f RNA, extensive precautions were taken to prevent the 
contamination of RNA solutions and the various reagents with RNases. Water treated 
with diethyl pyrocarbonate (DEPC), an inhibitor of RNase activity, was used for the 
preparation of RNA solutions and RT reactions. All consumables were baked or 
autoclaved, as appropriate, before use.
2.1.1 RNA isolation
Two-month-old female Wistar-Kyoto rats fed on normal diets (Labsure Diets, 
Cambridgeshire, U.K.; 113 mmol Na+/kg and 187 mmol K+/kg) were killed by lethal 
overdose o f halothane when approximately two months old. Tissue was removed and 
immediately immersed in liquid nitrogen, then stored at -70°C until required.
To isolate RNA, 4ml ice-cold RNAzol B (Biogenesis, Poole, U.K.) was placed 
in a 14ml polypropylene Falcon tube (Becton Dickinson U.K. Ltd., Oxford, U.K.). 
~ lcm 3 of tissue was added to the tube and homogenised at full speed for 
approximately 15 seconds using a Polytron homogeniser (Kinematica AG, Littau- 
Luceme, Switzerland). 400pl ice-cold chloroform was added to the homogenate
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before being mixed and placed on ice for 5 minutes. The tube was then centrifuged at 
12,000g for 15 minutes at 4°C. The upper layer was retained and transferred to 
autoclaved 15ml Corex tubes. An equal volume o f isopropanol was added to the 
tube, mixed by inversion and left on ice for 15 minutes. The tube was centrifuged at 
12,000g for 15 minutes at 4°C to give an RNA pellet. (If the pellet was especially 
large due to the presence of glycogen, it was resuspended in 2ml of 4M lithium 
chloride and centrifuged at 12,000g for 15 minutes at 4°C before proceeding with the 
rest of the protocol.) The supernatant was removed and the pellet resuspended in 2ml 
of 70% ethanol before being centrifuged at 7,500g for 10 minutes at 4°C. Using a 
sterile Pasteur pipette, as much of the ethanol as possible was removed and the pellet 
left on ice to dry. The pellet was resuspended in lOOpl of cold DEPC-treated H20. 
The RNA solution was stored at -70°C.
2.1.2 Analysis of isolated RNA
Agarose gel electrophoresis: A 1% (w/v) agarose gel was prepared as described in 
section 1.1.6. A mixture of 2pl RNA solution, 3pi DEPC H20  and lp l 6xloading dye 
was loaded per well. The gel was electrophoresed at 60V for an hour and then 
visualised under UV light. Distinct rRNA bands indicated good RNA samples 
whereas poor or degraded RNA appeared as a smear on the gel.
Spectrophotometry: 5pl of RNA solution was added to 995pl of H20  in a quartz 
cuvette (i.e. a 1:200 dilution) and its optical density at 260nm (O D 26o) measured 
using a spectrophotometer. An O D 26o of 1 corresponds to 40pg/ml RNA in an 
undiluted sample. Therefore, for the diluted sample:
x  = (O D 26o x 40 x 200) pg ssRNA in l,000pl 
where x  is the RNA concentration of the unknown sample in pg/ml.
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OD28o of the sample was also measured. Pure preparations o f RNA have an 
OD260/OD28o ratio of 2.0. Ratios o f 1.8 to 2.3 indicate a good level of purity.
Aliquots of the stock RNA solutions were diluted with DEPC-H20  to give 
working solutions with a concentration of lpg/ml.
2.1.3 Reverse transcription
RT-PCR reactions were performed using the GeneAmp RNA-PCR kit (Perkin 
Elmer, Warrington, U.K.). The reverse transcription reaction mixture was assembled 
in GeneAmp thin-walled reaction tubes (Perkin Elmer) on ice:
Solution Volume
RNA (lpg/pl) l.Opl
MgCl2 (25pM) 4.0pl
lOxPCR buffer II 2.0pl
dATP (lOpM) 2.0pl
dCTP(lOpM) 2.0pl
dGTP (lOpM) 2.0pl
dTTP(lOpM) 2.0pl
RNase inhibitor (20U/pl) 1 .Opl
MuLV reverse transcriptase (50U/pl) 1 .Opl
01igo-(dT)i6 primers (25pM) 1 .Opl
DEPC-treated H20  2.0pl
Control reactions omitting either reverse transcriptase (-RT control) or RNA 
(water blank) were also prepared. Reaction constituents were mixed briefly and then 
overlaid with a drop of mineral oil before being incubated on a 480 DNA thermal 
cycler (Perkin Elmer) under the following conditions:
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15 minutes 42°C
5 minutes 99°C
5 minutes 5°C
The resulting first strand cDNA products were stored at -20°C until required 
for PCR.
2.1.4 Oligonucleotide synthesis
Synthetic oligonucleotide primers were designed from published sequences and
obtained, in HPLC-purified form, from a commercial source (Oswel DNA Service,
Southampton, UK). Primers were designed to be free of hairpin structures and, where 
possible, to consist o f approximately 50% guanine and cytosine nucleotides with a 
melting temperature (Tm) of around 65°C. For a list of primers, see appendix 2.
2.1.5 PCR of first strand cDNA
Solutions from the GeneAmp RNA PCR kit were combined with the RT 
reaction product from section 2.1.3 in GeneAmp thin-walled reaction tubes:
Solution Volume
RT reaction product 20.0pl
lOx PCR buffer II 8.0pl
Sense primer l.Opl
Antisense primer l.Opl
MgCl2 (25mM) 4.0pl
AmpliTaq DNA polymerase 0.5pl
H20 65.5p.l
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The reactions were mixed and microcentrifuged briefly before being overlaid with a 
drop of mineral oil and placed on a Perkin Elmer 480 DNA thermal cycler. The sense 
and antisense primers relevant to each reaction are listed in appendix 2 together with 
their specific annealing temperatures.
The basic template for all PCR incubations was:
1. Denaturation 94°C for 3 minutes
2. Denaturation 94°C for 1 minute
3. Annealing x°C for 1 minute 35 cycles
4. Extension 72°C for 2 minutes
5. Extension 72°C for 7 minutes
Steps 2 to 4 were repeated for 35 cycles before proceeding to step 5. The 
resulting PCR reactions were stored at 4°C until required for subsequent 
electrophoresis and Southern blotting.
2.1.6 Agarose gel preparation and electrophoresis
A 1% (w/v) agarose gel was prepared by adding lg  agarose (Life 
Technologies, Paisley, U.K.) to 100ml lxTAE buffer. This was heated for 2 minutes 
at full power in a 750W microwave oven, stirring at 1 minute, lp l of lOmg/ml 
ethidium bromide (EtBr) solution was added to the agarose before being poured into 
a gel tray with a comb and left to set. The comb was removed and the gel placed in 
an electrophoresis tank (Bio-Rad Laboratories Ltd., Hemel Hempstead, U.K.) 
containing lxTAE buffer. lOpl of loading dye was added to the PCR reactions from 
section 2.1.5 and mixed. 30pl of this was loaded per well. 10pl o f the relevant 
marker (e.g. Haelll <|>X174 digest or Hindlll X digest (New England Biolabs (U.K.)
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Ltd, Hitchin, U.K.)) was loaded in the appropriate wells. The gel tank was connected 
to a power source and the gel was run for ~1 hour at 100V. The gel was visualised 
under UV light to ensure that the bands were well separated.
2.1.7 Southern blotting
The agarose gel resulting from the previous section was immersed in 0.25M 
HC1 with gentle shaking, causing the loading dyes in the gel to change colour. The 
gel was left in the HC1 for a further 10 minutes, rinsed in distilled water and then 
immersed in denaturing buffer for 30 minutes, again with gentle shaking. After this, 
the gel was rinsed in distilled water and immersed in neutralising buffer for 15 
minutes with gentle shaking; this step was repeated.
A capillary blot was constructed. A platform was placed in a container filled 
with 20xSSC buffer. Three strips of 3MM chromatography paper (Whatman Inc., 
Maidstone, U.K.) were placed on the platform, dipping into the buffer to act as a 
wick. On top of this was placed the gel, then a sheet o f Hybond-N+ nylon membrane 
(Amersham Pharmacia Biotech U.K. Ltd., Little Chalfont, U.K.) and a thick wad of 
paper towels. The membrane and towels were cut to the same size as the gel to avoid 
short-circuiting of the buffer and care was taken to avoid the formation of air bubbles 
between the layers. Weights were placed on top of the paper towels, and the whole 
apparatus was covered with clingfilm and left overnight.
The next day, the membrane was washed briefly in 2xSSC. DNA on the 
blotted membrane was crosslinked using a Stratalinker 1800 (Stratagene Europe, 
Amsterdam, The Netherlands) . The blot was wrapped in clingfilm, ensuring that it 
was kept moist until required for hybridisation.
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2.1.8 Radioactive labelling of probes
Primers required for hybridisation to a Southern blot were radioactively 
labelled with y32P adenosine triphosphate (y32P-ATP) (Amersham Pharmacia Biotech 
U.K. Ltd.) using T4 polynucleotide kinase (New England Biolabs (U.K.) Ltd.) by 
assembling the following in a sterile Eppendorf tube:
Components Volume
Primer (10pmol/pl) 5.0pl
H20  34.0pl
Polynucleotide kinase (1 OU/pl) 1 .Opl
P.K. buffer (New England Biolabs) 5.0pl
y32P-ATP 5.0^1
The reaction tube was placed in a radioactive shield box and incubated at 37°C 
for 1 hour. Addition o f the y32P-ATP was performed behind a perspex shield, and 
basic precautions against radioactive contamination were observed throughout.
2.1.9 Hybridisation and washes
The blot was placed in a hybridising oven and rotated in hybridising solution 
for 2 hours at 40°C. The hybridising solution was replaced by sufficient fresh 
hybridizing solution to cover the blot, and the 50pl of radioactively-labelled primer 
from section 2.1.8 was also added. This was left to hybridise overnight at 40°C.
The next day, the hybridising solution was disposed of and the blot incubated 
with 6xSSC for 15 minutes, at a temperature appropriate to the hybridised primer 
(see appendix 2). The radioactivity of the blot was monitored with a Geiger/Muller 
tube and, if  still uniformly high, the blot was washed for a further 15 minutes with 
2xSSC at the same temperature. This was repeated until the backgorund level of
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radioactivity had diminished to <30 counts per second. At this point, the blot was 
wrapped in clingfilm and the radioactive bands detected using either a Fluor-S 
Multilmager (Bio-Rad Laboratories Ltd.) or X-ray film (Amersham Pharmacia 
Biotech U.K. Ltd.) with subsequent development in a Kodak X-Omat..
2.2 SDS-Polvacrvlamide Gel Electrophoresis (SDS-PAGE) And Im m unoblotting
Preparation of immunoblots was performed under both denaturing/reducing 
conditions and native (i.e. non-denaturing/reducing) conditions. The basic protocol 
for denaturing/reducing immunoblotting is given in sections 2.2.2 to 2.2.8. 
Variations to this protocol for native conditions are given in section 2.2.9.
2.2.1 Antibody production
The antibodies raised against the rat forms of aldosterone synthase and 11 (3- 
hydroxylase were a gift from Professor Celso E. Gomez-Sanchez. They were 
monoclonal antibodies of the IgGl subclass and were prepared in mice using 
synthetic peptides corresponding to hydrophilic areas of aldosterone synthase and 
11 P-hydroxylase that exhibited minimal homology (Research Genetics Inc., 
Huntsville, AL, U.S.A.).
The aldosterone synthase monoclonal antibody was generated by immunising 
CD-I mice with the multiple antigenic peptide MAP-KVRQNARGSLTMDVQQ 
corresponding to residues 175-190 (Tam, 1988). The 11 p-hydroxylase antibody was 
generated in Swiss-Webster mice immunised with the peptide 
KNVYRELAEGRQQS corresponding to residues 272-285 and conjugated to 
chicken serum albumin. The spleens o f the mice with the highest titre were fused to 
an SP-2 myeloma cell line and the clones selected for their ability to bind
107
immobilised sonicated zona glomeralosa mitochondria from rats on a low sodium 
diet. Both antibodies were of the IgGl type.
Three aldosterone synthase antibodies were supplied by Professor Gomez- 
Sanchez, all derived from the same mouse fusion but resulting from different clones. 
These were named AS IG5 HC3, AS IE6 and AS IC11. The 11 p-hydroxylase 
antibody was named 11BLA4.
2.2.2 Tissue homogenisation
Total tissue protein: Two-month-old female Wistar-Kyoto rats that had been fed on 
normal diets (see section 2.1.1) were killed by lethal overdose o f halothane. Tissue 
was removed and placed in ice-cold homogenisation buffer for transport to the 
laboratory where homogenisation was performed immediately. ~ lcm  lump of tissue 
was placed in a 14ml polypropylene Falcon tube (Becton Dickinson U.K. Ltd., 
Oxford, U.K.) with ~4ml homogenisation buffer. The tissue was homogenised at full 
speed for approximately 15 seconds using a Polytron homogeniser (Kinematica AG, 
Littau-Luceme, Switzerland), until no large lumps of tissue were visible. The 
Polytron head was changed between different tissue types to prevent cross­
contamination of samples. The homogenates were aliquotted and stored at -70°C 
until required for use.
M itochondrial protein: Two-month-old female Wistar-Kyoto rats that had been fed 
on normal diets (see section 2.1.1) were killed by lethal overdose o f halothane. 
Tissue was removed and placed in ice-cold isolation buffer for transport to the 
laboratory where homogenisation in isolation buffer using a Polytron was performed, 
as above. The homogenate was transferred to polypropylene Falcon tubes and 
centrifuged at 800g for 7 minutes at 4°C to sediment nuclei, cell debris and red blood
cells The supernatant was decanted to fresh tubes; this centrifugation step was 
repeated. A crude mitochondrial pellet was formed by centrifuging the supernatant at 
6,500g for 15 minutes at 4°C. A single pellet was resuspended in a small volume of 
isolation buffer, and divided between two fresh tubes which were then filled to 
capacity with isolation buffer and centrifuged at 6,500g for 7 minutes at 4°C. These 
pellets were resuspended, combined in a single tube filled to capacity with isolation 
buffer and recentrifuged at 6,500g for 7 minutes at 4°C. The resulting pellet was 
resuspended in a small volume of isolation buffer and stored at -70°C until required.
2.2.3 D eterm ination of protein concentration
The protein concentration of a given homogenized sample was calculated using 
either of the following methods.
Lowry assay: Bovine serum albumin (Fraction V) standards in the range 0 -  
lOOmg/ml were prepared in duplicate, and 1:10 dilutions of samples in triplicate. 
These were made up to 1ml with distilled H2O. lOOpl 0.15% sodium deoxycholate 
was added to each and left for 10 minutes at room temperature. lOOpl 72% 
trichloroacetic acid was then added and the standards and samples mixed. The 
standards and samples were centrifuged at 2500g for 15 minutes at room 
temperature. The supernatant was discarded and the pellets resuspended in 1ml 
distilled H 2O. 1ml of reagent A was added to each, mixed and left to stand for 10 
minutes at room temperature, after which 0.5ml reagent B was added, mixed and left 
to stand for a further 30 minutes. Light absorption of the samples at 750nm was 
measured for each standard and sample. A standard curve was derived from the 
standards and used to determine the protein concentration of the samples.
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Bio-Rad protein assay: Protein concentration was also measured using the Bio-Rad 
protein assay kit (Bio-Rad Laboratories Ltd.). Bovine serum albumin standard 
solutions (lOOpl, 0.2-1.4mg/ml) were prepared in duplicate. Bio-Rad reagent 
concentrate was diluted 1:5 and filtered through Whatman No.l filter paper 
(Whatman Inc.). 5ml diluted dye reagent was added to each standard and to lOOpl 
volumes of protein sample. These were mixed, then incubated at room temperature 
for 30 minutes. Light absorption of the samples at 595nm was measured for each 
standard and sample. A standard curve was derived from the standards and used to 
determine the protein concentration of the samples. The Bio-Rad protein assay has 
been shown to yield results comparable to the Lowry assay under most 
circumstances.
2.2.4 Polyacrylamide gel preparation
The gel-facing sides of glass plates measuring 20cm x 20cm were cleaned with 
ethanol and the gel-casting apparatus assembled with 1.5mm spacers. A 10% 
resolving gel was assembled from the following solutions:
Solution Volume
Buffer 1 8.5ml
30% Acrylamide solution/0.8% N,N’-methylene-bis-acrylamide 11.3ml 
(Life Technologies, Paisley, U.K.)
H20 11.6ml
50% Glycerol 2.3ml
10% Ammonium persulphate 127.0pl
TEMED 11.5(41
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The reagents were mixed well and poured between the gel plates using a pipette. 
0.1% SDS was layered over the top o f the gel to prevent oxidation and it was left to 
set for 2 hours. A 3% stacking gel was then prepared as follows:
Solution Volume
Buffer 2 5.6ml
H20  14.4ml
30% Acrylamide solution/
0.8% N,N’-methylene-bis-acrylamide 2.2ml
10% Ammonium persulphate 225.0pl
TEMED 12.0pl
The 0.1% SDS was poured away from the resolving gel and the stacking gel 
poured on top, with a comb in position at the top of the plates. The gel was left to set 
for exactly one hour and then clipped into the gel tank, gaps sealed with vacuum 
grease and the wells of the tank filled with tank buffer. Air bubbles around the gel 
were flushed out with a syringe and hypodermic needle.
2.2.5 Precipitation of protein for electrophoresis
A volume of homogenate containing the desired amount of protein (up to a 
maximum of 200pg) was added to an Eppendorf tube, together with sufficient H20  
to bring the total volume up to 150pl. The following solutions were added, in order:
Solution Volume
2% Sodium deoxycholate 6.3pi
H20  750.0pl
24% Trichloroacetic acid 250.0pl
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The contents of the tube were mixed and then centrifuged at 7,000g in a 
microcentrifuge for 20 minutes at room temperature. The supernatant was poured 
away and the protein pellet left to dry. The pellet was resuspended in 20pl each of 
1M Tris base and Laemmli buffer and the tubes were boiled for 3 minutes. Each 
protein sample was then loaded into a single well of the gel. 20pl of Amersham full 
range Rainbow markers (Amersham Pharmacia Biotech U.K. Ltd.) or Bio-Rad 
Kaleidoscope prestained standards (Bio-Rad Laboratories Ltd.) was also loaded 
directly on to the gel for size comparison. The gel tank was then connected to a 
power source and left to run at ~50V until the dye front ran off the bottom of the gel.
2.2.6 Protein transfer
The gel was unclipped from the tank, the plates prised apart and the stacking 
gel cut away from the resolving gel with a scalpel. The blotting cassette was built up 
in a container filled with blotting buffer, the resolving gel placed next to a layer of 
Hybond-P polyvinylidene difluoride (PVDF) membrane (Amersham Pharmacia 
Biotech U.K. Ltd.). These were sandwiched by filter paper and sponge, then placed 
in a blotting cassette. Care was taken to avoid the formation of air bubbles between 
the gel and the membrane. The cassette was placed into a blotting tank filled with 
blotting buffer, ensuring polarity was correct. The tank was transferred to a cold 
room and connected to a power pack. Transfer was performed at 100V for 1 hour 30 
minutes at 4°C.
After transfer, the membrane was blocked (see section 2.2.7), while the gel 
was immersed in Coomassie brilliant blue G stain for 2 hours and then in destain 
overnight in order to confirm the efficiency o f protein transfer from the gel to the 
membrane.
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2.2.7 Blocking and antibody incubation
The membrane was washed in distilled water for 10 minutes and then blocked 
for 2 hours in 100ml of blocking solution at room temperature, with gentle shaking. 
The membrane was removed from the blocking solution and split into several 
sections. Each section could be incubated in different concentrations of antibody. 
One section was incubated without any primary antibody; this served as a control, 
showing which of the bands detected on the blot could be attributed to primary 
antibody binding and which to secondary. Antibodies were diluted in antibody 
diluent (Dako Ltd., Ely, Cambridge, U.K.). Sections of membrane were left in 
primary antibody solution overnight at 4°C with gentle shaking. The blot was 
removed from the primary antibody solution and subjected to five vigorous 10- 
minute washes in generous amounts of TBS/0.4% Tween 20. Horseradish 
peroxidase-labelled sheep anti-mouse IgG secondary antibodies were used (Scottish 
Antibody Production Unit, Carluke, U.K. or Amersham Pharmacia Biotech U.K. 
Ltd.). The membrane was incubated in the secondary antibody solution for 2 hours at 
37°C with gentle shaking and then washed vigorously in five 10-minute washes with 
TBS/0.4% Tween.
2.2.8 Signal detection
Antibody binding to the membrane was detected by enhanced 
chemiluminescent (ECL) reactions catalysed by the horseradish peroxidase enzymes 
bound to the secondary antibody. Three different types of ECL system were used: 
ECL Plus (Amersham Pharmacia Biotech U.K. Ltd.), Supersignal chemiluminescent 
substrate for Western blotting and Supersignal ULTRA chemiluminescent substrate
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(both Pierce & Warriner, Chester, U.K.). All systems, used according to the 
manufacturer’s instructions, involved immersion o f the membrane in 
chemiluminescent substrate for 1-10 minutes. The membrane was then drained of 
substrate, wrapped in clingfilm and exposed to Hyperfilm-ECL film (Amersham 
Pharmacia Biotech U.K. Ltd., Little Chalfont, U.K.) for a period of 30 seconds to 
several hours, depending on the intensity of the signal. The film was then developed 
in a Kodak X-Omat.
2.2.9 Native PAGE and immunoblotting
Immunoblotting was also performed under non-denaturing conditions. The 
basic procedure was the same as for the SDS-PAGE and immunoblotting described 
in sections 2.2.3 to 2.2.8, with the following changes:
1) Buffer 1 is replaced by an equal amount of 1.5M Tris (pH 8.8) in the 10% 
resolving gel mixture.
2) Buffer 2 is replaced by an equal amount of 0.5M Tris (pH 6.8) in the 3% 
stacking gel mixture.
3) The required amount of protein homogenate is mixed with native loading 
buffer and loaded directly on to the gel. No pelleting or resuspension is 
necessary.
4) SDS is omitted from the tank buffer.
2.3 P reparation And Imm unostaining O f Crvosections
2.3.1 Preparation of crvosections
Two-month-old female Wistar-Kyoto rats that had been fed on normal diets 
(see section 2.1.1) were killed by lethal overdose o f halothane. Tissue was removed
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and immediately flash-frozen in liquid nitrogen. Sections with a thickness of 5pm 
were cut using a cryostat and mounted on 3-aminopropyltriethoxysilane (APES) 
coated slides by Mr Niall Whyte of the Department of Pathology, Western Infirmary, 
Glasgow, U.K. Sections were stored at -70°C.
2.3.2 Immunostaining of crvosections (ABC protocol)
All subsequent steps were performed at room temperature; slides were kept in a 
humidified chamber during incubation steps to prevent drying o f samples. Sections 
were thawed for 10 minutes, fixed in 100% acetone for 10 minutes and washed in 
PBS for 5 minutes, all at room temperature. A wax ring was drawn round the tissue 
with an immunohistochemistry pen (Dako Ltd.). Peroxidase activity was removed 
from the tissue by immersion in 0.5% H2O2 in methanol for 30 minutes. Slides were 
then washed thoroughly in PBS for 10 minutes; this step was repeated. Samples were 
blocked with 20% rabbit serum (Scottish Antibody Production Unit) in PBS for 30 
minutes. The serum was tapped off the sections and replaced with primary antibody 
diluted in antibody diluent (Dako Ltd.). Sections were left to incubate overnight at 
room temperature.
The next day, slides were subjected to two 5-minute washes in PBS and then 
incubated for 30 minutes with biotinylated rabbit anti-mouse secondary antibody 
(Dako Ltd.) at a 1:200 dilution in 2% rabbit serum and 5% rat serum (both Scottish 
Antibody Production Unit). The slides were given another two 5-minute washes in 
PBS and then incubated for 30 minutes with streptavidin-HRP (Dako Ltd.) diluted 
1:400 in PBS. Sections were washed twice more in PBS, followed by incubation in 
3,3’-diaminobenzidine tetrahydrochloride (DAB) staining solution for 10 minutes in 
the dark. The slides were washed in PBS for 5 minutes, followed by running tap
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water for a further 10 minutes. Sections were counterstained in filtered Harris 
hematoxylin solution for 1 minute and then washed under running tap water again for 
several minutes. Sections were dehydrated through alcohols in the sequence 50% 
ethanol, 70% ethanol, 95% ethanol twice, 100% ethanol twice and, finally, 100% 
xylene twice. Sections were mounted in DPX mountant under glass coverslips (both 
BDH, Poole, Dorset, U.K.).
2.4 Preparation And Immunostaining Of Paraffin-Embedded Tissue Sections
2.4.1 Preparation of paraffin-embedded tissue sections
Adult female Wistar-Kyoto rats fed on normal diets were killed by lethal 
overdose. The tissue was removed and fixed in formalin or 4% (w/v) 
paraformaldehyde solution for 24 hours. Mr Niall Whyte dehydrated the tissue 
through a series of alcohols before embedding it in paraffin wax. Sections with a 
thickness o f 5pm were mounted on to APES-coated slides and air-dried.
2.4.2 Deparaffinisation and rehvdration of tissue sections
All subsequent steps were performed at room temperature; slides were kept in a 
humidified chamber during incubation steps to prevent drying o f samples. Sections 
were placed in an oven at 60°C for 30 minutes and then deparaffinised and 
rehydrated by passing through 100% xylene for 5 minutes twice, 100% ethanol for 5 
minutes twice, 95% ethanol for 5 minutes twice and distilled water for 5 minutes. 
Pretreatments were performed on the tissue at this point (see section 2.4.3).
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2.4.3 Antigen-retrieval pretreatm ents of paraffin-embedded tissue sections
The deparaffinised and rehydrated sections were subjected to one or both of 
these pretreatments before proceeding with the immunohistochemistry protocols 
described in section 2.4.4 or 2.4.5.
Microwave oven heating: Slides were immersed in 200ml of target retrieval 
solution (Dako Ltd.) within a non-metallic container. Empty spaces within the slide 
rack were filled with blank slides to ensure uniform heating throughout. Optimal 
conditions for these tissues involved heating the container on full power for two 7- 
minute periods in a 750 watt microwave oven with turntable; the level o f liquid 
within the container was topped up with distilled water between heatings. The 
sections were left in the container for 20 minutes to cool at room temperature before 
proceeding with the immunostaining protocol.
Proteolytic pretreatm ent: 300ml of 0.01% calcium chloride solution was heated to 
37°C in a water bath. 30mg o f type XXVII protease was dissolved in this solution 
immediately before the slides were to be treated. Slides were immersed in the 0.01% 
protease/0.01 % CaCL solution for 30 seconds and then washed thoroughly in cold 
running water.
2.4.4 Imm unostaining of paraffin-embedded tissue sections (ABC protocol)
A wax ring was drawn round the tissue with an immunohistochemistry pen and 
the slides were left in PBS for 5 minutes. Peroxidase activity was removed from the 
slides by immersion in 0.5% H2 O2 in methanol for 30 minutes. Slides were then 
washed thoroughly in PBS for 10 minutes; this step was repeated. Samples were 
blocked with 20% rabbit serum in PBS for 30 minutes. This was removed and the 
sections were then subjected to endogenous avidin blocking treatment. This involved
117
incubation with avidin D blocking solution (Vector Laboratories, Peterborough, 
U.K.) for 15 minutes, followed by a 5 minute wash in incubation and a 15 minute 
incubation with biotin blocking solution (Vector Laboratories). The blocking 
solution was tapped off and replaced with primary antibody in antibody diluent 
(Dako Ltd.). From this point on, the method was identical to that used for the 
immunostaining of cryosections, as given in section 2.3.2.
2.4.5 Immunostaining of paraffin-embedded tissue sections (CSA kit protocol)
A wax ring was drawn round the tissue with an immunohistochemistry pen and 
the slides were left in TBS for 5 minutes. Subsequent steps used components from 
the CSA, peroxidase kit (Dako Ltd.) supplied in bottles labelled 1-12. Endogenous 
peroxidase activity was removed from the sections by covering them with hydrogen 
peroxide (bottle 1) for 5 minutes. Slides were rinsed gently in 0.1% Tween 20 in 
TBS (TBST) from a wash bottle and then immersed in TBS for 5 minutes. Excess 
buffer was tapped off the slides and the section covered in protein block (bottle 2) for 
5 minutes. The blocking solution was tapped off and the section covered in avidin D 
blocking solution (Dako Ltd.) for 15 minutes. This was removed and replaced by 
biotin blocking solution (Dako Ltd.) for 15 minutes. The blocking solution was 
tapped off and primary antibody diluted in antibody diluent was applied and left to 
incubate for 2 hours at room temperature.
Slides were rinsed with TBST from a wash bottle then immersed in fresh 
TBST for 5 minutes. The sections were incubated with link antibody (bottle 4) for 15 
minutes and then washed in TBST as before. Streptavidin-biotin complex was 
applied to the sections. Streptavidin-biotin complex was prepared 30 minutes prior to 
use by mixing thoroughly 40pl each of streptavidin-biotin complex reagent A (bottle
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5) and streptavidin-biotin complex reagent B (bottle 6) with 1ml of streptavidin- 
biotin complex diluent (bottle 7). The streptavidin-biotin complex was removed after 
a 15 minute incubation and the tissues were again washed with TBST. Amplification 
reagent (bottle 8) was applied to the section for 15 minutes and then washed away 
with TBST in the usual manner. Streptavidin-peroxidase (bottle 9) was applied to the 
slides for 15 minutes and then washed away with TBST. Buffer was tapped from the 
slides and any excess liquid removed with a tissue before the application of 
substrate-chromogen solution. Substrate chromogen solution was prepared by 
dissolving a substrate tablet (bottle 10) in 10ml distilled water mixed with 10 drops 
of tris buffer concentrate (bottle 11). 200pl o f substrate hydrogen peroxide (bottle 
12) was added to the solution immediately before use. Substrate-chromogen solution 
was removed from the slides after 5 minutes. They were then rinsed in distilled water 
from a wash bottle and counterstained in filtered Harris hematoxylin solution for 5 
minutes. The sections were dipped quickly into 37mM ammonia 10 times and rinsed 
in distilled water. Sections were dehydrated through alcohols in the sequence 50% 
ethanol, 70% ethanol, 95% ethanol twice, 100% ethanol twice and, finally, 100% 
xylene twice. Sections were mounted in DPX mountant under glass coverslips.
2.4.6 Quenching of antibody binding bv antigenic peptides
Peptides matching the sequences against which the anti-11 p-hydroxylase and 
anti-aldosterone synthase antibodies had been raised were synthesised by Alta 
Bioscience, Birmingham, U.K. The peptide sequences were KNVYRELAEGRQQS for 
the anti-11 P-hydroxylase antibody and KVRQNARGSLTMDVQQ for the anti­
aldosterone synthase antibodies (see appendix 1). The peptides were dissolved in 
TBS and a series of ten-fold dilutions were made. These were mixed with a fixed
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amount o f primary antibody in antibody diluent (Dako Ltd.) and incubated overnight 
at 4°C. The peptide/antibody mixture was then incubated with tissue at the primary 
antibody incubation stage of the immunostaining protocol (see section 2.4.5).
2.5 Preparation And Immunostaining Of Fetal Hippocampal Neurons
2.5.1 Preparation of fetal hippocampal neurons for immunostaining
Primary hippocampal neuronal cultures were prepared from embryonic day 18 
Wistar rats. Briefly, hippocampi were dissected out according to the methods 
detailed by Goslin and Banker (Banker G and Goslin K, 1991). Tissue was washed 
three times in Hanks balanced salt solution (Life Technologies) containing HEPES 
buffer, pH 7.4, and was then trypsinised (1 mg/ml) for 10 minutes at 37°C and 
dissociated by trituration through a 25-gauge sterile needle. Cells were seeded at a 
density of 4><105 cells per 8 well poly-L-lysine-coated culture slide (Becton 
Dickinson) in Neurobasal medium (GibcoBRL, Paisley, U.K.) containing B27 
growth supplement and 0.5mM L-glutamine and grown in a humidified incubator at 
37°C/5% CO2 . The next day, cytosine arabinoside (5mM) was added to the medium 
to inhibit glial proliferation. Cells were left to grow for 7 days before experiments 
were carried out. Cultures typically contained less than 5% glia as determined by 
immunohistochemical staining with glial fibrillary associated protein (GFAP) 
antibody.
Cells were fixed for immunostaining by immersion in acetone for 10 minutes.
2.5.2 Immunostaining of fetal hippocampal neurons
Fetal hippocampal neurons were immunostained using the CSA peroxidase kit 
(Dako Ltd.) as described in section 2.4.5. No pretreatments were used.
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2.6 In Vitro Conversion Of 3H-DOC and DOC To Aldosterone And
Corticosterone Bv Fetal Hippocampal Neurons
2.6.1 Preparation of fetal hippocampal neurons for steroid conversion studies
Cells were prepared for conversion studies using the same basic protocol given 
in section 2.5.1. The only difference occurred after dissociation, where cells were 
seeded at a density o f 2x106 cells per 6 well poly-L-lysine-coated tissue culture plate 
(Becton Dickinson). Cells were then grown as normal.
24 hours prior to the incubation experiment, the composition o f the cell 
medium was altered, with N2 supplement being substituted for B27. This was due to 
the small levels o f corticosterone present in B27.
2.6.2 DNase treatment of RNA
DNase reactions were performed using the RQ1 DNase (Promega, 
Southampton, U.K.). The DNase reaction mixture was assembled in GeneAmp thin- 
walled reaction tubes (Perkin Elmer) on ice:
Solution Volume
RNA (200ng/pl) 50.0pl
MgCl2 (25mM) 20.0pl
1 Ox PCR buffer (Mg2+-free) 10.Opl
RQ1 DNase (lU /pl) 20.0pl
Tubes were incubated at 37°C for 1 hour. The reaction was terminated by the 
addition o f lOOpl phenol/chloroform. Tubes were vortexed for 10 seconds then spun 
at 7,000g for 5 minutes in a microfuge kept at 4°C. The aqueous upper layer was 
removed and placed in a clean tube with 3 volumes of 100% ethanol and 1/10th 
volume o f DEPC-treated 3M sodium acetate (pH 5.5) to precipitate the RNA. This
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was spun at 4°C again at 7,000g for 30 minutes. The supernatant was discarded and 
the pellet air-dried on ice for 15 minutes. The pellet was then resuspended in lOpL of 
DEPC-treated water. RNA concentration and purity was determined as described in 
section 2.1.2. RNA was stored at -70°C.
2.6.3 Steroid conversion experiments
Each well of a 6-well plate was incubated with 2mL of lOpM DOC in 
Neurobasal medium (GibcoBRL, Paisley, U.K.), 1% N-2 supplement and 0.1% 
gentomycin. Control medium omitted DOC. Medium was removed after 24 hours 
and stored at -20°C. Cells were suspended in PBS and retained for subsequent 
protein measurement using the Bio-Rad protein assay kit (see section 2.2.3).
2.6.4 M easurem ent of tritiated  steroid products
The medium was extracted with freshly distilled dichloromethane and the 
extract was evaporated to dryness under nitrogen at 30°C. Unlabelled aldosterone 
(lOOpg) and corticosterone (lOOpg) were added and the residue subjected to paper 
chromatography (system B5; (Bush, 1952)). The steroid regions were located by both 
ultraviolet light (220-240nm) and by scanning for 3H (Bioscan System 200 Imaging 
Scanner) and then eluted in methanol (5ml). The solution was evaporated to dryness 
and the residue rechromatographed. Finally, the steroids were again located, eluted 
and their 3H content measured by liquid scintillation spectrometry using Ecoscint 
scintillant (National Diagnostics, Atlanta, GA, U.S.A.). Pure 3H-standards were 
subjected to the same procedure to allow correction for recovery. The H-standards’ 
specific activities were 50 Ci/mmol for 3H-DOC (ICN Pharmaceuticals Ltd., 
Basingstoke, U.K.), 50 Ci/mmol for 3H-aldosterone (Amersham Pharmacia) and 49
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Ci/mmol for 3H-corticosterone (NEN, Boston, MA, U.S.A.). Recoveries for 3H- 
aldosterone and 3H-corticosterone were 17.3% and 29.4% respectively. A 2ml 
aliquot of incubation medium was extracted with dichloromethane, the residue 
dissolved in methanol (lOOpl) and 3H content measured. Efficiency for 3H was 63%.
2.6.5 Measurement of nonradioactive steroid products
H-Corticosterone (25,000cpm) or H-aldosterone (25,000cpm) was added to 
aliquots of incubation medium removed from replicate samples o f two cell batches. 
The samples were extracted with freshly distilled dichloromethane and the extract 
washed once with water and evaporated to dryness with at 37°C under nitrogen. The 
residues were chromatographed on paper (system B5 for aldosterone, system B1 for 
corticosterone) and the appropriate steroid regions located by isotope scanning and 
eluted in methanol (5ml). Aldosterone samples were evaporated to dryness at 37°C 
under nitrogen and the residue redissolved in radioimmunoassay diluent (Diagnostic 
Products Ltd., Gwynedd, U.K.). Aliquots were removed for measurement o f 3H 
content in order to assess recovery. Aldosterone was measured by direct 
radioimmunoassay (Diagnostic Products Ltd.) and corticosterone by the method of 
Fraser et al. (1973).
2.6.6 GCMS identification of aldosterone
Aldosterone standards were derivatised as follows. lOOpg of aldosterone was 
dissolved in lOOpg methanol to which 0.5ml of 0.5M periodic acid (HIO4) in 1% 
pyridine (aq) was then added. This was incubated in the dark at room temperature for
1.5 hours to form y-lactone. 1ml o f water was added and steroid extracted by the 
addition of 6ml of freshly distilled dichloromethane followed by the removal o f the
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aqueous layer. The extract was washed in 1ml of water, the aqueous layer was again 
removed and the remainder evaporated to dryness under nitrogen. To the residue was 
added 60jj.1 of heptafluorobutyric anhydride (HFBA) and 60pl toluene. This was 
incubated for 30 minutes at 60°C and then evaporated to dryness under nitrogen. The 
residue was dissolved in 1ml of hexane, lp l of this was injected on to the gas 
chromatography mass spectrometer (GCMS) (Varian Saturn GCMS System, Varian, 
Walnut Creek, California, U.S.A.). The derivatisation is summarised in figure 2.6a.
Aldosterone from cell medium samples was prepared by extracting 1ml o f the 
cell medium with 6ml o f freshly distilled dichloromethane, which was then washed 
with 1ml of water and evaporated to dryness under nitrogen. This was partially 
purified by paper chromatography using system B5 (Bush, 1952). Aldosterone 
standards were run alongside and used to detect the samples on a UV scanner 
(Bioscan System 200 Imaging Scanner). Samples were eluted in 5ml o f methanol, 
evaporated to dryness under nitrogen and then derivatised in the same way as the 
aldosterone standards (see above).
CHjOH
Aldosterone
H104 in 
pyridine (aq)
Y -L ic tone
1'HFBA
Figure 2.6a Derivatisation of aldosterone for GCMS
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Chapter 3
Results: Reverse Transcription-Polvmerase Chain Reaction (RT-PCR1 And 
Southern Blotting Of Steroidogenic Gene Transcripts
3.1 Introduction
Total RNA from a range of rat tissues was analysed for the presence of 
CYP11B1, CYP11B2, CYP11B3, CYP11A1 and adrenodoxin gene transcripts using 
the reverse transcription-polymerase chain reaction (RT-PCR). CYP11B1 and 
CYP11B2 are o f obvious importance, their products being the terminal enzymes in 
the cortisol and aldosterone pathways without which the corticosteroids cannot be 
produced. CYP11B3 transcription was also investigated in these tissues as 
comparatively little is known about where and when this occurs. CYP11A1 
transcription was examined due to its position at the start o f the biosynthetic 
pathway, performing the initial conversion step from cholesterol to pregnenolone. Its 
presence in extraadrenal tissues would give an indication of whether corticosteroid 
synthesis occurs de novo (i.e. from cholesterol), or whether synthesis of aldosterone 
or cortcosterone relies on the tissue converting intermediary metabolites such as 
progesterone or DOC. Finally, adrenodoxin is a vital cofactor for aldosterone 
synthase, 11 p-hydroxylase and the side-chain cleavage enzyme; the expression of 
these enzymes’ genes would serve no purpose without the co-expression of 
adrenodoxin.
The tissues selected for analysis were whole brain, kidney, liver, heart, 
mesenteric artery and spleen, the last anticipated to act as a negative control. 
Previous work by other groups had singled out the hypothalamus as a brain region of 
particular interest. This was also dissected out and subjected to RT-PCR separately.
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3.2 Methods
The general RT-PCR, Southern blotting and probing methods for all genes is 
described in section 2.1. The RT-PCR protocols were adapted from previously 
published work (Nomura et al. 1993; Stromstedt and Waterman, 1995).The full 
sequences of the rat C Y P llB l  and CYP11B2 genes, together with the corresponding 
positions of relevant oligonucleotides, are given in appendix 1. The sequences of all 
oligonucleotide primers are listed in appendix 2.
Adrenal tissue was used as a positive control throughout. The integrity of 
isolated RNA was tested by spectrophotometry and agarose gel electrophoresis; the 
distinctive bands formed by the three ribosomal RNA (rRNA) species (28S, 18S and 
5S) which account for 85% of mammalian RNA are not visible in degraded samples. 
An example of this is given in figure 3.2a. RNA integrity was also confirmed 
through the RT-PCR of transcripts from the constitutively-expressed ‘housekeeping’ 
gene for glyceraldehyde phosphate dehydrogenase (GAPDH).
Heart RNA Mesenteric RNA
1 2  1 2
28S rRNA
18S rRNA
5S rRNA
Figure 3.2a RNA isolated from heart and mesenteric artery separated on a 1% 
agarose gel stained with ethidium bromide and visualised under ultraviolet 
light. The samples display the distinctive bands of rRNA except for mesenteric 
RNA sample 2 which has degraded during the isolation process.
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The design of oligonucleotide primers in experiments such as these is crucial to 
the specificity of the reactions. Primers were used which spanned the exon-intron 
boundaries of the relevant genes. Therefore, if  there was any genomic DNA 
contamination of the RNA sample, it resulted in a larger band size which could easily 
be distinguished from those caused by the amplification of transcripts. Such genomic 
bands would also be visible in control samples that had not been treated with reverse 
transcriptase.
3.3 Results
3.3.1 Adrenodoxin
The RNA from all the tissues tested was found to contain adrenodoxin gene 
transcripts (see figure 3.3a). Indeed, the distinctive 289 base pair band was intense 
enough to be seen on ethidium bromide-stained agarose gels under ultraviolet light, 
rendering Southern blotting unnecessary. Control reactions performed in the absence 
of reverse transcriptase, or with water substituted for RNA, were all negative.
3.3.2 CYP11A1
The RT-PCR products were separated on 1% agarose gels and Southern blotted 
to nylon membranes before probing with the CYP1 /^7-specific oligonucleotide 
V8822. After exposure to film, this revealed specific bands within the adrenal, brain, 
kidney, heart and hypothalamus samples at positions on the blot that corresponded to 
the expected 583bp band size on the original agarose gels (see figure 3.3b). A 
slightly smaller band was also visible in these lanes. No bands were visible in liver, 
spleen or mesenteric artery RNA reactions, nor in those control reactions performed 
in the absence o f reverse transcriptase or with water instead o f RNA.
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3.3.3 CYP11B1
As with CYP11A1, the RT-PCR products were separated on 1% agarose gels 
and Southern blotted to nylon membranes. The blots were probed with the CYP11B1- 
specific oligonucleotide P5815. Exposure to film revealed bands only in the adrenal, 
brain and hypothalamus samples (see figure 3.3c). These bands corresponded to the 
expected 342bp band size on the original agarose gels. No bands were visible in the 
kidney, liver, spleen, heart or mesenteric artery reverse transcriptase reactions. 
Control reactions were also negative.
3.3.4 CYP11B2
RT-PCR products subjected to conditions identical to the previous CYP11B1 
samples were separated on 1% agarose gels and Southern blotted to nylon 
membranes. The CFP777?2-specific oligonucleotide P5814 was used to probe the 
blots, which were then washed and exposed to film. Bands corresponding to the 
expected 342bp product size were identified in adrenal, brain, spleen and 
hypothalamus samples (see figure 3.3d). Kidney, liver and heart samples were 
negative, as were the mesenteric artery sample and the control reactions.
3.3.5 CYP11B3
RT-PCR products subjected to the same conditions as those of CYP11B1 and 
CYP11B2 were run on 1% agarose gels, Southern blotted and the resulting membrane 
probed with the CTP777?3-specific oligonucleotide P5816. Despite lengthy exposures 
to film, no bands, specific or otherwise, could be identified on the blot, even in the 
adrenal sample.
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Adrenal Brain Kidney Liver Water Marker
+  -  +  -  +  -  +  -  +  -
310bp
Adrenal Spleen Heart Mesenteric Water Marker
+ -  + -  + -  + -  + -
310bp
Adrenal Hypothal. Brain Water Marker
+  -  +  -  + -  +  -
3 lObp
Figure 3.3a RT-PCR of RNAs from various tissues using primers specific for 
adrenodoxin in the presence (+) and absence (-) of reverse transcriptase. RT- 
PCR products were separated on 1% agarose gels and detected by ethidium 
bromide staining visualised under ultraviolet light. RT-PCR products were run 
alongside H aelll <J>X174 digest marker; the position of the 310bp m arker band is 
indicated.
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Adrenal Brain Kidney Liver Water
+  -  +  -  +  -  +  -  +  -
583bp t  •
Adrenal Spleen Heart Mesenteric Water
+  -  +  -  +  -  +  -  +  -
583bp
Adrenal Hypothal. Water
+  -  +  -  +  -
583bp
Figure 3.3b RT-PCR of RNAs from various tissues using primers specific for 
CYP11A1 in the presence (+) and absence (-) of reverse transcriptase. RT-PCR 
products were separated on 1% agarose gels and Southern blotted to nylon 
membranes, then probed with the radiolabelled CYP11A1-specific
oligonucleotide V8822. The blots were washed and exposed to film. Bands 
corresponding to the expected size of 583bp are indicated.
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Adrenal Brain Kidney Liver Water
+  -  +  -  +  -  +  -  +  -
342bp >  m
Adrenal Spleen Heart Mesenteric Water
+  -  + -  +  -  +  -  +  -
342bp
Adrenal Hypothal. Water
+  -  +  -  +  -
342bp
Figure 3.3c RT-PCR of RNAs from various tissues using primers specific for 
CYP11B in the presence (+) and absence (-) of reverse transcriptase. RT-PCR 
products were separated on 1% agarose gels and Southern blotted to nylon 
membranes, then probed with the radiolabelled CYP11B1-specific 
oligonucleotide P5815. The blots were washed and exposed to film. Bands 
corresponding to the expected size of 342bp are indicated.
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Adrenal Brain Kidney Liver Water
+  -  + -  +  -  +  -  +  -
342bp
Adrenal Spleen Heart Mesenteric Water
+  -  +  -  +  -  +  -  +  -
342bp
Adrenal Hypothal. Water
+  -  +  -  +  -
342bp — ►
Figure 3.3d RT-PCR of RNAs from various tissues using primers specific for 
CYP11B in the presence (+) and absence (-) of reverse transcriptase. RT-PCR 
products were separated on 1% agarose gels and Southern blotted to nylon 
membranes, then probed with the radiolabelled CYP11 /L?-specific 
oligonucleotide P5814. The blots were washed and exposed to film. Bands 
corresponding to the expected size of 342bp are indicated.
132
3.4 Discussion
In recent years, and due in no small part to the increased sensitivity of 
molecular biological techniques, evidence has accumulated to suggest that 
corticosteroid production may occur in tissues other than the adrenal cortex. The 
reverse transcription-polymerase chain reaction (RT-PCR) allows gene transcription 
to be analysed with much greater sensitivity than was previously possible. Using this 
technique, isolated RNAs from a variety of different tissues can be screened for the 
presence of a particular mRNA species. RT-PCR, therefore, commends itself to the 
detection o f steroidogenic enzyme mRNAs in extraadrenal tissues.
The sensitivity of RT-PCR is often such that the final reaction product can be 
separated and visualised directly on ethidium bromide-stained agarose gels under 
ultraviolet light, as was the case here with the adrenodoxin samples. Previous 
investigations into adrenodoxin expression concluded that it was transcribed in 
virtually all rat tissues and these results supported this. Stromstedt and Waterman 
(1995), using a protocol similar to the one employed here, were also able to detect 
bands directly on ethidium bromide-stained gels. Their work investigated RNA from 
the adrenal, liver, testis and various brain subregions. Mellon and Kushner (1991) 
achieved positive results in all the tissues they tested, apart from spleen, using an 
RNase protection assay. The detection of adrenodoxin transcripts in spleen here may 
be attributed to the greater sensitivity of RT-PCR. The apparent ubiquity of 
adrenodoxin expression suggests that mitochondrial cytochrome P450 enzymes such 
as side-chain cleavage enzyme, 11 P-hydroxylase and aldosterone synthase would be 
able to function in any extraadrenal tissues where they happened to be expressed.
Where direct visualisation of PCR products on a gel is not possible, the further 
technique of Southern blotting is required; this also increases specificity. Products
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are transferred from the agarose gel to a nylon membrane which can then be probed 
with specific radiolabelled oligonucleotides. This technique was used here for two 
reasons. First, the radiolabelled oligonucleotides are a more sensitive method of 
detection than visualisation of the gel under UV light; probing can identify 
previously invisible positive PCR bands. Second, the CYP11B1, CYP11B2 and 
CYP11B3 genes are so similar that it is difficult to find long regions of sufficient 
heterogeneity between them in order to construct specific PCR primers. Instead, 
common PCR primers were used for the CYP11B genes, the three being 
distinguished only by specific radiolabelled oligonucleotides after Southern blotting.
Stromstedt and Waterman (1995) also used RT-PCR and Southern blotting to 
demonstrate CYP11A1 transcription in certain brain subregions (cerebellum and 
brain stem) but, in common with the findings here, could not do so in liver. They also 
encountered bands of a higher molecular weight; these could not be attributed to the 
amplification o f genomic DNA as they were absent from the -R T controls. Non­
specific bands were also found with the CYP11A1 probe here, but in this case they 
were of a lower molecular weight. Although it is possible that they are the products 
o f alternative splicing events, it is more probable that they result from non-specific 
interactions similar to those found by the other group.
The investigation of CYP11A1 expression was designed to demonstrate 
extraadrenal tissues’ potential for de novo corticosteroid production. While these 
results confirm that this is possible in tissues such as kidney, brain and heart, side- 
chain cleavage enzyme is required for numerous other steroid pathways besides that 
which leads to the corticosteroids. CYP11A1 was also deemed worthy o f examination 
due to its supposed role at the rate-limiting step of the corticosteroid pathway. 
However, the rate-limiting factor in the corticosteroid pathway is now known to be
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the delivery of cholesterol by StAR and, in retrospect, it would have been advisable 
to investigate this protein’s extraadrenal transcription too. Recent work by Furukawa 
et al. (1998) has used RT-PCR and RNase protection assays to show that the StAR 
gene and CYP11A1 are transcribed in the rat brain. Their subsequent in situ 
hybridisation work showed a colocalisation of these genes’ transcripts within the 
pyramidal cells o f the hippocampus and the Purkinje cells o f the cerebellum. 
Transcripts for 3P-HSD, the enzyme that follows CYP11A1 in the pathway, were 
also found in these regions. This suggests a real potential for brain tissue to produce 
corticosteroids from cholesterol.
CYP11A1 transcription was also found in heart, although work by Zhao et al. 
failed to find evidence of 3(3-HSD transcription in this tissue thus undermining the 
possibility o f de novo corticosteroid production. However, their analysis involved the 
less sensitive RNase protection assay, and also failed to find the brain 3(3-HSD 
transcripts subsequently identified by Furukawa et al.
According to the findings here, CYP11B1 and CYP11B2 are both transcribed in 
brain tissue, with the isolated hypothalamus also giving a strong signal for both. This 
agrees with findings by several other groups (Mellon and Deschepper, 1993; 
Stromstedt and Waterman, 1995; Gomez-Sanchez et al. 1996; Erdmann et al. 1996). 
These groups performed their analysis on various subregions o f the brain, leading to 
data that are often contradictory. RT-PCR is not an ideal technique to provide 
detailed information about localisation of expression; such data are better provided 
by in situ hybridisation or immunostaining of tissue sections (see chapter 5).
The strong positive signal for CYP11B2 in the spleen is intriguing, given the 
negative results for CYP11B1 and CYP11A1 in the same tissue. The inability to 
detect either transcript in heart or mesentric artery was puzzling given the previous
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success by others in this area. Takeda et a l  (1997) found CYP11B2 in the mesenteric 
arteries o f SHRSP and WKY rats. Silvestre et a l  (1998) were also able to show 
CYP11B1 and CYP11B2 transcription in the left ventricles of WKY animals. It may 
be that their technique -  which employed digestion of the RT-PCR product rather 
than Southern blotting to distinguish between the amplified CYP11B1 and CYP11B2 
-  was more sensitive than the one used here. As with the CYP11A1 RT-PCR, 
additional bands appeared on the final blots. As these were absent from the -RT 
controls, they cannot be attributed to genomic DNA amplification but are, again, 
most probably the result o f non-specific interactions between the radiolabelled 
oligonucleotide primer and certain cDNA species within the RT-PCR product.
The final RT-PCR investigation involved the CYP11B3 gene and proved to be 
entirely negative. This is not surprising as the gene is thought to be transcribed only 
for a short time in the neonatal adrenal gland (Mellon et a l  1995). Therefore, the 
usual positive control of adult adrenal RNA was not adequate. Similarly, Silvestre et 
al (1998) showed the CYP11B3 transcripts’ presence in the 21-day-old rat heart but 
not the two-month-old. Given these data, it would have been better to use neonatal 
adrenal RNA as a positive control for these experiments to confirm whether the 
negative results were due to the absence o f CYP11B3 transcription or to a failure in 
the protocol.
Taken in combination, these results from various tissues suggest that the most 
promising candidate as an extraadrenal tissue capable of de novo corticosteroid 
synthesis is the brain. Together with the findings of Silvestre et a l  (1998), the heart 
also appears to be a good prospect. Although other tissues were positive for certain 
transcripts -  CYP11A1 in the kidney, CYP11B2 in the spleen -  they did not have the 
multiple gene expression required for corticosteroid production.
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Female rats were used throughout these experiments. This was due to the 
practical reason that they tend to have larger adrenal glands, thus yielding more 
RNA. As male rats were not tested, the possibility that they have different patterns of 
expression cannot be ruled out although similar studies have tended to find no sex 
differences (see section 1.8).
The RT-PCR technique employed here is not quantitative; semi-quantitative 
RT-PCR would require an additional PCR product within the same reaction derived 
from a sequence of known quantity which could be used as a reference point for 
comparison with the transcript of interest. Nevertheless, there can be little doubt that 
the levels of all transcripts, with the possible exception of adrenodoxin, occurs at 
lower levels within the extra-adrenal tissues than in the adrenal cortex. This may be 
due to less transcription within extra-adrenal tissues or to production of less stable 
transcripts that degrade more rapidly than their adrenal equivalents. Less 
transcription within the tissue does not necessarily mean that every cell is 
transcribing the same genes more slowly than those of the adrenal cortex. Instead, 
transcription may be occurring at the same rates -  or even higher -  but within fewer 
cells. Thus, for example, parts of the brain may transcribe CYP11B1 at a very high 
rate but the concentration of these transcripts would decrease within the total brain 
RNA samples used for these RT-PCR reactions. Such local concentration of 
expression would also be reflected in the concentrations of steroids produced at such 
sites. For example, aldosterone in the rat myocardium has a concentration o f 16nM 
which is almost 20 times the level found in plasma (Delcayre and Silvestre 1999). 
Given such differences between adrenal and extra-adrenal expression, the question 
arises of whether transcriptional regulation in extra-adrenal tissues occurs
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independently of that in the adrenal cortex and, if  so, what factors might influence 
this (see section 1.4).
Having established that the transcription of steroidogenic genes occurs in select 
extraadrenal tissues, it is necessary to show that these transcripts go on to form the 
relevant polypeptide products. This is the subject o f chapters 4 and 5.
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Chapter 4
Results: SDS-Polvacrvlamide Gel Electrophoresis (SDS-PAGE) And
Immunoblotting
4.1 Introduction
The control of gene expression operates at several levels and, although the 
most common of these is the regulation of gene transcription, the presence o f mRNA 
within a cell does not guarantee its translation into a functioning polypeptide product. 
Therefore, besides the transcriptional information provided by such techniques as 
RT-PCR and in situ hybridisation, studies o f gene expression must show evidence of 
the protein’s presence. This can be done by immunoblotting (also known as Western 
blotting) and/or immunostaining which require an antibody specific for the protein of 
interest. Given the range of proteins expressed by an organism and their variations 
from species to species, it is a common source o f frustration that no specific antibody 
is readily available for the detection of a particular protein. It was fortunate, 
therefore, that antibodies specific for the rat forms of 11 p-hydroxylase and 
aldosterone synthase were made available for this research through a kind gift from 
Professor Celso E. Gomez-Sanchez. This chapter deals with attempts to detect l lp -  
hydroxylase and aldosterone synthase by immunoblotting.
4.2 Methods
The techniques used in this chapter are described in section 2.2. A brief 
account of antibody preparation is given in section 2.2.1. The general SDS-PAGE 
protocol is detailed in sections 2.2.2 to 2.2.8. This was also performed in a modified,
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non-denaturing, non-reducing (i.e. native) form and the changes to the standard 
protocol this entailed are given in section 2.2.9.
4.3 Results
Using SDS-PAGE, a band corresponding to the expected 52,000 molecular 
weight was identified using the anti-llp-hydroxylase 11BIA4 antibody in 
mitochondrial fractions prepared from adrenal tissue. See figure 4.3a.
The 11BIA4 antibody was raised against residues 272-285 o f l lp -  
hydroxylase. The band could not be detected in mitochondrial fractions derived from 
brain tissue.
No specific bands corresponding to aldosterone synthase could be identified in 
adrenal or brain mitochondrial fractions using any of the three antibodies raised 
against a peptide from this enzyme (AS IG5 HC3, AS IE6 and AS IC11).
A single band corresponding to a molecular weight o f 25,000 was present in all 
lanes, including those which had not been exposed to 1° antibody. For this reason, 
this band was attributed to a non-specific interaction with the horseradish peroxidase- 
labelled 2° antibody.
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A D R  H I P P A D R  H I P P A D R  H I P P A D R  H I P P A D R  H I P P
52 .0 0 0 — ► ^  -
m ol. w t. 
2 5 .0 0 0 — ►
m ol. w t. *
1 °  a b :  A n t i - 1113- A n t i - l l p - A n ti-a ld o A n ti-a ld o N o n e
h y d ro x y lase h y d ro x y la se sy n th ase sy n th ase
(1 1 B IA 4 ) ( 1 1B IA 4) (A S  IE 6) (A S  IE 6)
1°  a b  d i l n . :  1:250 1:500 1:250 1:500 n/a
Figure 4.3a Immunoblot detecting 11 (3-hydroxylase in adrenal tissue. 200 pg of 
denatured, reduced adrenal or hippocampal mitochondrial protein samples 
were separated on a 10% SDS-polyacrylamide gel. The proteins were then 
transferred to Hybond-P membrane which was blocked, then split into five 
parts. Each part was subjected to different 1° antibody incubations at 37°C 
overnight, followed by incubation with HRP-labelled sheep anti-mouse 2° 
antibody at a 1:1,000 dilution for 2 hours at 37°C. Bands were detected using 
Supersignal ULTRA chemiluminescent substrate followed by exposure to film 
for 5 minutes. Size was determined by comparison with Rainbow markers 
(range 10,000-250,000) run alongside samples on the gel.
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4.4 Discussion
As the primary antibodies were not obtained from a commercial source, it was 
necessary to determine the optimum conditions for their use in immunoblotting and a 
large number of variations to the SDS-PAGE protocol were attempted before the 
final form given in section 2.2 was found to be the most effective. The various stages 
of the SDS-PAGE procedure and the modifications to the protocol at each o f these 
stages are detailed below.
1. Preparation of protein from Wistar-Kyoto rats. Initially, whole adrenal gland 
and brain homogenates were used for the immunoblotting procedure. When this 
failed to yield positive results, mitochondrial fractions were prepared from fresh 
tissue in the hope that this would concentrate the mitochondrial cytochrome P450 
enzymes under investigation and thus give a stronger signal.
2. Preparation of polyacrylamide gel and protein for electrophoresis. Most 
antibodies are raised against the protein in its denatured, reduced state and, for 
this reason, gels were prepared containing sodium dodecyl sulphate (SDS). Later, 
proteins were electrophoresed under non-denaturing, non-reducing (i.e. native) 
conditions, with SDS omitted from the gel and tank buffer to see if this favoured 
antibody binding but this was found to offer no advantage. Under denaturing 
conditions, proteins were loaded on to the gel in Laemmli buffer which contains 
SDS, urea and dithiothreitol (DTT). Samples were usually boiled for 3 minutes 
before loading but this step was omitted to see if this altered the outcome of the 
experiment. Immunoblots prepared under native conditions used a non­
denaturing, non-reducing loading buffer.
3. Blotting of proteins on to membrane. Proteins were initially blotted on to 
nitrocellulose membranes. This was later changed to Hybond-P, a hydrophobic
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polyvinylidene difluoride (PVDF) transfer membrane, which has a higher 
protein-binding capacity and gives a more intense, longer-lasting signal when 
used with certain ECL substrates (see step 8).
4. Blocking of membrane. Various blocking times, from 30 minutes to 3 hours, 
were tried, before settling on a 2 hour period.
5. Incubation of membrane with 1° antibody. The optimum dilution of each 
antibody was resolved experimentally. The length and temperature of antibody 
incubations is often a compromise between the amount of antibody binding and 
its specificity; attempts to increase the intensity o f a signal will often result in the 
emergence of additional, non-specific bands. Various incubation temperatures 
ranging up to 37°C (where one would expect antibody binding to be greatest but 
also least specific) were tried, with the best results being obtained from 
incubations at a low temperature of 4°C overnight.
6. Washing of membrane. The wash solution consisted of Tris-buffered saline 
(TBS) plus the detergent Tween 20. A low amount of Tween 20 may not wash 
off sufficient antibody to reduce background and non-specific signals, while too 
high a concentration can wash off specifically-bound antibody. A range of Tween 
20 concentrations from 0.05% to 0.5% were used within this TBST mixture 
before settling on 0.4% Tween 20 in TBS.
7. Incubation of membrane with 2° antibody. The optimisation of experimental 
conditions that applied to the 1° antibody (see above) was also appropriate for the 
2° antibody. A 2-hour incubation at 37°C was found to be best. Also, the supplier 
o f HRP-labelled sheep anti-mouse IgG was changed from SAPU (Scottish 
Antibody Production Unit, Carluke, U.K.) to Amersham Pharmacia Biotech U.K. 
Ltd., as the latter product yielded fewer non-specific bands, possibly due to its
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high-species specificity which would prevent cross-reaction with rat proteins on 
the membrane.
8. Signal detection by enhanced chemiluminescence (ECL). Chemiluminescent 
reagents such as the diacylhydrazide luminol undergo a reaction in the presence of 
horseradish peroxidase which results in the production of light (see figure 4.4a). 
This light can be detected by exposure to film making the technique a valuable 
method for the detection of bound antibody. Several types of chemiluminescent 
substrate were used during the course of the immunoblotting experiments. The 
use of ECL Plus (Amersham Pharmacia Biotech U.K. Ltd.) was stopped in favour 
of Supersignal and Supersignal ULTRA (both Pierce & Warriner, Chester, U.K.) 
upon a colleague’s recommendation, and these were found to give more intense 
and sustained signals.
I.unuiuil
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Figure 4.4a Schematic representation of a chemiluminescent reaction using 
enhanced luminols.
Despite these adjustments to the protocol, 11 (3-hydroxylase was not detected in 
extra-adrenal tissues and aldosterone synthase could not be found in any tissue,
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including the adrenal gland. The failure to detect these enzymes was attributed to the 
insensitivity o f the immunoblotting technique. One would expect adrenal 11(3- 
hydroxylase to be the most abundant of the proteins that were sought, whereas 
adrenal aldosterone synthase levels would be much lower given the size of the zona 
glomerulosa in comparison to the zona fasciculata/reticularis; brain levels of either 
enzyme are likely to be lower still given the results of the RT-PCR experiments. The 
maximum amounts of protein (~ 200pg/well) had been loaded on to the gel, so this 
could not be increased, although it might have been possible to enrich the levels of 
CYP11B1 and/or CYP11B2 within the samples by treating the animals with, for 
example, a low sodium diet. LeHoux et al. (1996) were able to increase dramatically 
the levels of CYP11B2 in hamster adrenal tissue in this way.
Attempts were made to increase the sensitivity of the immunoblotting 
technique using a commercially available avidin biotin kit (Vectastain ABC, Vector 
Laboratories Ltd., Peterborough, U.K.) to amplify weak signals. Unfortunately, this 
technique resulted in the appearance of numerous non-specific bands as well as a 
significant increase in background signals; any positive bands that might have been 
present were masked by these non-specific signals (see figure 4.4b). A compromise 
between the lack of signal and complete overload by background could not be 
established.
Personal communications with Professor Gomez-Sanchez established that he 
had had some success in his immunoblotting experiments with these antibodies. With 
the anti-11 (3-hydroxylase antibody, he identified a distinct band o f unspecified size in 
adrenal tissue but, additionally, found a band in the brain with a molecular weight of 
approximately 35,000. Using one of the three aldosterone synthase antibodies, he 
was also able to detect a distinct band of unspecified size in adrenal samples as well
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Figure 4.4b Immunoblot prepared using Vectastain ABC kit. 200 pg of 
denatured, reduced adrenal (A) or hippocampal (H) mitochondrial protein 
samples were separated on a 10% SDS-polyacrylamide gel alongside Rainbow 
markers (M) of molecular weight 10,000 to 250,000. The proteins were then 
transferred to Hybond-P membrane which was blocked and then split into five 
parts. These were subjected to differing 1° antibody incubations at 37°C 
overnight. M embrane sections prepared without the use of Vectastain were then 
incubated with HRP-labelled sheep anti-mouse 2° antibody at a 1:1,000 dilution 
for 4 hours at 37°C. O ther sections were incubated with biotinylated rabbit anti­
mouse 2° antibody at a 1:1,000 dilution for 2 hours at 37°C and then Vectastain 
ABC for 1 hour at room tem perature. Bands were detected using Supersignal 
ULTRA chemiluminescent substrate followed by exposure to film for 5 seconds. 
A faint positive band for 11 [3-hydroxylase in adrenal tissue is indicated by the 
dotted line.
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as a larger band of molecular weight 60,000-70,000 in brain. Despite emulating 
some of his techniques, attempts to reproduce these unpublished results proved 
unsuccessful and this must be attributed to some unidentified technical difference.
From their amino acid sequences, rat 11 P-hydroxylase and aldosterone 
synthase should have identical molecular weights. This is also the case with the 
human forms of the enzymes. However, when the human adrenal forms of 
aldosterone synthase and 11 p-hydroxylase underwent electrophoresis on SDS- 
polyacrylamide gels, they were found to have molecular weights of 49,000 and 
51,000 respectively (White et al. 1994). This may be related to post-translational 
modifications to these proteins, although nothing concerning the phosphorylation or 
glycosylation of the enzymes is known.
The differing rigours that proteins must undergo during preparation for 
immunoblotting and immunostaining mean that a target antigen may adopt slightly 
different conformations. Therefore, it is possible for an antibody to be better suited 
for one or other of these techniques, depending on which o f them presents the 
epitope in the form best recognised by the antibody. For this reason, it was decided to 
proceed with immunostaining experiments using these same primary antibodies in 
spite of the disappointing results of immunoblotting.
147
C hapter 5
Results: Detection O f ll[3-Hvdroxvlase And Aldosterone Synthase In Adrenal 
And Extra-Adrenal Tissue Bv Imm unostaining
5.1 Introduction
In the previous two chapters, homogenised tissue was assayed for the presence 
o f particular mRNAs or polypeptides. While extremely valuable, such methods are 
limited in the information they convey about the localisation o f expression. This is of 
particular importance when looking at brain tissue, where gene expression is by no 
means homogenous even within a single region such as the cerebellum or 
hypothalamus. Detailed localisation studies require that whole sections of tissue be 
stained specifically for particular enzymes. This chapter describes the staining of rat 
tissue sections using specific antibodies in order to establish the distribution of 11 (3- 
hydroxylase and aldosterone synthase within adrenal and extra-adrenal tissue.
5.2 Methods
The protocol used for the preparation and immunostaining of cryosections is 
described in section 2.3. The protocols for preparation, pretreatment and 
immunostaining of paraffin-embedded tissue sections are given in section 2.4. 
Briefly, an avidin biotin enzyme complex (ABC) technique was used for the 
immunostaining of cryosections and initially for paraffin-embedded sections also. 
This was later changed to the DAKO CSA kit method (see section 2.4.5). This 
technique is capable of greater signal amplification than the ABC method.
Control sections were incubated with DAKO Mouse IgGl Negative Control. 
This is a mouse monoclonal antibody with a specificity for Aspergillus niger glucose
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oxidase, an enzyme absent from mammalian tissues. As an additional control, 
primary antibodies were preincubated with their respective immunogenic peptides 
(see section 2.4.6). This quenches specific antibody binding and, therefore, positive 
staining thereby confirming the specificity of the primary antibodies.
The preparation of the primary antibodies, which are identical to those used in 
chapter 4 for immunoblotting, is described in section 2.2.1.
5.3 Results
3,3’-Diaminobenzidine tetrahydrochloride (DAB) was the chromogen used in 
all immunostaining reactions, resulting in a brown colour in positively-stained areas. 
The counterstain, Harris hematoxylin solution, gave a purple/blue colour.
Initial immunostaining experiments were performed on adrenal cryosections 
using an ABC method (see figure 5.3a). Immunostaining using the anti-11(3- 
hydroxylase antibody 11BIA4 was localised to the zona fasciculata/reticularis of the 
adrenal cortex and was absent from the zona glomerulosa. Incubation with the anti­
aldosterone synthase antibodies resulted in no staining. Control sections were also 
negative.
A similar protocol was used on adrenal paraffin-embedded tissue that had been 
fixed for 24 hours in formalin solution (40% w/v formaldehyde). Protease and 
microwave pretreatments were performed on the sections before immunostaining and 
a biotin blocking step was added to the protocol that had been used on cryosections 
(see figure 5.3b). Again, the 11BIA4 antibody stained the zona 
fasciculata/reticularis, albeit rather faintly. Use of the AS IG5 anti-aldosterone 
synthase antibody was also able to produce staining. This localised to the zona 
glomerulosa, forming a thin, broken ring round the outside of the adrenal cortex.
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Control sections were negative. No staining could be produced in brain tissue using 
this method.
A CSA kit protocol was adopted to increase staining intensity. The tissue used 
throughout was fixed in 4% w/v paraformaldehyde for 24 hours prior to embedding 
in paraffin and sectioning. Microwave pretreatments were used. The anti-11 p- 
hydroxylase antibody 11BIA4 and the anti-aldosterone synthase antibody AS IE6 
were used throughout. This method was found to intensify the staining in adrenal 
tissue which followed the same zonal patterns observed using the previous methods 
(see figures 5.3c and 5.3d). In particular, the outer zona fasciculata was intensely 
stained, with a more diffuse or banded appearance in the inner zona fasciculata. Little 
staining was apparent in the zona reticularis. In addition, however, the staining 
produced by 11BIA4 extended into the adrenal medulla (see figure 5.3e).
Immunostaining was also observed in brain sections and, unlike the adrenal 
gland, staining for 11 p-hydroxylase and aldosterone synthase was found to 
colocalise. Two particular regions of the brain produced distinct, reproducible 
staining for both enzymes. One was the cerebellum (see figure 5.3f). Staining was 
heavier in the molecular layer, lighter in the granular layer and was almost absent 
from the white matter. However, the Purkinje cells which line the boundary o f the 
molecular and granular layers were found to be stained most intensely of all (see 
figure 5.3g).
The other region of the brain to show strong staining for both enzymes was the 
hippocampus (see figure 5.3h). The pyramidal cells of this region were stained 
intensely throughout the dentate gyrus and CA1-3 cells o f Ammon’s horn. The cells 
o f the CA3 region are shown with higher magnification in figure 5.3i.
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The specificity of staining produced by this method was confirmed by two 
types of control. The first employed the Mouse IgGl Negative Control described 
previously. The second involved the preincubation o f a constant amount of 
monoclonal antibody together with differing concentrations of the peptide against 
which it was raised. At higher concentrations of peptide, specific staining is 
quenched as all antibody is bound by its peptide and it is therefore unable to bind to 
the tissue. As the peptide concentration decreases the antibody-tissue binding 
gradually returns, as does the staining. Examples of this can be seen in figures 5.3j 
and 5.3k. Figure 5.3j shows the quenching of immunostaining in the adrenal zona 
fasciculata/reticularis by the preincubation of the anti-1 lp-hydroxylase antibody 
11BIA4 with the peptide against which it was raised. Figure 5.3k shows the 
quenching of immunostaining in the cerebellar Purkinje cells by preincubation of the 
anti-aldosterone synthase antibody AS IE6 with its immunogenic peptide.
Finally, given the interest in cardiovascular production of corticosteroids (see 
section 1.6.1), attempts were made to extend the CSA kit immunostaining protocol 
to paraffin-embedded heart tissue. The protocol was identical to that used for the 
successful adrenal and brain immunostainings but heart tissue stained non- 
specifically. Sections incubated with Mouse IgGl Negative Control were 
indistinguishable from those exposed to the specific monoclonal antibodies (see 
figure 5.31).
5.4 Discussion
Antigens are better preserved during cryosection preparation than with 
paraffin-embedded sections. However, the frozen sections do tend to have inferior 
morphological detail. For these reasons, the initial intention was to identify specific
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Figure 5.3a. Immunostaining for 1 lp-hydroxylase and aldosterone synthase in 
adrenal tissue cryosection using the ABC protocol, a: lip-hydroxylase; b: 
aldosterone synthase; c: control. Scale bar = 100pm.
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Figure 5.3b. Immunostaining for 11 (3-hydroxylase and aldosterone synthase in 
paraffin-embedded adrenal tissue sections using the ABC protocol, a: 110- 
hydroxylase; b: aldosterone synthase; c: control. Scale bar = 100pm
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Figure 5.3c. Immunostaining for 11 (3-hydroxylase and aldosterone synthase in 
paraffin-embedded adrenal tissue sections using the CSA kit protocol, a: 1113- 
hydroxylase; b: aldosterone synthase; c: control. Scale bar = 500pm. The regions
of the adrenal gland are indicated on section c.
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Figure 5.3d. Immunostaining for 11 (3-hydroxylase and aldosterone synthase in
paraffin-embedded adrenal tissue sections using the CSA kit protocol, a: 11(3- 
Hydroxylase; b: aldosterone synthase; c: control. Scale bar = 50pm.
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Figure 5.3e. Immunostaining for 11 (3-hydroxylase in adrenal medulla cells of
paraffin-embedded adrenal tissue sections using the CSA kit protocol, a: 1113- 
hydroxylase; b: control. Scale bar = 50pm.
156
Figure 5.3f. Immunostaining for 11 (3-hydroxylase and aldosterone synthase in 
the cerebellum of paraffin-embedded brain sections using the CSA kit protocol, 
a: 11 (3-hydroxylase; b: aldosterone synthase; c: control. Scale bar = 500pm.
Figure 5.3g. Immunostaining for lip-hydroxylase and aldosterone synthase in
cerebellar Purkinje cells of paraffin-embedded brain sections using the CSA kit 
protocol, a: llp-hydroxylase; b: aldosterone synthase; c: control. Scale bar = 
50pm. Arrows indicate the positions of Purkinje cells on section c.
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Figure 5.3h. Immunostaining for 11 (3-hydroxylase and aldosterone synthase in 
the hippocampus of paraffin-embedded brain sections using the CSA kit 
protocol, a: 11 (3-hydroxylase; b: aldosterone synthase; c: control. Scale bar = 
500pm.
159
■' W l, * . V. *V*"* * f‘ v#
■' • . ’ -. * £> ' *<' '* J f '  ; O '■ ”V •'
>. ■.v .i - . ' V ^  L x  ^ \
< *  ■ ■ *
«4 .^* 4fc' j -t
P
w
> •
<
“ 1 ---------
Figure 5.3i. Immunostaining for 11 (3-hydroxylase and aldosterone synthase in 
the CA3 cells of paraffin-embedded brain sections using the CSA kit protocol, a: 
11(3-Hydroxylase; b: aldosterone synthase; c: control. Scale bar = 50pm.
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Figure 5.3j. Quenching of immunostaining in adrenal tissue by preincubation of 
anti-11 (3-hydroxylase antibody 11BIA4 (1:100 dilution) with its immunogenic 
peptide. The CSA kit protocol was used, a: Antibody without peptide; b: 
antibody with lOpM peptide; c: antibody with 0.1 pM peptide. Scale bar=500pm.
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Figure 5.3k. Quenching of immunostaining in cerebellar Purkinje cells by 
preincubation of anti-aldosterone synthase antibody ASIE6 (1:50 dilution) with 
decreasing concentrations of its immunogenic peptide. The CSA kit protocol was 
used, a: antibody with Im M  peptide; b: antibody with lOpM peptide; c: 
antibody with lOOnM peptide; d: antibody with InM  peptide. Scale bar = 50pm.
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Figure 5.31. Immunostaining for 11 (3-hydroxylase and aldosterone synthase in 
paraffin-embedded heart sections using the CSA kit protocol, a: 11(3- 
hydroxylase; b: aldosterone synthase; c: control. Scale bar = 100pm.
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staining in adrenal tissue cryosections before adapting this same protocol for use 
with paraffin sections of adrenal and extra-adrenal tissue. Using cryosections, anti- 
11 P-hydroxylase staining was identified. This followed the known distribution of the 
enzyme throughout the zona fasciculata-reticularis, with the outer zona glomerulosa 
completely clear. However, this ABC method could not produce positive results for 
aldosterone synthase in the same tissue. Attempts were also made to stain for 11P- 
hydroxylase in brain tissue but this was unsuccessful. Despite these results, it was 
decided to make further attempts at immunostaining using paraffin-embedded tissue.
The adrenal tissue used had been fixed in formalin solution (40% w/v 
formaldehyde in water) for 24 hours. Such formaldehyde-based fixatives form cross- 
linking methylene bridges between basic amino acids. Although this action preserves 
the tissue, it can also mask the antigen, preventing access of the antibody to its 
specific binding site. For this reason, certain pretreatments -  such as proteolytic 
digestion or heating of the tissue in citrate buffers -  are necessary to expose the 
antigen once more. When using the ABC method on paraffin-embedded tissue, 
proteolytic treatment followed by microwave heating were found to be necessary 
and, under these conditions, specific staining for both 11 p-hydroxylase and 
aldosterone synthase in adrenal tissue was achieved. However, brain tissue still gave 
negative results.
Nevertheless, these results did confirm the specificity of the antibodies for their 
respective enzymes. The antibodies bound specifically to the expected regions o f the 
adrenal cortex (see section 1.2.4) and were apparently free o f cross-specificities. 
This is an important consideration given the high degree of amino acid sequence 
homology between 11 P-hydroxylase and aldosterone synthase.
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The failure to detect the enzymes in extra-adrenal tissue was, as with the 
immunoblotting in the previous chapter, attributed to the lower levels of these 
enzymes that were expected to be present. Therefore, a biotinylated tyramide method 
was adopted in order to increase the intensity of staining resulting from any bound 
primary antibody. In such protocols, a streptavidin-biotin-peroxidase complex is 
formed at the site of the bound primary antibody, as with the ABC method. However, 
instead of performing the chromogenic reaction at this point, the peroxidase enzymes 
that have been assembled at the site are reacted with biotinylated tyramide. This adds 
biotin at the site which then binds streptavidin-peroxidase conjugates, thus greatly 
increasing the number of peroxidase enzymes in the region of the bound primary 
antibody. Therefore, the intensity of the final chromogenic reaction is greatly 
enhanced (see figure 5.4a). The DAKO catalysed signal amplification (CSA) system 
kit which works on this principle was used in all subsequent immunostaining 
experiments. It is appropriate only for paraffin-embedded tissue.
Immunostaining of tissue using the CSA method required some changes to the 
pretreatment of tissue. First, formalin-fixed tissue gave heavy background staining. 
More specific immunostaining was achieved using 4% w/v paraformaldehyde as a 
fixative; this was the recommended fixative for use with the kit. Protease 
pretreatment also resulted in intense background staining. This step was omitted but 
microwave pretreatment was retained.
Staining of adrenal tissue using the CSA kit followed the same zonal 
distribution as with the ABC protocol although, as would be expected, staining was 
more intense. The zonal distribution o f these enzymes has been shown previously by 
immunohistochemistry using these antibodies (Holzwarth et al. 1996; Engeland et al. 
1996) and also polyclonal antibodies raised in rabbits (Mitani et al. 1994). Although
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not a main purpose of the study, the absence of 11 P-hydroxylase from the zona 
reticularis suggests that it does not contribute significantly to glucocorticoid 
production. This deficiency may account for the relatively high DOC levels in the 
rat. A similar situation in man may explain its role as a source o f adrenal androgens. 
By double-staining for both enzymes on the same tissue section, it has been shown 
that there is a layer of cells between the zona glomerulosa and the zona fasciculata- 
reticularis which expresses neither enzyme (Mitani et al. 1994). These groups also 
showed that a low Na+ diet increased the width of the zona glomerulosa (Holzwarth 
et al. 1996). However, they failed to detect the surprising finding here that the 
adrenal medulla stained positively for 11 p-hydroxylase. This staining had been faint 
and therefore ambiguous when using the ABC method but the CSA method gave an 
undisputable positive result with stained cells apparently extending from the zona 
reticularis into the medulla. Previously, lip -H S D l has been localised to the rat 
adrenal gland’s corticomedullary junction. Its presence was thought to optimise the 
delivery of corticosterone from the cortex to the medulla, thereby stimulating adrenal 
catecholamine biosynthesis (Paxinos and Watson, 1998). Medullary 11 P-hydroxylase 
may perform a similar function, either by converting precursor which passes into the 
medulla or by de novo synthesis, although the presence of other enzymes in this 
pathway within the medulla has not been demonstrated. Shimojo et al. were therefore 
surprised to find 11P-HSD2 expression within the medulla. This posed the question 
of why the adrenal medulla should produce corticosterone only to inactivate it? The 
discovery of 11 P-hydroxylase expression within the medulla only adds to this puzzle. 
Further, more precise histology will be required to ascertain whether the l ip -  
hydroxylase-expressing cells are typical chromaffin cells, displaced adrenocortical 
cells or even part of the local vascular system.
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Consistent staining in brain tissue proved more difficult to achieve. As with the 
immunoblotting experiments, various antibody dilutions, incubation times and 
temperatures were used before settling on the final protocol given in section 2.4.5. 
This method gave reproducible staining in brain tissue. The staining varied greatly in 
intensity throughout the section, suggesting that it was not simply blanket 
background staining. The staining was most intense in two particular regions of the 
brain, the cerebellum and the hippocampus. In marked contrast to the adrenal 
staining for the two enzymes, the brain staining for 11 p-hydroxylase and aldosterone 
synthase colocalised. Staining for both was visible in the cerebellum and the 
hippocampus. Colocalisation may imply interaction. The enzymes may compete for 
their principal substrate, DOC. llp-Hydroxylase synthesises corticosterone but this 
is a poor substrate for aldosterone synthase. The level of interaction will obviously 
depend on relative expression rates and on the relative affinities o f the brain enzymes 
for DOC. These remain to be determined.
Although the distribution of lip-hydroxylase and aldosterone synthase 
throughout the brain has not previously been investigated in such detail, those of 
several other enzymes in the corticosteroid pathway have. The distribution of 
CYP11A1, 3P-HSD and StAR transcripts has been analysed by in situ hybridisation 
and the results of these studies were recently published. Purkinje cells contained 
transcripts from all three of the genes investigated (Guennon et a l  1995; Furukawa 
et al. 1998; Ukena et al. 1999). These cells also produced intense immunostaining 
when incubated with a P450scc-specific antibody (Ukena et al. 1998). This matches 
the findings here, where cerebellar staining for 11 p-hydroxylase and aldosterone 
synthase was most intense within the Purkinje cells. The other studies are also in
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broad agreement with the presence of these enzymes in the molecular and granular 
layers of the cerebellum but not the white matter.
The hippocampal expression of CYP11B1 and CYP11B2 also agrees with 
investigations into the distribution of StAR, P450scc and 3p-HSD. Aldosterone 
synthase and 11 p-hydroxylase were detected throughout the pyramidal cells of the 
hippocampus, in the CA1, CA2 and CA3 cells of Ammon’s horn as well as in the 
dentate gyrus. StAR transcript levels are slightly lower in the hippocampus than in 
the cerebellum (which has the highest expression level within the brain) but, along 
with the olfactory bulb, these are the only brain regions to demonstrate strong StAR 
expression; levels in such regions as the thalamus and hypothalamus are far lower 
(Furukawa et al. 1998). In situ hybridisation to CYP11A1 and 3p-HSD transcripts 
overlap with StAR’s expression pattern in the cerebellum and hippocampus, except 
for the CA3 region of the hippocampus where 3p-HSD transcription cannot be 
detected. 3P-HSD has also been detected by immunohistochemistry in the rat 
hippocampus and cerebellum (Guennon et al. 1995).
These two brain regions also have the greatest density of MR (Agarwal et al. 
1993). GR, although widespread throughout the brain, is highly expressed in the 
hippocampus. As 11 P-hydroxylase and aldosterone synthase seem to colocalise to 
hippocampus and cerebellum, this raises the question of whether there is any MR/GR 
selectivity in these regions. llp-H SD  activity in homogenates of cerebellum and 
hippocampus is estimated to be at 10-30% of the level found in kidney and liver 
(Seckl, 1997). It is open to question whether this would confer MR selectivity on 
these regions of the brain.
Work on the presence of P450scc and 3P-HSD in the Purkinje cell has 
focussed on its possible developmental role. P450scc has a constant expression level
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within the rat Purkinje cell from its differentiation at 3 days of age to the final 
formation of the cerebellum at around 21 days (Ukena et al. 1998). 3p-HSD 
transcript levels, on the other hand, are low at 3 days, high at the 10-day stage and 
then fall back by 60 days of age. Distribution o f expression also changes. 3P-HSD 
transcripts are detectable in Purkinje and all granular cells at 10 days but become 
restricted to Purkinje cells and fewer granule cells by 60 days (Ukena et al. 1999). 
Ukena et a l (1999) are unsure whether steroids produced by these cells could 
perform a developmental role or whether the changing expression pattern of 3P-HSD 
simply reflects the increasing differentiation o f the cells within the region. The 
presence of aldosterone synthase and 11 P-hydroxylase in these cells suggests that the 
progesterone produced by 3P-HSD may only be an intermediate product and that it is 
required for the ultimate production of aldosterone and corticosterone by these cells.
The expression of these enzymes within Purkinje cells is an important finding 
for another reason. It has long been established that the glial cells of the nervous 
system are capable of neurosteroid production and, in culture, can express 
steroidogenic genes including CYP11A1 (Mellon and Deschepper, 1993; Sanne and 
Krueger, 1995). The weight o f evidence suggests that these neuronal cells are also 
capable of neurosteroidogenesis. (Further evidence in favour of steroid production by 
neurons is presented in the next chapter.)
The accumulation of evidence suggesting that all the components o f the 
corticosteroidogenic machine are present in the hippocampus is also compelling 
although, as with the cerebellum, there is little understanding of what purpose these 
enzymes might serve. As reviewed in chapter 1, the corticosteroids have many 
effects on this region of the brain although it is still unclear whether locally-produced 
hormone is of physiological significance.
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Although the expression of these genes appears strong in certain regions of the 
brain, it is confined to comparatively few cells. Such expression would probably be 
incapable of exerting any significant endocrine effects. Therefore, a more probable 
action would be through a paracrine or even autocrine mode. Work on the heart has 
shown that, even where expression is highly regional, large local concentrations of 
steroid can be achieved (Delcayre and Silvestre, 1999).
Finally, attempts were made to investigate the distribution o f 11 p-hydroxylase 
and aldosterone synthase within the rat heart, given previous evidence of their 
expression in that tissue (see section 1.6.1). However, non-specific staining was 
sufficiently strong to render the control sections indistinguishable from those 
incubated with primary antibody. It may be that specific staining did occur but that it 
was masked by the intensity o f the non-specific staining. The staining was probably 
due to cross-reactivity with endogenous immunoglobulins which is acknowledged by 
the manufacturers as a limitation of the CSA kit. This results in ‘staining in the 
negative control around blood and lymph vessels, in connective tissue, and in 
extravascular tissue spaces’ as well as ‘certain types of epithelium’. Antigen retrieval 
protocols such as the microwaving method used here are known to increase this 
effect. Therefore, this method is probably inappropriate for use on heart tissue. The 
rigorous controls performed on the adrenal gland and brain confirm that the 
immunostaining produced in those tissues is specific and does not result from the 
non-specific interactions encountered with the heart.
Having identified the presence of 11 P-hydroxylase and aldosterone synthase 
within the rat brain, the next chapter assesses whether neurons derived from the fetal 
rat brain are able to synthesise corticosteroids.
171
Chapter 6
Results: Corticosteroid Production Bv Primary Cultures Of Fetal Rat
Hippocampal Neurons 
6.1 Introduction
The immunostaining results presented in the previous chapter highlighted the 
hippocampus as one of two regions of the adult rat brain that react positively with 
specific anti-11 P-hydroxylase and anti-aldosterone synthase antibodies. It would be 
desirable to study such cells in isolation from other brain cell types in order to assess 
their corticosteroidogenic capabilities. Although adult rat neurons are not capable of 
cell division that would make their culture possible, fetal hippocampal neurons 
possess the ability to divide and grow in culture. Dr Margaret Lai of the Molecular 
Medicine Centre at the University o f Edinburgh is skilled in the preparation o f such 
cells and provided rat fetal hippocampal neurons for the work presented here.
The results of various experiments on these cells are presented in this chapter. 
First, their capacity to transcribe CYP11B1, CYP11B2 and other steroidogenic genes 
was established by RT-PCR. Expression of 11 p-hydroxylase and aldosterone 
synthase polypeptides was then confirmed by immunostaining. Finally, their 
enzymatic activity was assessed by incubating them with the corticosteroid precursor 
DOC and measuring aldosterone and corticosterone production.
6.2 Methods
The procedure used by Dr Lai to prepare the primary cultures of fetal 
hippocampal neurons for these experiments is described in section 2.6.1.
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Dr Lai also provided total RNA isolated from these cells which was used for 
RT-PCR and Southern blotting experiments as described in sections 2.1.3 to 2.1.9. 
The RNAs for these experiments were subjected to DNase treatment before use, as 
described in section 2.6.2. Immunostaining of the cells was performed using the 
CSA kit protocol in section 2.4.5. No pretreatments were necessary.
The procedure for the incubation of cells with DOC and analysis of the steroid 
products is given in sections 2.6.3 to 2.6.6.
6.3 Results
6.3.1 RT-PCR
The cells were tested for the presence of the three types o f CYP11B transcripts, 
and a positive result was observed for each of these (see figure 6.3a). The presence 
of adrenodoxin and CYP11A1 transcripts was also established (see figure 6.3b). All 
controls were clear.
6.3.2 Immunostaining
The cells stained positively in the presence of the anti-11 p-hydroxylase 
antibody 11BIA4 and the anti-aldosterone synthase antibody AS IE6. Controls were 
clear (see figure 6.3c). There appeared to be a difference in the subcellular 
localisation of staining; 11 p-hydroxylase staining was more apparent in the dendrites 
while aldosterone synthase staining tended to be within the cell body.
173
Adrenal Brain Fetal Hipp. Water
+  -  +  -  +  -  +  -
342bp ^
Adrenal Brain Fetal Hipp. Water
+  -  +  -  +  -  +  -
342bp
Adrenal Brain Fetal Hipp Water
+  -  +  -  +  -  +  -
342bp
Figure 6.3a RT-PCR of CYP11B RNAs from adult ra t adrenal gland, whole 
adult ra t brain and prim ary cultures of fetal rat hippocampal neurons 
performed in the presence (+) and absence (-) of reverse transcriptase, (a) 
CYP11B1; (b) CYP11B2; (c) CYP11B3. Transcripts were detected by Southern 
blotting and subsequent hybridisation with a specific, radiolabelled probe.
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a  Adrenal Brain Fetal Hipp. Water
+  -  +  -  +  -  +  -
583bp —►
fo Fetal
Adrenal Brain Hipp. Water
+  -  +  -  + _ + _
289bp
Figure 6.3b RT-PCR of RNAs from adult ra t adrenal gland, whole adult rat 
brain and primary cultures of fetal ra t hippocampal neurons performed in the 
presence (+) and absence (-) of reverse transcriptase, (a) CYP11A1 transcripts 
detected by Southern blotting and subsequent hybridisation with a specific, 
radiolabelled probe.; (b) Adrenodoxin transcripts visualised on agarose gels 
under ultraviolet light.
cr*
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Figure 6.3c. Immunostaining for 11 (3-hydroxylase and aldosterone synthase 
prim ary cultures of fetal ra t hippocampal neurons using the CSA kit protocol. 
11 (3-hydroxylase; b: aldosterone synthase; c: control. Scale bar = 50pm.
6.3.3 Conversion of tritiated DOC to aldosterone and corticosterone
The initial conversion experiments incubated primary cultures o f fetal rat 
hippocampal neurons in medium containing lOpM DOC plus ~0.5xl06c.p.m. of 3H- 
DOC. After 24 hours, the medium was removed and aldosterone and corticosterone 
extracted from it. The 3H content of these steroids was then measured after partial 
purification (see section 2.6.4). The results are given in table 6.3a.
Samples c.p.m. % standard Corrected c.p.m. %
(n=10) ±S.D. recovery ±S.D. conversion
Aldosterone 2680.2±409.7 17.3 15519.0±2372.0 2.8
Corticosterone 1908.7±224.5 29.4 6606.8±777.1 1.2
Table 6.3a Conversion of 3H-DOC to aldosterone and corticosterone by primary 
cultures of fetal rat hippocampal neurons in a 24-hour period. A total of 549,352 
c.p.m. 3H was added to each sample.
6.3.4 Conversion of unlabelled DOC to aldosterone and corticosterone
Subsequent conversion experiments incubated the cells in medium containing 
only unlabelled DOC at a concentration of 1 OpM. After a 24-hour incubation period, 
the medium was removed from the cells. Aldosterone and corticosterone were 
extracted from the medium and their concentrations measured by radioimmunoassay 
(see section 2.6.5), The total protein content o f the cells in each sample was also 
measured. Control medium, which contained no DOC, was also analysed (see table 
6.3b and figure 6.3d). There was an apparent strong correlation between aldosterone 
and corticosterone production. However, this may have been due to the variable state 
of the cells between aliquots.
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Sample
Corticosterone Aldosterone
pmol/L
medium
pmol/mg
protein
pmol/L
medium
pmol/mg
protein
Control 1 4175 79 550 10
Control 2 2300 78 550 19
Sample 1 149150 2451 103175 1696
Sample 2 74000 1138 61750 949
Sample 3 187375 2034 114925 1248
Sample 4 54150 941 825 14
Sample 5 46125 615 52350 698
Sample 6 75500 2267 62075 1864
Sample 7 1150 48 725 30
Sample 8 132625 15789 141300 16821
Sample 9 203975 5319 141575 3692
Sample 10 1150 35 275 8
Table 6.3b Conversion of lOpM DOC to aldosterone and corticosterone by 
primary cultures of fetal rat hippocampal neurons in a 24-hour period. 
Products were measured by radioimmunoassay and corrected for recovery and 
protein content. DOC was omitted from control sample medium.
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Figure 6.3d Scatter plot showing conversion of 10pM DOC to aldosterone and 
corticosterone by primary cultures of fetal rat hippocampal neurons in a 24- 
hour period. Products were measured by radioimmunoassay and corrected for 
recovery and protein content. DOC was omitted from control sample medium.
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6.3.5 Identification of aldosterone bv gas chrom atography mass spectrom eter 
(GCMS)
Incubated cell medium was subjected to paper chromatography in order to 
isolate any aldosterone within the sample. This partially purified sample was then 
injected on to a GCMS where it gave a distinctive peak with a retention time o f 37.84 
minutes. This matched the retention time of 37.88 minutes obtained for the 
aldosterone standard. (The trivial difference in retention time between sample and 
standard is due to the imprecision o f manual injection on to the GCMS.) These peaks 
were found to have identical mass spectra. See figure 6.3e.
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Chromatogram of aldosterone from incubated cell mediumw
Retention time 
37.84 minutes
Chromatogram of aldosterone standard
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Spectrum of aldosterone from incubated cell medium
Spectrum of aldosterone standard
480
Figure 6.3e Chromatograms and mass spectra of aldosterone from incubated 
cell medium samples and standard solution.
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6.4 Discussion
The RT-PCR results mostly confirmed the findings described in chapter 3. 
Transcription o f the CYP11B1, CYP11B2, CYP11A1 and adrenodoxin genes was 
demonstrated in fetal hippocampal neurons, and this is predictable in the light of 
those previous results.
More surprising was the discovery of CYP11B3 transcription not just in the 
fetal rat hippocampal neurons but also in the adult rat adrenal and brain tissue 
homogenates which had been used as controls. These tissues had previously been 
found negative for CYP11B3 transcription (see chapter 3). CYP11B3 transcription 
has never before been detected in adult tissues (Mellon et al. 1995). The most likely 
explanation for this inconsistent result is the treatment o f the RNA samples used in 
this chapter with DNase. This step was introduced because o f genomic DNA 
contamination in the hippocampal cell RNA provided which led to PCR primers 
hybridising with genomic DNA sequences as well as any cDNA that may have been 
present. This effectively lowered the concentration of PCR primers within the 
reaction and any resulting bands were therefore fainter or undetectable. DNasing of 
the samples removed this problem and increased the sensitivity of the RT-PCR 
technique. The control RNA samples were also DNased. The detection of a 
CYP11B3 signal in these adult RNAs therefore introduces the possibility that the 
results of chapter 3 might have been different if all the RNA samples had been 
treated in the same way. However, although there may have been some falsely 
negative results produced in that work, this in no way throws into doubt the veracity 
of the positive results.
An alternative reason for the positive CYP11B3 results is that the washes to 
remove any hybridised CYP11B3 probes were somehow less stringent than those
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used in chapter 3, despite the use of the same protocol. The nature o f the CYP11B 
genes is such that some similarity between hybridising probes is inevitable. Although 
the probes for CYP11B1 and CYP11B2 are very different, the CYP1753-specific 
probe has similarities to the B1 and B2 sequences at the hybridising region. 
Therefore, it is possible that, rather than detecting CYP11B3, this probe is detecting 
one or both o f the other CYP11B genes.
The immunostaining results show that the CYP11B1 and CYP11B2 transcripts 
are translated into their respective polypeptide products within these cells. This, 
together with the RT-PCR findings, confirms the evidence in chapter 5 that 
suggested neurons as well as glia can express steroidogenic enzymes such as 
aldosterone synthase and lip-hydroxylase. From the subcellular staining o f the fetal 
hippocampal neurons, there is a suggestion that the distribution of these two proteins 
might be different. 11 p-hydroxylase staining tends to be within the dendrites 
projecting from the cell body while aldosterone synthase staining is seen more within 
the cell body itself Mitochondria are found within both the cell bodies and the 
dendrites of neurons and these immunostaining results are therefore consistent with 
their cellular location.
The incubation experiments were performed initially with 3H-DOC as it 
renders any conversion of DOC to aldosterone or corticosterone easier to detect. In 
the event, the detection of these products was not difficult and conversion occurred at 
a higher rate than had been expected. Having obtained these preliminary results, 
further incubations using lOpM concentrations o f non-radioactive DOC were 
performed. Although the rates of conversion showed a great deal of sample-to- 
sample variation, in most cases the DOC-incubated samples contained much more
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product than the controls. The identification of aldosterone within the incubated 
samples by GCMS confirmed this finding.
The ability o f brain cells to perform reactions from the corticosteroid pathway 
has been tested before, although this has usually involved homogenates o f brain 
tissue (Gomez-Sanchez et al. 1996; Ukena et al. 1999) or cultures o f glial cells 
(Jung-Testas et al. 1989). Ukena et al. (1999) showed that cerebellar homogenates 
were able to convert pregnenolone to progesterone, suggesting the presence o f active 
3P-HSD. Gomez-Sanchez et al. (1996) demonstrated that minces of various brain 
regions including hippocampus, hypothalamus and cerebellum could convert H- 
DOC to corticosterone, 11-dehydrocorticosterone and 18-OH-DOC. However, such 
methods cannot distinguish conversion by glial and neuronal cells and, as with RT- 
PCR, it is often difficult to dissect tissue precisely, especially in such a heterogenous 
tissue as the brain. The work presented here demonstrates conversion by neuronal 
cells of a single, homogenous type.
Having established that the cells perform the terminal stages of aldosterone and 
corticosterone production, the next logical step would be to explore the earlier stages 
of the pathway. Are the cells capable of de novo corticosteroid production from 
cholesterol? These cells may also be a good model for studying how corticosteroid 
production is regulated in neural tissue. Incubation of substrate together with 
potential modulators of corticosteroid production could give insights into such 
regulatory mechanisms and provide more detailed information about this potentially 
important site of extra-adrenal corticosteroidogenesis. It remains to be seen whether 
conventional factors such as ACTH, Angll or K+ also control brain expression or, 
more interestingly, whether control depends on local neurotransmitters such as 
serotonin or noradrenaline.
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Chapter 7
General Discussion
Steroid hormones are ubiquitous switches controlling the rate o f gene 
transcription. By binding to receptors, corticosteroids control genes involved in many 
metabolic processes. Over recent decades, our understanding of the biosynthesis, 
secretion and action of mineralocorticoids and glucocorticoids has become almost 
complete, although some details (e.g. transcription factors) are not fully resolved. 
The action of aldosterone on the distal nephron or of cortisol on liver or adipose 
tissue is now well understood. General attention in the next decades may concentrate 
on achieving a similar level o f understanding of the brain.
Corticosteroids are of major importance in regulation of CNS function. Their 
varied effects on such complex aspects of behaviour as mood or memory have been 
established but are poorly understood. The effects of corticosteroids in the brain on 
blood pressure are clearly different from those exerted systemically. Further 
complexity must now result from the fact that the brain, or specific parts o f it, 
receives its supply of corticosteroids from two distinct sources, the adrenal cortex 
and the brain cells themselves. The work in this thesis has contributed new 
information on the local neural synthesis of aldosterone and corticosterone in the rat. 
In particular, it confirms and strengthens the evidence that CYP11B1 and CYP11B2 
are transcribed, that the enzyme proteins are formed and that, in rat fetal 
hippocampal cells at least, these enzymes can convert the proximal precursor to their 
respective products. Indeed, the identification of enzymes catalysing earlier steps in 
the biosynthetic pathway strongly supports the possibility of de novo synthesis from 
cholesterol within the brain. Strikingly, aldosterone synthase and 11 P-hydroxylase
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are coexpressed within the same brain cells, although not necessarily in the same 
intracellular compartment.
Thus, the rat brain makes aldosterone and corticosterone, although at a lower 
rate than the adrenal cortex. It is probable, therefore, that the human brain produces 
aldosterone and cortisol. The physiological significance of this local production, 
however, is not clear. It may merely be a device for achieving or maintaining local 
hormone levels, as with the high local cortisol levels that are necessary in the adrenal 
medulla. Alternatively, it may provide a mechanism for brain tissue to respond to a 
set of stimuli completely different from those encountered in the adrenal cortex. If 
this is the case, then the control of gene expression must be different. This exciting 
prospect could be investigated by, for example, analysing in vitro gene expression in 
response to particular agonists. Alternatively, it may be the production o f 
conventional agonists such as Angll, which is also synthesised in the brain, that is 
controlled differently.
The clinical implications of neural corticosteroid synthesis are profound. 
Excess glucocorticoid has deleterious effects on brain function, so can local synthesis 
contribute to this? Very small increases in brain aldosterone levels markedly raise 
blood pressure. Where studies of systemic physiology have largely failed to account 
for common hypertensive syndromes, could aberrations of local brain synthesis 
provide an explanation? Investigation of these questions will require considerable 
ingenuity in both technical innovation and experimental design. Finally, if  specific 
clinical significance is established, manipulation of these enzyme systems or of the 
brain receptors on which their products act may become a useful approach to 
therapy. For this, a detailed knowledge of brain corticosteroid molecular biology and
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physiology is an absolute prerequisite. Thus, there remain numerous challenging 
avenues for research in the future.
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Appendix 1: Nucleotide and deduced peptide sequences of
CYP11B1 and CYP11B2
Nucleotide Sequences The nucleotide sequences for rat CYP11B1 and CYP11B2, 
obtained from the EMBL database, are shown below. The accession numbers for 
these sequences are:
CYP11B1 CYP11B2
5’ Region and exons 1-2 D14086 D 14092
Exons 3-4 D14087 D14093
Exon 5 D14088 D 14094
Exon 6 D14089 D14095
Exons 7-8 D 14090 D 14096
Exon 9 D14091 D 14097
Exons, TATA boxes and cAMP-responsive elements (CREs) are shown in bold 
type. Introns are shown in lower case. The transcription initiation site is marked by 
an asterisk. The oligonucleotides listed in appendix 2 are indicated by their name in 
bold letters above the relevant underlined sequence. Sense and antisense 
oligonucleotides are denoted by the symbols > and <, respectively.
R at CYP11B1
agatctggac tcaggttctc atagttgacc aactaagtca tcctcttacc 50
ctatggcaaa tggagttcat tgttatttct caatttgaag agaaatgaga 100
aattctaaaa gccaacactt aaccgtaaat cacgacagtg agtaaagacc 150
cactccctaa atctggctag ggaattttaa actaggatga atcattcaag 200
gttccacaaa gggaaaatat gtgcatctga cggctctcac catgggggag 250
gagaaagaag gctctgacca ccattggact atttttgagt gttaaagtag 3 00
agtctgcacc ctcccaccca ccagcaggca ttgcagaggt aggaaaaggg 3 50
agaaagcctc tacctccaga agaaccatca gctcagtata catttctagg 400
188
CRE
gcaagtccag ggacacatcc tgcagtgaca ttatcagtca gcgatttata 450
TATA BOX *
tcctcaagac aagataaaag gccacggact aaacacagga agagaggagg 500
Exon 1
atggcaATGG CTCTCAGGGT GACAGCAGAT GTGTGGCTGG CAAGACCCTG 550
GCAGTGCCTG CACAGGACGA GGGCACTGGG CACTACGGCA AAAGTGGCCC 600
CCAAGACACT GAAGCCCTTT GAAGCCATAC CACAATACTC CAGGAACAAG 650
TGGCTGAAGA TGATACAGAT CCTGAGAGAG CAGGGCCAAG AGAACCTACA 700
Intron 1
CCTGGAGATG CACCAGGCCT TCCAAGAGCT GGGGCCCATT TTCAGgtaag 750
(3 70bp)
ggctttcctt ccccatagcc aagcacagat atagcttgct gtcctctggt 800
tgcccaggct ctgcagggta ggaggtgctg cattctcctg taggcacccg 850
gcattccttc tttaggaaga cagggaggga gaacaggagg ttctgggact 900
gactcgtggg ctctccacag ggacagagaa aggcacttct cactgctgag 950
aggacagagt gctgaagtgg agtgcagaca ctgggagagt cctcctgtgg 1000
gggaagcaag ggctaggaga ggatgagatg agagagcaca ctgacagggc 1050
tggctgtgca gcgagctcag gtggaggaca ctccacttac agcagggctg 1100
Exon 2
tgtgcttcac cgcagGCACA GTGCAGGGGG AGCACAGATT GTGTCTGTGA 1150
TGCTGCCTGA GGACGCTGAG AAGCTGCACC AGGTGGAGAG TATCCTCCCG 1200
P5812>
CATCGGATGC CCCTGGAGCC GTGGGTGGCC CACAGAGAAC TCCGTGGCCT 1250
Intron 2 (14 OObp)
GAGACGTGGT GTGTTCTTGC Tgtgagtgga c--------- 2661
Exon 3
tgttctgcag AAATGGGGCA GACTGGCGCT TCAACCGACT GCAGCTGAAT 2711
CCAAATATGC TGTCACCAAA AGCCATTCAA TCTTTTGTCC CCTTTGTGGA 2761
TGTGGTAGCA AGGGACTTTG TGGAAAACCT GAAGAAGAGA ATGCTGGAGA 2811
P5815>
ATGTTCATGG AAGCATGTCT ATAAACATTC AGTCCAATAT GTTCAACTAT 2861
Intron 3 (114bp)
ACCATGGAAG gtatgtatgg ggaaggctcc agcttgagag aggcagggac 2911
ggcagaggcc aggaaggagg aaaaatattg agagcaatga ctgccttggt 2961
Exon 4
tcattgataa tattctctct gcagCCAGCC ATTTTGTTAT TTCCGGAGAG 3011
CGTCTGGGCC TCACAGGCCA TGACCTGAAA CCTGAGAGCG TGACATTCAC 3061
P5813<
TCATGCTCTG CACTCAATGT TCAAGTCCAC CACACAGCTC ATGTTCTTAC 3111
CCAAGAGCTT GACTCGTTGG ACAAGCACCC GGGTGTGGAA AGAACACTTT 3161
Intron 4 (270bp)
GATTCCTGGG ATATCATCTC TGAGTATGgt aaggaccc-- 3449
Exon 5
tcttccgcag TCACAAAATG TATCAAGAAT GTGTATCGCG AACTGGCAGA 3499
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G6GTCGCCAA CAGTCCTGGA GTGTCATATC CGAGATGGTA GCACAGAGTA 3 5 4 9
CTCTGTCAAT GGATGCCATC CATGCCAACT CAATGGAACT TATTGCTGGA 3599
Intron 5 (1400bp)
AGTGTTGACA CGgtcaggat cc-------- 5001
Exon 6
gctcctgcag ACAGCAATCT CCTTGGTAAT GACCCTTTTT GAGCTGGCTC 5051
GGAACCCAGA TGTTCAGCAG GCCCTGCGGC AGGAGAGCCT AGCAGCTGAG 5101
GCCAGCATCG TTGCTAATCC CCAGAAGGCC ATGTCAGACC TGCCCTTGCT 5151
Intron 6 (240bp)
GCGGGCTGCC CTTAAAGAGA CCTTGAGgta ggtgctg- - 5408
Exon 7
tcatctccag GCTCTACCCT GTTGGTAGCT TTGTAGAGAG AATCGTACAC 5458
Intron 7 (87bp)
TCAGACCTGG TGCTTCAGAA CTATCATGTC CCTGCTGGGg tgagtgatct 5508
tcatgccctt accaactgcc cttccctcta tctcctcaaa aaagcagctg 5558
Exon 8
aacttaccct tggcctctgc ccacagACAT TCGTCATAAT TTATCTGTAC 5608
TCCATGGGCC GAAACCCTGC AGTGTTCCCA AGGCCTGAGC GCTACATGCC 5658
TCAGCGCTGG CTGGAGAGGA AAAGGAGTTT CCAGCATCTG GCCTTCGGCT 5708
TTGGGGTGCG CCAGTGCCTG GGGCGGCGCC TGGCAGAGGT GGAGATGCTG 5758
Intron 8 (25 0bp)
CTCCTGCTTC ACCATgtgag cacct----- 6013
Exon 9
tgtgttccag ATGCTGAAAA CCTTCCAAGT GGAGACACTG AGACAAGAGG 6063
ATATGCAGAT GGTTTTTCGC TTTCTTTTGA TGCCCAGCTC TAGTCCTTTC 6113
End of Exon 9
CTTACTTTCC GGCCTGTGAG CTAG 6137
R at CYP11B2
aagctttctt cattttttaa gaaagtaaat tcaaacttgt tgggggaaaa 50
ttacaatgct tttatgtact ttctagtctt tagatttatt ttcactaaaa 100
acacacacac acacacacac acacacacac acacacacac acacacacac 150
acccaagtct attaaaagaa accaaggtct tctaggatat cttcaaaaga 200
gaggatccat ccatcttccc ttttccatct atagtgagaa aagagtaatt 250
tcttcccctt ctacctcagg caacacagtt ccgcatgtgg acactacacc 300
tgctcttagt ttctaccccc cagcaggctt tgcaggtgtt ggggagctgg 350
tcatatgctt ctactgacag ttgagcccca accatgacca gagctcagat 400
190
CRE
acctcagaca agtccaggga cagtttcttc catgacgtga ttagctgaac 450
TATA Box *
agtacagtac ttaggcagga taaaaggctg tgagctgaag ggaggaggat 500
Exon 1
ggcaATGGCT CTCAGGGTGA CAGCAGATGT GTGGCTGGCA AGACCCTGGC 550
AGTGCCTGCA CAGGACGAGG GCACTGGGCA CTACGGCAAC ACTGGCCCCT 600
AAGACACTGA AGCCCTTTGA AGCCATACCA CAATACTCCA GGAACAAGTG 650
GCTGAAGATG ATACAGATCC TGAGGGAGCA GGGCCAAGAG AACCTACACC 700
Intron 1
TGGAGATGCA CCAGGCCTTC CAGGAGCTGG GGCCCATTTT CAGgtaaggg 750
(370bp)
ctttccttcc ccatagccaa gcacagacat agcttgctgt cctctggttg 800
cccaggctct gcagggtacg aggtgctgca ttctccagta ggcaccaggc 850
attccatcat taggaagaca gggagggaga acaggaggtt ctgggactga 900
ctcgtgggct ctccacaggg acaaagaaaa gcacttctca ctgctgagag 950
gacagagtgc tgaagtggag tgcagaoact gggagagtcc tcctgtgggg 1000
gaagcaaggg ctaggagagg atgagatgag agagcacact gacagggctg 1050
gctgtgcagc gagctcaggt ggaggaoact ccacttacag cagggctgtg 1100
Exon 2
tgcttcacca cagGCACAGT GCAGGGGGAG CACAGATTGT GTCTGTGATG 1150
CTGCCTGAGG ACGCTGAGAA GCTGCACCAG GTGGAGAGTA TCCTCCCGCG 1200
P5812 >
TCGGATGCAC CTGGAGCCGT GGGTGGCCCA CAGGGAACTC CGTGGCCTGA 1250
Intron 2 (1500bp)
GACGTGGTGT GTTCTTGCTg tgagtggac- 2759
Exon 3
tgttctgcag AAATGGGGCT GAATGGCGCT TCAACCGACT GAAACTGAAC 2809
CCAAACGTGC TGTCACCAAA AGCTGTTCAA AATTTTGTCC CCATGGTGGA 2859
CGAGGTAGCA AGGGACTTCT TGGAGGCCCT GAAAAAGAAG GTGCGTCAGA 2909
P5814>
ATGCTCGAGG GAGCCTTACC ATGGATGTCC AGCAAAGTCT CTTCAACTAC 2959
Intron 3 (115bp)
ACTATAGAAG gtatgtggcc agaggaaagt ctcaacttaa gggaggcagg 3009
gagggagaca gggagagaca aggcagtctt gaggacaggg attcccttac 3059
Exon 4t
ctcagaggca ccattcattt tgcagCCAGC AACTTTGCAC TTTTTGGAGA 3109
GAGGCTGGGC CTCCTTGGTC ATGACCTGAA CCCTGGTAGC CTGAAGTTCA 3159
P5 813 <
TCCATGCCCT ACATTCAATG TTCAAGTCCA CCACACAGCT CCTGTTCTTA 3209
CCCAGAAGCT TGACTCGCTG GACAAGCACC CAGGTGTGGA AAGAACATTT 3259
Intron 4 (270bp)
TGATGCCTGG GATGTCATCT CTGAGTATGg tgagggccg- 3548
Exon 5
acatctctag CCAACAGATG TATCTGGAAG GTGCACCAGG AACTCAGACT 3598
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CGGCAGCTCT CAGACCTACA GTGGCATTGT GGCAGCACTA ATAACTCAGG 3 6 4 8
GAGCTTTACC TCTGGACGCC ATCAAAGCCA ACTCTATGGA GCTCACTGCT 36 98
Intron 5 (900bp)
GGGAGCGTTG ACACGgtcag gcggt ----------   4613
Exon 6
cctcctgcag ACAGCAATCC CCTTGGTAAT GACACTTTTT GAGCTGGCTC 4663
GGAACCCAGA TGTTCAGCAG GCCCTGCGGC AGGAGACCCT GGCAGCTGAG 4713
GCCAGCATCG CTGCTAATCC CCAGAAGGCC ATGTCAGACC TGCCCTTGCT 4763
Intron 6 (240bp)
GCGGGCTGCC CTTAAAGAGA CCTTGAGgta ggtgctg---  ---  5020
Exon 7
tcatctccag ACTCTACCCT GTTGGTGGCT TTTTGGAGAG AATCCTAAAC 5070
Intron 7 (87bp)
TCAGACCTGG TGCTTCAGAA CTATCATGTC CCTGCTGGGg tgagtgatct 5120
tcataccctc accaattgcc cttccctcta tctcctcaaa gaagcagctg 5170
Exon 8
actttatcct tggcctctgc ccacagACGT TGGTCCTACT TTATCTGTAC 5220
TCCATGGGCC GAAACCCTGC AGTGTTCCCA AGACCTGAGC GCTATATGCC 5270
TCAGCGCTGG CTGGAGAGGA AAAGGAGTTT CCAGCATCTG GCCTTCGGCT 5320
TTGGGGTGCG CCAGTGCCTG GGGCGGCGCC TGGCAGAGGT GGAGATGCTG 5370
Intron 8 (25 0bp)
CTCCTGCTTC ACCATgtgag cacct ----------    5605
Exon 9
tgtcttccag ATGCTGAAAA CCTTCCAGGT GGAGACACTG AGACAAGAGG 5655
ATGTGCAGAT GGCCTATCGC TTTGTTTTGA TGCCCAGCTC TAGTCCTGTC 5705
End of Exon 9
CTCACTTTCC GGCCCATCAG CTAG 5729
Peptide Sequences The peptide sequences were derived from the nucleotide 
sequences for the CYP11B1 and CYP11B2 coding regions (Nomura et al. 1993). The 
parts of the sequences corresponding to the immunogenic peptides used to generate 
the monoclonal antibodies are given in bold. These regions were chosen for their 
lack of homology between CYP11B1 and CYP11B2 and for their hydrophilic 
properties. Searches on the SWISSPROT protein sequence database failed to find 
any known mammalian proteins containing these peptide sequences.
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Rat 11 (3-hydroxylase
MALRVTADVW LARPWQCLHR TRALGTTAKV APKTLKPFEA IPQYSRNKWL 50
KMIQILREQG QENLHLEMHQ AFQELGPIFR HSAGGAQIVS VMLPEDAEKL 100
HQVESILPHR MPLEPWVAHR ELRGLRRGVF LLNGADWRFN RLQLNPNMLS 150
PKAIQSFVPF VDWARDFVE NLKKRMLENV HGSMSINIQS NMFNYTMEAS 200
HFVISGERLG LTGHDLKPES VTFTHALHSM FKSTTQLMFL PKSLTRWTST 250
RVWKEHFDSW DIISEYVTKC IKNVYRELAE GRQQSWSVIS EMVAQSTLSM 300
DAIHANSMEL IAGSVDTTAI SLVMTl FELA RNPDVQQALR QESLAAEASI 350
VANPQKAMSD LPLLRAALKE TLRLYPVGSF VERTVHSDLV LQNYHVPAGT'400
FVIIYLYSMG RNPAVFPRPE RYMPQRWLER KRSFQHLAFG FGVRQCLGRR 450
LAEVEMLLLL HHMLKTFQVE TLRQEDMQMV FRFLLMPSSS PFLTFRPVSS 500
PYIWGPS 507
Rat aldosterone svnthase
MALRVTADVW LARPWQCLHR TRALGTTATL APKTLKPFEA IPQYSRNKWL 50
KMIQILREQG QENLHLEMHQ AFQELGPIFR HSAGGAQIVS VMLPEDAEKL 100
HQVESILPRR MHLEPWVAHR ELRGLRRGVF LLNGAEWRFN RLKLNPNVLS 150
PKAVQNFVPM VDEVARDFLE ALKKKVRQNA RGSLTMDVQQ SLFNYTIEAS 200
NFALFGERLG LLGHDLNPGS LKFIHALHSM FKSTTQLLFL PRSLTRWTST 250
QVWKEHFDAW DVISEYANRC IWKVHQELRL GSSQTYSGIV AALITQGALP 300
LDAIKANSME LTAGSVDTTA IPLVMTLFEL ARNPDVQQAL RQETLAAEAS 350
IAANPQKAMS DLPLLRAALK ETLRLYPVGG FLERILNSDL VLQNYHVPAG 400
TLVLLYLYSM GRNPAVFPRP ERYMPQRWLE RKRSFQHLAF GFGVRQCLGR 450
RLAEVEMLLL LHHMLKTFQV ETLRQEDVQM AYRFVLMPSS SPVLTFRPIS 500
SPYIWGPN 508
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Appendix 2: Sequences of oligonucleotide primers
Primers for RT-PCR experiments
The melting temperature (Tm) for PCR primers was calculated by the formula: 
Tm = 2(A + T) + 4(G + C) °C 
where A, T, G and C respectively represent the number of adenine, thymine, guanine 
and cytosine bases in a given primer’s sequence. Generally, the annealing 
temperature used for a particular primer in a PCR was 5°C lower than its melting 
temperature.
The primer pairs used in the RT-PCR detailed in chapter 3 are given below.
N a m e P r i m e r S e q u e n c e  ( 5 ’- 3 ’l P r o d u c t
P 5 8 1 2 CYP11B1/2/3  ( S ) AAC TCC GTG GCC TGA GAC G 3 4 2 b p
P 5 8 1 3 CYP11B1/2/3  ( A S ) GCT GTG TGG TGG ACT TGA AC
V 7 9 5 3 A d r e n o d o x i n  ( S ) GAC TCT CTG CTA GAT GTT GTG ATT 2 8 9 b p
V 7 9 5 4 A d r e n o d o x i n  ( A S ) ATT CTT GCT CAT GTC AAC AGA CTG TCG
V 7 9 5 5 CYP11AI  ( S ) CAA CAT CAC AGA GAT GCT GGC AGG 5 8 3 b p
V 7 9 5 6 CYP11A1 ( A S ) CTC AGG CAT CAG GAT GAG GTT GAA
P 5 8 1 7 G A P D H  ( S ) ACC ACA GTC CAT GCC ATC AC 4 5 0 b p
P 5 8 1 8 G A P D H  ( A S ) TCC ACC ACC CTG TTG CTG TA
Primers for Southern blot hybridisation
The sequences o f the probes hybridised to Southern blots are given below.
N a m e P r i m e r S e q u e n c e  ( '5 ’- 3 ’ ')
P 5 8 1 5 CYP11B1 P r o b e TAA ACA TTC AGT CCA ATA
P 5 8 1 4 CYP11B2  P r o b e TGG ATG TCC AGC AAA GTC
P 5 8 1 6 CYP11B3  P r o b e TGG ACA TTC AGT CCA ATG
V 8 8 2 2 CYP11A1 P r o b e GGT GGA GTC TCA GTG TCT
CCT TGA TGC TGG CTT TGA G
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Appendix 3: Reagents
Unless stated otherwise, all standard chemicals and reagents were purchased 
from Sigma (Sigma-Aldrich Chemical Co. Ltd., Poole, Dorset, U.K.).
RT-PCR and Southern blotting
DEPC-PLO: 0.1% (v/v) diethyl pyrocarbonate in sterile H2O
6x Loading dve: 0.25% (w/v) bromphenol blue, .0.25% (w/v). xylene cyanol, 15% . 
(w/v) Ficoll in sterile H2 O
Gene Amp RNA-PCR core kit: (Perkin Elmer, Warrington, U.K.)
Reagents supplied in kit:
-Recombinant Moloney Murine Leukemia Virus (MuLV) RT (50U/pl) 
-AmpliTaq DNA polymerase (5U/pl)
-RNase inhibitor (20U/pl)
-dATP, dCTP, dGTP, dTTP (lOmM each)
-GeneAmp lOxPCR buffer II 
-MgCL solution (25mM)
-Oligo d(T)i6 primers (50mM)
-Random hexamer primers (50mM)
Tris-Acetate (TAE) buffer: 40mM tris-acetate, ImM EDTA
Denaturing buffer: 0.5M sodium hydroxide, 1.5M sodium chloride
Neutralising buffer: 1.3M tris, 4M sodium chloride, pH 7.2
20xSSC buffer: 3M sodium chloride, 0.3M sodium citrate, pH 7.2
Hybridizing solution: 6xSSC, 0.1% (w/v) SDS, 0.25% (w/v) dried skimmed milk
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SDS-PAGE and immunoblotting
Homogenization buffer: lOmM tris, ImM EDTA, pH 7.5
Isolation buffer: 225mM mannitol, 75mM sucrose, 0.5mM EGTA, 2mM MOPS, pH
7.4
CTC: 0.1% copper sulphate, 0.2% sodium potassium tartrate, 10% sodium carbonate
Reagent A: 0.025% copper sulphate, 0.05% sodium potassium tartrate, 2.5% sodium 
carbonate, 2.5% SDS, 0.2M sodium hydroxide
Reagent B: 1 volume Folin and Ciocalteu’s phenol reagent to 5 volumes H2O
Bio-Rad protein assay kit: (Bio-Rad Laboratories Ltd., Hemel Hempstead, U.K.) 
Reagents supplied in kit:
-Biorad protein assay dye reagent concentrate 
-Bovine serum albumin (1.42mg/ml)
Buffer 1: 1.5M tris, 0.4% SDS, pH 8.8
Buffer 2: 0.5M tris, 0.4% SDS, pH 6.8
Tank buffer: 0.025M tris, 0.2M glycine, 0.1% SDS
Laemmli buffer: 5M urea, 0.17M SDS, 0.4M dithiothreitol, 0.05M tris, pH 8.0. A 
few crystals of bromphenol blue were added for colour.
Blotting buffer: 0.2M glycine, 0.025M tris, 20% (v/v) methanol
Coomassie brilliant blue G stain: 45% (v/v) H2O, 45% (v/v) methanol, 10% (v/v)
glacial acetic acid. A few crystals of Coomassie brilliant blue G were added for 
colour.
Destain: 45% (v/v) H2O, 45% (v/v) methanol, 10% (v/v) glacial acetic acid
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Tris-buffered saline (TBS): 0.5M NaCl, 0.02M tris, pH 7.5. TBS with added Tween 
20 (usually 0.05%) was termed TBST.
Blocking solution: 5% (w/v) dried skimmed milk in TBS.
Primary antibody solution: 1% (w/v) dried skimmed milk, 0.05% (v/v) Tween 20 in 
TBS, pH 7.5. An amount of antibody was added to give the desired dilution. A 
pinch of thimerosal was added, allowing the solution to be stored at -20°C and 
reused twice.
Secondary antibody solution: As for primary antibody solution, but omitting
thimerosal as this interferes with the ECL detection systems. For this reason 
the secondary antibody solution cannot be reused.
Native loading buffer: 10% glycerol, 0.06M tris, pH 6.8. A few crystals of 
bromphenol blue were added for colour.
ECL Plus Western blotting detection system: (Amersham Pharmacia Biotech U.K. 
Ltd., Little Chalfont, U.K.)
Reagents supplied in kit:
-Solution A: ECL Plus substrate solution with tris buffer 
-Solution B: Stock acridan solution in dioxane and ethanol
Supersignal chemiluminescent substrate for Western blotting: (Pierce & Warriner, 
Cambridge, U.K.)
Reagents supplied in kit:
-Luminol/enhancer solution 
-Stable peroxide buffer
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Supersignal ULTRA chemiluminescent substrate: (Pierce & Warriner)
Reagents supplied in kit:
-Luminol/enhancer solution 
-Stable peroxide buffer
Immunostaining
Paraformaldehyde: Heat 200ml distilled water to 65°C in a fume hood. Add 40g of . 
paraformaldehyde and a few drops o f 1M sodium hydroxide solution until the 
solution becomes clear. Filter the solution and add 200ml of 0.2M phosphate 
buffer. Make up to 1 litre with distilled water and store at 4°C for one week.
0.2M phosphate buffer: For 1 litre, mix 190ml of 0.2M NaH2P0 4  solution and 810ml 
of 0.2M Na2HPC>4 solution.
Phosphate-buffered saline flPBS): 0.01M sodium phosphate (monobasic, anhydrous), 
0.15M sodium chloride, pH 7.5
3.3’ -Diaminobenzidine tetrahvdrochloride (DAB1 staining solution: Dissolve 1 DAB 
tablet (Sigma) in 15mL 50mM Tris (pH 7.6). Add 12pl hydrogen peroxide, 
mix and leave for 10 minutes before use. The solution is prepared in a 
Universal tube covered with tin foil to omit light.
ChemMate Buffer for Antigen Retrieval: (DAKO) Supplied as xlO concentrate.
0.01 M anhydrous citric acid, pH 6.0
Avidin/Biotin Blocking Kit: (Vector Laboratories)
Reagents supplied in kit:
-Avidin D blocking solution 
-Biotin blocking solution
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DAKO Catalysed Signal Amplification fCSA') System. Peroxidase Kit: (Dako Ltd.)
Reagents supplied in kit:
-Hydrogen peroxide: 3% hydrogen peroxide in water 
-Protein block: serum-free protein in PBS with 0.015M sodium azide 
-Link antibody: biotinylated rabbit anti-mouse IgG in Tris-HCl buffer with 
carrier protein and 0.015M sodium azide 
-Streptavidin-biotin complex,.reagent A: streptavidiij in PBS with ajiti- . . . 
microbial agent
-Streptavidin-biotin complex, reagent B: biotin conjugated to horseradish 
peroxidase in PBS with anti-microbial agent 
-Streptavidin-biotin complex, diluent: PBS containing carrier protein and anti­
microbial agent
-Amplification reagent: Biotinyl tyramide and hydrogen peroxide in PBS 
containing carrier protein and an anti-microbial agent 
-Streptavidin-peroxidase: Streptavidin conjugated to horseradish peroxidase in 
PBS containing carrier protein and an anti-microbial agent 
-Substrate tablets, DAB chromogen: Tablets containing lOmg 3,3’- 
diaminobenzidine tetrahydrochloride (DAB)
-Substrate, Tris buffer concentrate: Tris-HCl buffer concentrate 
-Substrate, Hydrogen Peroxide: 0.8% hydrogen peroxide in water
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Fetal Hippocampal Neuron Studies
Coat-A-Count Aldosterone Kit: (Diagnostic Products Ltd.)
Reagents supplied in kit:
-Aldosterone antibdy-coated tubes 
-125I-Aldosterone 
-Aldosterone Calibrators
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